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Dengue virus (DENV) is the most important mosquito-borne viral disease, 
affecting millions of people in tropical and subtropical countries annually. However, 
antiviral drugs and vaccines are still not available in the market yet. This is mainly 
due to the incomplete understanding of the viral and host factors in the pathogenesis 
of DENV. Dengue capsid (C) protein was known to localize in both the cytoplasm 
and nucleus during infection but the significance of nuclear phase for a positive-
stranded RNA virus is still shrouded in mystery. In this study, the underlying 
molecular mechanism of nuclear translocation of DENV C protein and its non-
structural roles in the nucleus is elucidated.  
Two functional bipartite nuclear localization signal (NLS) motifs were 
detected in DENVC protein and site-directed mutagenesis studies confirmed that 
second bipartite NLS2 motif (85-100 amino acids) was the most crucial part for 
nuclear translocation of DENV C protein. The first NLS motif (NLS1) was found to 
enhance the nuclear translocation ability of DENV C protein. The transporting partner 
of DENV C protein was also identified in this study. It was shown that DENVC 
protein interacted with importin-α protein allowing importin-β protein to bring the 
whole complex into the nucleus. Co-immunoprecipitation and mammalian-2-hybrid 
assays corroborated that the main binding site of DENV C protein to the importin-α 
protein was the whole NLS2 motif while NLS1 motif enhanced the binding of DENV 
C protein to importin-α protein. In addition, this transportation process was regulated 
by phosphorylation. Inhibition of the activity of protein kinase C (PKC) retarded the 
nuclear translocation of DENV C protein. Further investigation revealed that amino 
acid residue 71 was the phosphorylation site responsible for nuclear translocation of 





To decipher non-structural roles of DENVC protein in the nucleus, an 
optimized platform was developed to engineer, express and purify biotinylated full-
length DENVC protein for high-throughput screening of novel interacting partners via 
ProtoArray® platform. Thirty-one protein interactors were identified and 50 % of 
them were nuclear proteins. One of the main categories in the list of identified 
interacting partners is related to cell cycle control. Cell cycle analyses demonstrated 
that DENV arrested infected cells at S- and G2- / M-phases during infection. It was 
also shown that virus production was greatly reduced when host cells were arrested at 
G1-phase during infection. Hence, DENV C protein translocated into nucleus and 
interacted with cyclin B3 (CCNB3), GADD45A, and CHES1 proteins to promote cell 
cycle progression from G1- to S-phase and from S- to G2- / M-phase. Another 
identified non-structural role of DENV C protein in the nucleus is to manipulate host 
transcriptional and translational activities. SRP19 protein which is involved in protein 
biogenesis was found to reduce DENV viral RNA replication resulting in lower virus 
production. To counter this effect, DENV C protein translocated into nucleus and 
degraded SRP19 protien via direct interaction. 
In summary, this study deciphered the molecular mechanism of the nuclear 
transportation of DENV C protein and unravelled the non-structural roles of DENV C 
protein in the nucleus. This allowed for better understanding on the ability of 
flavivirus in overcoming the limited genomic information constraint by having 
multifunctional viral proteins. 
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1.  Literature Review 
1.1. Dengue Virus 
Dengue Fever epidemics were first recorded in 1779 in Batavia (Indonesia) 
and Cairo (Egypt) (Gubler, 1998). The disease is caused by an arthropod-borne virus 
or arbovirus called Dengue Virus (DENV), and is transmitted to its human host by 
mosquito vectors. This virus belongs to the family Flaviviridae, genus Flavivirus. In 
Latin, “Flavi” means “Yellow”. This name was derived from one of the greatest 
plagues which occurred hundreds of years ago, namely Yellow Fever. Other members 
of the Flavivirus genus include Yellow Fever virus (YFV), West Nile virus (WNV), 
Japanese Encephalitis virus (JEV), and Tick-Borne Encephalitis virus (TBEV). Figure 
1.1 shows the taxonomy of family Flaviviridae.  
There are four known DENV serotypes designated as DENV-1, DENV-2, 
DENV-3 and DENV-4 which are genetically and antigenically distinct. DENV 
infection encompasses a wide spectrum of severity ranging from a mild febrile illness 
known as Dengue Fever (DF) to a more critical and fatal illness known as Dengue 
Haemorrhagic Fever (DHF) / Dengue Shock Syndrome (DSS). It is one of the most 
medically important arboviral diseases in terms of human morbidity and mortality. 
More than 3.6 billion people are at risk of DENV infection in more than 100 countries 
(Gubler, 2011). There are approximately 390 million Dengue cases reported annually, 
of which 96 million  are DHF / DSS cases (Bhatt et al., 2013). Hence, great 
endeavour has been put together by the government and scientists to fight against this 






Figure 1.1: Taxonomy of family Flaviviridae (Calisher & Gould, 2003; 
Lindenbach et al., 2007; Stapleton et al., 2011). There are three known genara 
(Flavivirus, Pestivirus and Hepacivirus) under the family Flaviviridae. Dengue virus 
is in the Flavivirus genus which contains the most number of viruses. # Pegivirus is 





1.1.1. Epidemiology of dengue virus infection 
The transmission of DENV increased dramatically after World War II and it 
marked the onset of global DENV pandemic (Gubler, 1997). As shown in Figure 1.2, 
almost all the tropical and sub-tropical countries are susceptible to DENV infection to 
date. With increase of epidemic transmission, many countries have evolved from non 
endemic to hypoendemicity (one serotype present) or from hypoendemicity to 
hyperendemicity (multiple serotypes present) as indicated in Figure 1.3 (Gubler, 1998; 
2011). Since epidemic of DHF was first recognized in Manila, Philippines in 1953, 
cases of DHF were also recorded in other Southeast Asia (SEA) countries such as 
Malaysia, Singapore, Myanmar, Thailand, Vietnam and Indonesia (Gubler, 1997). 
Figure 1.4 showed that SEA countries are still among the top 30 most highly dengue 
endemic countries in the world for the past eight years. Other countries such as Brazil, 
Mexico, India, Sri Lanka, and Paraguay are also badly affected. Hence, DENV 
infection indeed poses a major global health issue resulting in significant social and 
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Figure 1.2: The global DENV risk in various countries (Simmons et al., 2012). Tropical and sub-tropical countries are at greater risk of 
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Figure 1.3: Distribution of DENV serotypes in the world between the Year 1970 and 2011 (Gubler, 2011). To date, almost all DENV 
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Figure 1.4: The average number of DENV cases in the 30 most highly endemic countries (WHO, 2012).  Southeast Asia countries are at the 





1.1.2. Mosquito vector of dengue virus 
One of the strategies to prevent DENV infection is to eradicate the vector that 
carries the virus, namely mosquito vector. DENV is predominantly transmitted by 
Aedes mosquitoes such as Aedes aegypti, Aedes albopictus, Aedes polynesiensis, and 
Aedes scutellaris (Holtzclaw, 2002). Generally, A. aegypti is the main vector in urban 
transmission but A. albopictus is shown to be more competent and more susceptible to 
experimental infection (Kramer & Ebel, 2003). A. albopictus is a less selective feeder 
so it becomes less epidemiological significance.  
Aedes aegypti is an efficient vector for DENV transmission. Its eggs could 
remain viable even in dry condition for months. However, they are not able to survive 
in cool temperature. As such, the distribution of A. aegypti is confined to warmer 
latitude and lower altitudes nearest to the equator, explaining the high susceptibility of 
tropical and sub-tropical countries to DENV infection as indicated in Figure 1.2.  
Female mosquito is a nervous feeder. Any disruption like a slight movement 
during the feeding will alert it to fly away. Therefore, it usually feeds on few persons 
for a single blood meal. If the female mosquito feeds on an infected person, the 
DENV would be transmitted to several persons in a short time. This explains why 
A. aegypti can transmit DENV so efficiently. After a person is bitten by an infected 
A. aegypti, the virus needs 3-14 days to incubate before the person experiences the 
acute fever with a variety of nonspecific symptoms (Gubler, 1998). During the febrile 
period, the viruses are circulated in human peripheral blood. If a female mosquito 








1.1.3. Clinical manifestations of dengue virus infection 
DENV infection causes a wide spectrum of severity ranging from an 
asymptomatic, mild febrile illness to more critical and fatal hemorrhagic 
manifestations. The incubation period of DENV is approximately 3 to 15 days with an 
average of 5 to 8 days. World Health Organization (WHO) 1997 classification and 
2009 classification define the criteria for classification of DF, DHF and DSS patients 
and guidance for diagnosis (Table 1.1). 
 
Table 1.1:  Classification and level of severity of dengue infection (WHO, 1997; 
2009) 
WHO 1997 Dengue Classification 
Grade of disease Signs and Symptoms 
I 
Fever with mild non-specific symptoms with a positive 
tourniquet test (inflating a blood pressure cuff midway between 
systolic and diastolic pressure for 5 minutes and then counting 
the number of petechia appears below the cuff). 
II Similar to Grade I but accompanied by spontaneous hemorrhagic manifestation, usually skin or other hemorrhages. 
III 
Circulatory failure manifested by rapid, weak pulse and narrow 
pulse pressure (<20mmHg) or hypotension with the presence of 
cold, clammy skin. 
IV Profound shock with undetectable pulse and blood pressure.  
WHO 2009 Dengue Classification 
Grade of disease Signs and Symptoms 
Dengue ± 
Warning Sign 
Fever with two of the following criteria: nausea, vomiting, rash, 
aches and pains, tourniquet test positive, leukopenia, and any 
warning signs such as abdominal pain or tenderness, persistent 
vomiting, clinical fluid accumulation, mucosal bleed, lethargy or 
restlessness, liver enlargement more than 2 cm, and increase in 
hematocrit concurrent with rapid decrease in platelet count.  
Severe Dengue 
Severe plasma leakage (lead to shock and accumulation of fluid 
with respiratory distress), severe bleeding and severe organ 
involvement (Liver: aspartate aminotransferase or alanine 
aminotransferase ≥ 1000 unit/liter; Central Nervous System: 
impaired consciousness; Heart and other organs)      
 
However, all the symptoms described above are not constant findings in all the 





For example, hepatomegaly is common in Bangkok but gastrointestinal bleeding is 
common in Indonesia (Henchal & Putnak, 1990). Therefore, there is still a dire need 
to investigate and understand the pathogenesis mechanism of DENV infection.  
 
1.2. Dengue Virus Genome and Proteins 
To study the pathogenesis of DENV infection, we must first understand the 
genome of the virus. DENV contains a single-stranded plus-sense RNA that has type-
I 5′-cap of m7GpppA but lacks a 3′-end poly(A) tail (Chambers et al., 1990). Its 
genomic RNA is directly infectious (Ada & Anderson, 1959). It mimics cellular 
mRNA and exploits cellular apparatus to synthesize its proteins during replication. 
The genomic RNA is about 11 kb and has an uninterrupted open reading frame (ORF) 
flanked by non-coding regions at both the 5′ and 3′ ends. The ORFs of DENV-1, 
DENV-2, DENV-3 and DENV-4 are 10188, 10173, 10170 and 10158 nucleotides in 
length, respectively (Chang, 1997).  
DENV genome encodes three structural proteins, namely capsid protein (C), 
precursor membrane protein (prM) and envelope glycoprotein (E), and five non-
structural (NS) proteins, namely NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5, as 
shown in Figure 1.5. 
 
 
Figure 1.5: Schematic representation of polypeptide encoded by flavivirus 
genomic RNA (Chang, 1997). C, prM and E denote capsid protein, precursor 
membrane protein and envelope protein, respectively. NS is non-structural protein 






The currently accepted model of DENV protein synthesis is that the full-
length ORF of DENV genome is translated into a single polyprotein. The polyprotein 
precursor of DENV-1, DENV-2, DENV-3 and DENV-4 are 3396, 3391, 3390 and 
3386 amino acids, respectively (Chang, 1997). The translated polyprotein is then 
cleaved by viral serine protease, host signalase, and other cellular proteases to yield 
individual viral proteins (Perera & Kuhn, 2008). Figure 1.6 shows the localization of 
each viral protein in the cytoplasm, endoplasmic reticular lumen and space between 
membranes. 
 
Figure 1.6: Schematic diagram of single polyprotein synthesized in the 
endoplasmic reticulum (ER) (Chang, 1997). This single polypeptide is cleaved by 
viral protease, host signalase and other cellular proteases to release single viral 
proteins. 
 
The first structural protein encoded at the 5′ end of flavivirus genome is capsid 
(C) protein which is the main focus of this study. The properties and functions of C 
protein will be discussed in more details in Section 1.4. The next encoded structural 
protein is pre-membrane (prM) protein. It is a glycoprotein that is synthesized as a 
precursor and will undergo proteolytic cleavage when the virus matures and exits 
from the host cell. It is suggested that prM protein helps to protect the envelope (E) 
protein, the third encoded structural protein, from misfolding or conformational 
change prior to maturation (Chambers et al., 1990; Chang, 1997). The E protein is the 
major virion surface glycoprotein involved in a number of biological activities such as 





neutralizing antibodies and virus assembly (Chambers et al., 1990; Heinz & Allison, 
2000; Modis et al., 2004; Roehrig, 1997). It consists of three structural domains, 
Domain I, II, and III. Domain III (DIII) is located at the C-terminus of E protein and it 
is deemed to be the receptor binding domain (Kuhn et al., 2002). 
Non-structural 1 (NS1) protein is another glycoprotein that is synthesized in 
rough endoplasmic reticulum before it is transported to Golgi for glycosylation 
(Chang, 1997). This protein is an important pathogenic factor that has been used as a 
diagnostic marker for DENV infection (Alcon et al., 2002). Non-structural 3 (NS3) 
protein is a hydrophilic protein that functions as serine protease and helicase (Li et al., 
1999) while non-structural 5 (NS5) protein is an RNA-dependent RNA polymerase 
(Khromykh et al., 1998). Non-structural 2B (NS2B) protein together with NS3 protein 
acts as an important protease to cleave the single polyprotein at the C/anchor C, 
NS2A/NS2B, NS2B/3, NS3/NS4A, and NS4B/5 junctions to generate individual viral 
proteins (Falgout et al., 1991). The functions of non-structural 2A (NS2A), non-
structural 4A (NS4A), and non-structural 4B (NS4B) proteins are still unclear. Table 
1.2 summarizes the known functions of each non-structural (NS) proteins. 
 
Table 1.2: Properties and functions of non-structural (NS) proteins 
Protein Properties & Functions References 
NS1  42 kDa glycoprotein 
 Exists in three forms: cytosolic, membrane-
associated, secreted 
 Antigen and antibody against NS1 can be found 
in the patients’ sera 
 Closely associated with viral double-stranded 
RNA in the replication complex 
 Involved in complement pathway 
(Alcon et al., 2002; 
Avirutnan et al., 
2010; Mackenzie et 
al., 1996; 
Noisakran et al., 
2007) 
NS2A  23 kDa hydrophobic protein 
 Co-localizes with viral double-stranded RNA 
 Important for virus packaging 
 Involved in interferon-α/β innate immune 
signalling 
(Jones et al., 2005; 
Liu et al., 2003; 
Mackenzie et al., 
1998) 
NS2B  14 kDa hydrophobic protein 
 Co-factor for NS3 serine protease 
(Chang et al., 





Protein Properties & Functions References 
 NS2B/NS3 complex is involved in type I 
interferon-α/β signalling 
 May involve in membrane permeability  
al., 1991; 
Rodriguez-Madoz 
et al., 2010) 
NS3  70 kDa hydrophilic protein 
 Serine protease activity 
 RNA helicase activity 
 RNA-stimulated nucleoside triphosphatase 
(NTPase) activity 
 RNA triphosphatase (RTPase) activity 
 NS2B/NS3 complex is involved in type I 
interferon-α/β signalling 
(Amberg & Rice, 
1999b; Benarroch 
et al., 2004; Li et 
al., 1999; 
Rodriguez-Madoz 
et al., 2010; 
Wengler & 
Wengler, 1993) 
NS4A  16 kDa hydrophobic protein 
 Involved in membrane modification 
 Involved in interferon-α/β signalling 
 Co-localizes with replication complex 
(Jones et al., 2005; 
Mackenzie et al., 
1998; Miller et al., 
2007) 
NS4B  27 kDa hydrophobic protein 
 Mediates the dissociation of NS3 protein from 
single-stranded viral RNA 
 Stimulates helicase activity of NS3 protein 
 Involved in interferon-α/β signalling 
(Jones et al., 2005; 
Umareddy et al., 
2006) 
NS5  104 kDa hydrophilic protein 
 RNA-dependent RNA polymerase 
 Methyl-transferase activity 
 Involved in STAT2 and interferon-α/β signalling  
(Khromykh et al., 
1998; Mazzon et 
al., 2009; Ray et 
al., 2006) 
 
1.3. Replication Cycle of Dengue Virus 
Understanding the life cycle of DENV is of paramount importance in the 
development of anti-viral strategies. Nonetheless, many gaps still remain in the 
knowledge of establishment of DENV infection in various cell types. The 
susceptibility of various cell types to DENV infection is different.  Monocytes and 
macrophages are recognized as the primary target cells for DENV (Kou et al., 2008). 
However, DENV antigens and RNA can also be detected in the hepatocytes of 
infected patient’s liver (Couvelard et al., 1999; Kangwanpong et al., 1995; 
Suksanpaisan et al., 2007).  
Despite the different infectivity of DENV in various cell types, the basic 
replication cycle of flavivirus is illustrated in Figure 1.7. Flavivirus binds to target 





a low-affinity co-receptor. Several primary receptors and co-receptors for flavivirus 
have been identified such as C-type lectin dendritic cell-specific ICAM (intercellular 
adhesion molecule) grabbing non-integrin (DC-SIGN), alpha V beta 3 (αvβ3) integrin, 
glucose-regulating protein78 (GRP18/BiP), CD14-associated molecules, Fc gamma 
receptor (FcγR), Ras-related protein 5 (Rab5), heat shock protein 70 (HSP70), Natural 
killer-activating receptor (NKp44), glycosaminoglycan and heparin sulphate 
(Cabrera-Hernandez et al., 2007; Chen et al., 1997; Chen et al., 1999; Chu & Ng, 
2004b; Hershkovitz et al., 2009; Hilgard & Stockert, 2000; Jindadamrongwech et al., 
2004; Krishnan et al., 2007; Lee & Lobigs, 2000; Navarro-Sanchez et al., 2003; 
Tassaneetrithep et al., 2003). It is still controversial which receptor(s) is/are the main 
attachment molecule(s) for flavivirus. It is possible that different combination of 
primary receptor and co-receptor is required for different flaviviruses. Besides, one of 
the reasons for different susceptibility of DENV infection on various cell types could 
be due to the types of receptor(s) present and their prevalence on the cell surface.  
 Upon binding of E protein with cell surface receptor, the virion is internalized 
into host cells via clathrin-mediated endocytosis (Acosta et al., 2008; Chu & Ng, 
2004a). The acidic environment of the endosome triggers conformational change of E 
proteins from homodimers into homotrimers resulting in exposure of E protein fusion 
peptide which facilitates viral membrane-endosome fusion (Bressanelli et al., 2004; 
Heinz & Allison, 2000; Mukhopadhyay et al., 2005). After membrane fusion, the 
nucleocapsid is released into the cytosol and disassociates spontaneously into C 
proteins and viral genome (Heinz & Allison, 2000). The dissociation of WNV 
nucleocapsid upon the release from endocytic vesicles has been documented by Chu 
and Ng (2004a). However, the contributing factor for this spontaneous dissociation is 





between the viral membrane and the hydrophobic regions of C proteins resulting in 
morphological instability of C protein homo-oligomer. Besides, there is also no 
publication thus far reporting the fate of the dissociated C proteins. These virus-
originated C proteins could be degraded by the host cell or they may have significant 
roles in the establishment of infection. 
 
 
Figure 1.7: Schematic diagram depicting the replication cycle of flavivirus 
(Lindenbach et al., 2007; Mukhopadhyay et al., 2005). Virus binds to the host cell 
surface receptor and enters the cell via endocytosis pathway. Nucleocapsid is released 
to the cytosol after low-pH membrane fusion of viral membrane and endosome. 
Nucleocapsid dissociates and viral genome is free for translation into a single 
polyprotein at the endoplasmic reticulum (ER). Viral RNA replication occurs on the 
ER membrane and buds into ER lumen during assembly. The immature virus is 
transported to the Trans-Golgi network (TGN) for further post-translational 
modification. After cleavage by host protease furin, mature virus egresses from the 






The released viral genome is translated by host cell machinery at the ER into a 
single polyprotein. Together with host proteases, NS2B-NS3 protein cleaves the 
polyprotein into individual viral components. After cleavage, C protein remains 
anchored on the cytoplasmic side of ER while prM and E proteins are on the luminal 
side. Non-structural 1 (NS1) protein is released into the ER lumen and continues 
further post-translational modification. Non-structural 5 (NS5) protein with RNA-
dependent RNA polymerase activity binds to positive-stranded viral genome and 
synthesizes the minus-strand RNA, forming the double-stranded RNA replicative 
form (RF). This RF then serves as template for new RNA synthesis in a replication 
complex composed of NS3-NS5 proteins, host proteins and other NS proteins (Uchil 
& Satchidanandam, 2003; Westaway et al., 1997b). During flavivirus replication, 
extensive membrane rearrangement forming membranous structures such as vesicle 
pockets, convoluted membranes, and paracrystalline arrays are observed (Ng, 1987; 
Welsch et al., 2009). It is believed that this extensive virus-induced membranous 
structure at the perinuclear region facilitates efficient synthesis, processing and 
assembly of virus particles (Mackenzie & Westaway, 2001; Ng, 1987).  
During maturation, C proteins oligomerize, bind to viral genome and assemble 
into nucleocapsids in the cytoplasm (Khromykh & Westaway, 1996; Ma et al., 2004). 
Physical nucleocapsid particles of WNV were first visualized accumulating in the 
infected Vero cells at 8 hr post-infection using cryo-immunoelectron microscope (Ng 
et al., 2001). However, the exact mechanism of encapsidation and nucleocapsid 
formation is still unclear. It is still shrouded in mystery whether C protein-RNA 
binding, homo-oligomerization of C protein, and nucleocapsid formation are well-





From the cytoplasm, nucleocapsid buds into ER lumen and is then surrounded 
by a 10 nm-thick host cell-derived lipid bilayer membrane anchored with 180 prM 
and E proteins each (Zhang et al., 2003). This immature form of virion is transported 
via kinesin along microtubules towards plasma membrane via Trans-Golgi network 
(TGN) where host protease furin cleaves prM protein to produce mature virion 
(Chambers et al., 1990; Chu & Ng, 2002; Stadler et al., 1997). The mature viruses 
egress from the cells via exocytosis with the help of actin filaments (Chu et al., 2003; 
Ng et al., 1994).  
 
1.4. Dengue Virus Capsid Protein 
DENV capsid (C) protein is the focus of this project. This protein is the first 
structural protein found in the ORF of flaviviral genome. The C-terminal hydrophobic 
signal sequence of full-length C protein is cleaved by its NS2B-NS3 proteins at the 
anchC/prM cleavage site to generate mature DENV C protein (Amberg & Rice, 1999a; 
Markoff, 1989). However, the binding of NS2B-NS3 protein with C protein and how 
it cleaves polyprotein at anchC/prM site is unclear.  
Capsid (C) protein has a molecular weight of about 12 kDa and it is a highly 
basic protein containing about 25 % of lysine and arginine residues (Henchal & 
Putnak, 1990). The high basic-residue content confers its RNA binding property to 
neutralize the negatively-charged viral RNA (Lindenbach et al., 2007). It is believed 
that C protein interacts with the 3′ end of the viral RNA to prevent recognition by 
RNA polymerase whereas 5′ end is still able to bind to ribosome to start translation 
continuously (Westaway, 1987). Capsid (C) proteins encapsidate its viral RNA and 





approximately 30 nm in diameter which can be seen as a dense particle under electron 
microscope (Hase et al., 1987).   
The sequence homology of C proteins among other flaviviruses is poorly 
conserved. As shown in Figure 1.8, only eleven amino acids are conserved among the 
nine mosquito-borne flaviviral C proteins. According to the sequence distance 
analysis using ClustalV method (Higgins et al., 1992; Higgins & Sharp, 1989) in the 
MegAlign, DNASTAR Lasergene 7.2 software, the sequence similarity among the 
nine flaviviral C proteins is mostly lower than 50 % and the sequence divergence is 
more than 100 % (Figure 1.9). The C proteins of all DENV serotypes share 
approximately 55-80 % amino acid sequence identity but diverge greatly (120-200 %) 
from other flaviviruses. The C proteins of JEV, MVEV (Murray Valley encephalitis 
virus), UV (Usutu virus) and WNV shares about 60 % amino sequence identity, 
implicating that they are more closely related to each other as compared to DENV. 
Nonetheless, the flaviviruses C protein is structurally and functionally similar 







Figure 1.8: Multiple sequence alignment of mosquito-borne flaviviral C protein sequences. ClustalW method in MegAlign, DNASTAR 
Lasergene 7.2 software is used to perform multiple sequence alignment. Sequences with the highest consensus strength among the nine 
flavivirus C proteins are highlighted. (DENV1-4 – Dengue virus serotype 1-4; JEV – Japanese Encephalitis virus; MVEV – Murray Valley 
encephalitis virus; UV – Usutu virus; WNV – West Nile virus; YFV – Yellow Fever virus; Accession number of the protein sequence is shown 






Figure 1.9: Sequence distances analysis of flaviviral C proteins. Sequence 
distances analysis using ClustalV method shows that the protein sequence similarities 
among the nine flavivirus C proteins are mostly lower than 50 % and the sequence 
divergence is more than 100 %. The percent identity refers to the percentage of 
sequence similarity between two sequences whereas the divergence percentage is 
obtained by comparing two sequences in relation to their relative positions in the 
phylogenetic tree. (DENV1-4 – Dengue virus serotype 1-4; JEV – Japanese 
Encephalitis virus; MVEV – Murray Valley encephalitis virus; UV – Usutu virus; 
WNV – West Nile virus; YFV – Yellow Fever virus; Accession number of the protein 
sequence is shown in the bracket.) 
 
1.4.1. Structure of dengue virus capsid protein 
Although the structure for the whole nucleocapsid is not documented yet, 
nuclear magnetic resonance structural studies revealed that C protein is a dimeric 
alpha-helical protein (Jones et al., 2003). As illustrated in Figure 1.10(A), the 
monomer of DENV C protein contains four α helices (α1-4) with an internal 
hydrophobic domain flanked by positively-charged residues. First helix (α1) includes 
amino acids from 26 to 31; second helix (α2) from amino acids 45 to 55; third helix 
(α3) from amino acids 63 to 69 whereas fourth helix (α4) is the longest helix from 
amino acids 74 to 96. Regions between helices are composed of short loops. The 
internal hydrophobic domain encompasses second and third helices (α2 & α3). 
Unfortunately, the N-terminus of C protein from amino acids 1 to 21 cannot be 





According to the structure of DENV C protein, the second and fourth helices 
(α2 & α4) form most of the dimer contact surfaces [Figure 1.10(B)]. This dimer is 
stabilized by the extensive hydrophobic interactions on both the helices (α2 & α4) 
while major fraction of the hydrophilic regions are buried after dimerization. A 
conserved residue, W69, positions at the dimer interface is deemed to stabilize the 
dimeric α-helical structure. Bhuvanakantham and Ng (2005) also reported that 
internal hydrophobic segment between amino acid positions 26 and 69 is essential for 
the C-C homodimerization in WNV.  
Crystal structure of WNV C protein revealed that C protein dimers organize 
into tetramers as shown in Figure 1.10(C) (Dokland et al., 2004). Dokland and his 
colleagues (2004) suggested that C protein tetramers form the building blocks for 
nucleocapsid assembly as this structure shielded most of the hydrophobic regions, 






Figure 1.10: Structure of flaviviral C protein (Dokland et al., 2004; Ma et al., 
2004).  (A) Monomer of C protein contains four α-helices (α1, α2, α3 and α4) as 
indicated in four different colours. The C protein monomer shown only includes 
amino acid 21st to 100th. (B) Dimer of C protein is formed via the hydrophobic 
regions between second and forth helices (α2 - α′2 and α4 - α′4) stabilized residues 
W69. (C) Tetramer of C protein is formed by two dimers at the longest helix, α4. The 
images are reproduced by Jmol (http://www.jmol.org/) using RCSB (Research 






1.4.2. Structural functions of capsid protein 
The main function of C protein is to encapsidate viral genomic RNA and form 
nucleocapsid during viral assembly. The RNA binding property of C protein was first 
reported for Kunjin strain of WNV (Khromykh & Westaway, 1996). They found that 
the positively-charged N-terminus and C-terminus of C protein were the RNA binding 
sites. This is further supported by Ma and colleagues’ (2004) proposed model as 
shown in Figure 1.11. The hydrophilic surface formed by the fourth helices of the C 
protein dimer (α4 and α′4) interacts with viral RNA whereas the conserved 
hydrophobic cleft formed by the first and second helices (α1-α′1 and α2-α′2) interacts 
with viral membrane. 
 
Figure 1.11: Proposed model of C protein interaction with viral RNA and 
nucleocapsid assembly. C protein dimer is shown in red and blue. The positively-
charge surface formed by helices α4 - α′4 faces the negatively-charged viral RNA 
while the hydrophobic regions of C protein dimer face the lipid bilayer membrane. 






Ivanyi-Nagy and colleagues (2008) demonstrated that C protein acted as RNA 
chaperone assisting in the proper folding of RNA by inducing RNA structural 
rearrangements via interaction with the N-terminal C protein. On the other hand, 
Zlotnick (2003) suggested that binding of RNA to C protein would elevate local C 
protein concentration and orientate C protein for proper dimerization. Hence, the 
interaction between C protein and RNA is essential for both components. This could 
be an evolution of symbiotic relationship between two viral components in flavivirus.  
According to Sindbis virus nucleocapsid assembly model, viral RNA contains 
an encapsidation signal facilitating RNA-C protein interaction which results in 
dimerization of C protein (Geigenmuller-Gnirke et al., 1993). Such encapsidation 
signal was also found in the viral RNA of Hantaan virus and coronavirus (Cologna et 
al., 2000; Severson et al., 2001). These encapsidation signals are complex secondary 
conformations such as stem loops and bulges (Khromykh & Westaway, 1996). 
Nevertheless, how exactly flaviviral RNA binds to C protein and induces 
nucleocapsid assembly is still elusive. 
 
1.5. Non-Structural Roles of Capsid Protein in the Cytoplasm  
It is widely accepted that flaviviral C protein is a multifunctional protein. It is 
not surprising since it will be beneficial for the virus to encode multifunctional 
proteins with its limited genomic content. Patkar and colleagues (2007) showed that C 
protein has a great functional flexibility although all the roles of C protein are not 
fully discovered yet. Studies are still on-going to uncover the non-structural roles of 
this multifunctional protein. 
Recently, it was discovered that WNV and DENV C protein interact with 





effect caused by hSec3p (Bhuvanakantham et al., 2010b). Human Sec3p is an exocyst 
component involved in the secretory pathways and exocytosis process. It was found 
that hSec3p affected flaviviral RNA transcription and translation via the sequestration 
of elongation factor 1 alpha (EF1α). Flaviviral C protein was able to antagonize this 
host-antiviral effect via direct binding to hSec3p and caused degradation of hSec3p, 
thereby releasing EF1α for viral RNA and protein synthesis. 
 
1.6. Nuclear Phase of Capsid (C) Protein 
Although positive-strand RNA viruses could exploit host cellular components 
to replicate in the cytoplasm, C proteins can also be visualized in the nucleus during 
replication (Tadano et al., 1989; Yasui et al., 1998). This observation implies that C 
protein might have potential non-structural roles in the nucleus. For other viruses such 
as HCV, C proteins were shown to localize in the nucleus / nucleolus of hepatocytes 
via immunoelectron microscopic study (Falcon et al., 2003). Moreover, other non-
structural proteins such as DENV NS5 (Kapoor et al., 1995), Kunjin virus NS4B 
(Westaway et al., 1997a), Semliki Forest virus nsP2 (Peranen et al., 1990) and HCV 
NS3 (Muramatsu et al., 1997) have been reported to localize in the nucleus / 
nucleolus of infected cells too.  
 
1.6.1. Roles of nuclear localization signal 
At least one putative nuclear localization signal (NLS) motif has been detected 
within all flaviviral C protein sequences but full characterization was not done (Chang, 
1997). Nuclear localization signal was first discovered in Simian Vacuolating Virus 
40 (SV40) Large Tumor Antigen (T-antigen). It is basically a stretch of protein 





types of classical NLS – monopartite NLS, namely one short region of about four to 
five basic residues, and bipartite NLS which consists of two regions of basic residues 
separated by 10 to 12 random residues (Dingwall & Laskey, 1991).  
Wang and co-workers (2002) discovered that a bipartite NLS motif, located at 
amino acids 85 to 100, was responsible for nuclear localization of DENV C protein. 
However, Mori and colleagues (2005) claimed that substitutions of Gly42 and Pro43 to 
alanine could also completely abolish the nuclear localization of DEVN C protein. 
This result contradicted with Wang and colleagues (2002) in which deletion of the 
first 45 amino acids at the N-terminus was reported to have no effects on the nuclear 
localization of DENV C protein. Another study using DENV infectious clones 
revealed that double alanine-substitutions mutation of residues (Lys73 and Lys74) and 
(Arg85 and Arg86) completely eliminate nuclear translocation ability of C protein 
while mutations on residues (Lys6 and Lys7) and (Arg97 and Arg98) reduced nuclear 
localization of C protein (Sangiambut et al., 2008). Hence, residues (Lys6 and Lys7) 
which are within the first 45 amino acids from the N-terminal C protein did play a 
role in the nuclear localization of C protein. 
Other than the classical NLS, Suzuki and co-workers (2005) showed that HCV 
C protein contains non-classical NLS whereby at least two out of three basic-residue 
clusters are required for efficient nuclear localization. Although Sangiambut and his 
colleagues (2008) demonstrated that nuclear localization ability of C protein did not 
correlate with viral growth properties, Bhuvanakantham and co-workers (2009) 
showed that deletion of NLS from WNV C protein completely inhibited virus 
production. Thus, NLS indeed plays an essential role in nuclear localization of 






1.6.2. Roles of importin-α/β proteins and phosphorylation 
It is widely accepted that NLS is important for nuclear protein import through 
the help of importin-α/β proteins (Friedrich et al., 2006; Reguly & Wrana, 2003; Weis, 
1998; Whittaker & Helenius, 1998). Karyopherins, including both importins and 
exportins, are responsible for majority of the nucleo-cytoplasmic trafficking in the cell. 
Importin-α protein binds to NLS-bearing protein and functions as an adapter to bind 
to importin-β protein. Importin-β protein docks the whole complex at the nuclear pore 
complex (NPC) and facilitates its translocation into the nucleus. Nuclear import of 
NLS-bearing proteins is an energy-dependent process (Gorlich & Mattaj, 1996).  
It was shown that DENV NS5 protein contains two functional NLS motifs at 
the central region which were recognized by importin-α/β proteins (Brooks et al., 
2002; Pryor et al., 2007). The NLS motifs of HCV C protein were shown to bind to 
importin-α protein (Suzuki et al., 2005). Bhuvanakantham and colleagues (2009) also 
showed that there was a direct binding between WNV C protein and importin-α 
protein using mammalian 2-hybrid (M2H) assay. The binding efficiency of C protein 
to importin-α protein would affect nuclear translocation of C protein. 
In addition, it was reported that phosphorylation also played an important role 
in the importins-mediated transportation of nuclear proteins. Phosphorylation was 
shown to enhance transportation of nuclear protein but the phosphorylated residues 
were not involved in the binding of importin-α protein (Fontes et al., 2000). The C 
protein of HCV was also demonstrated to be phosphorylated. Mutation analyses 
showed that phosphorylation of HCV C protein at residue Ser 53 and Ser 116 was 
important to regulate nuclear localization of C protein (Lu & Ou, 2002). 
Bhuvanakantham and colleagues (2010a) also reported that nuclear localization of 





the virus replication.  Other than nuclear localization, phosphorylation was also 
required to regulate nucleocapsid assembly by affecting the binding of C protein to 
the viral genomic RNA (Cheong & Ng, 2011; Law et al., 2003). Hence, it will be 
interesting to investigate the role of phosphorylation and importins in transporting 
DENV C protein into nucleus. 
 
1.6.3. Possible non-structural roles of capsid (C) protein in the nucleus 
To date, the significance of nuclear localization of C proteins still remains a 
mystery. Several studies have demonstrated that positive-stranded RNA viruses 
disrupt nucleo-cytoplasmic trafficking by inhibiting nuclear import of some nuclear 
proteins during virus infection (Gustin & Sarnow, 2006; Hiscox, 2003). It is believed 
that this redistribution of nuclear protein into cytoplasm is to inhibit antiviral response. 
However, viral protein that is responsible for this nucleo-cytoplasmic disruption has 
not been found yet and the exact role of nuclear protein redistribution is unclear.  
Since Bhuvanakantham and colleagues (2009) reported that nuclear localization of 
WNV C protein was essential for the virus replication, it is important to unravel the 
non-structural roles of C protein in the nucleus for better understanding of the 








Dengue virus (DENV) is a positive-stranded RNA virus. Based on the current 
understanding of flaviviral replication cycle, host cell nucleus is not involved during 
the transcription, translation and assembly of virus. This traditional notion is 
challenged when capsid (C) protein is found to localize in the infected cell nucleus. 
Since then, the role of DENV C protein in the nucleus has been an intriguing mystery 
for researchers to unveil. Understanding the roles of C protein in the nucleus will not 
only completes the missing puzzle of flaviviral replication cycle, but also provides 
insights for novel anti-viral strategies development. This study aims to decipher the 
nuclear transportation mechanism of C protein and to discover novel non-structural 
roles of C protein in the nucleus.  
 The specific objectives of this study are as follows: 
1. Determine the functional role of nuclear localization signal motif of 
DENV C protein 
2. Identify the transporting partners of DENV C protein during nuclear 
translocation 
3. Express and purify full-length DENV C protein for ProtoArray® screening 
4. Perform high-throughput screening for novel interacting partners of 
DENV C protein via ProtoArray® technology-based platform 
5. Validate and examine the roles of the identified interacting partners of 
DENV C protein in the nucleus 




2.  Materials and Methods 
2.1. Cell Culture Techniques 
All cell culture and media preparation works were performed in a Class II 
Type A2 Biosafety Cabinet (ESCO, Singapore) and cells were kept in a humidified 
37 oC incubator (Thermo Fischer Scientific, USA) supplied with 5 % carbon dioxide. 
 
2.1.1. Cell lines 
Five cell lines were used in this project, namely Baby Hamster Kidney 
(BHK)-21 cells, mosquito C6/36 cells, Human Embryonic Kidney (HEK)-293 cells, 
293FT cells and HeLa cells. Table 2.1 shows the origin, usage and the types of media 
used for each cell line. All media are supplemented with 10 % fetal calf serum [(FCS) 
(PAA Laboratories GmbH, Austria)]. 
   
Table 2.1: Cell lines and media used in this project 
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2.1.2. Propagation of cell lines 
Confluent flasks of the cell lines were sub-cultured into a new T-75 flask at a 
ratio of 1:3 for C6/36 cells or 1:10 for BHK-21, HEK293, 293FT and HeLa cells. Old 
growth medium [BHK-21 cells – RPMI growth medium (Appendix 1a); C6/36 cell – 
L-15 growth medium (Appendix 1b); HEK293 and HeLa cells – DMEM growth 
medium (Appendix 1c); 293FT cells – DMEM 293FT growth media (Appendix 1d)] 
was discarded and the cell monolayer was rinsed with 5 ml of phosphate-buffered 
saline [(PBS) (Appendix 1e)]. Two ml of trypsin (Appendix 1f) was added and the 
cell monolayer was incubated at 37 oC for 2 to 5 min to detach the cells. Cells were 
then dislodged by gentle tapping the flask. Eight ml of fresh growth medium 
(Appendices 1a – 1d) was added to the flasks to deactivate the enzymatic activities 
and the trypsinized cells were resuspended by pipetting up and down for a few times. 
Resuspended cells were aliquoted appropriately according to the required ratio and 
the final volume was topped up to 12 ml with respective fresh growth medium 
(Appendices 1a – 1d). C6/36 cells were grown at 28 oC while all other cell types were 
cultured at 37 oC.  
 
2.1.3. Cultivation of cells in 24-well and 6-well tissue culture plates 
Confluent monolayer of mammalian cells in a T-75 flask was used to seed on 
24-well or 6-well tissue culture plates (Greiner Bio-One, St. Loius, USA). The 
monolayer cells were treated as previously described in Section 2.1.2 to obtain single-
cell suspension. The number of viable cells in the suspension was determined using 
haemocytometer. Approximately 2 x 105 cells or 1 x 106 cells were pipetted into each 
well of the 24-well or 6-well plate, respectively. The plates were placed in a tray and 




incubated at 37 oC in a humidified incubator with 5 % carbon dioxide. The cells were 
ready for use when they were about 80-90 % confluent.   
 
2.1.4. Cultivation of cells on coverslips in 24-well tissue culture plates 
Sterile coverslips (Marienfeld, Germany) were placed into the wells of a 24-
well tissue culture plate using a sterile forceps. Coating of coverslip with poly-D-
lysine was required for HEK293 cells. Single-cell suspension was prepared according 
to Section 2.1.2 and the number of viable cells was determined via haemocytometer. 
Approximately 2 x 105 cells were seeded onto one coverslip and the whole plate was 
incubated at 37 oC until they reached about 80-90 % confluency.  
 
2.2. Virus Works 
All virus works were performed in a Class II Type A2 Biosafety Cabinet 
(ESCO, Singapore) located in a dedicated virus culture room. Dengue virus (DENV) 
serotypes 1-4 were Singapore strains which were kind gifts from the Environmental 
Health Institute of Singapore (EHI). West Nile virus (WNV) was Sarafend strain, a 
generous gift from late Emeritus Professor Edwin George Westaway from Australia. 
Both DENV and WNV were propagated in C6/36 mosquito cell lines. 
 
2.2.1. Preparation of virus stock 
Monolayers of C6/36 cells with 90 % confluency were grown in T-75 flask 
prior to DENV or WNV infection. Old L-15 growth medium (Appendix 1b) was 
discarded and the cell monolayer was washed with virus diluent (Appendix 2a). 
One ml of virus suspension was added onto the cell monolayer and incubated at 37 oC 
for 1 hr with rocking at 15 min interval to ensure even infection. After 1 hr incubation, 




15 ml of L-15 growth medium (Appendix 1b) supplemented with 2 % foetal calf 
serum (FCS) was added into the flask and incubated at 28 oC. WNV and DENV were 
harvested on Day 3 and Day 4 post-infection (p.i.), respectively. Syncytial was 
observed in DENV-2 infection on C6/36 cells. At the time of harvesting, the 
supernatant was adjusted to pH of 7.2 and aliquoted into sterile cryovials. All the 
cryovials were snap-freezed in cold ethanol and kept at -80 oC until further used. 
 
2.2.2. Plaque assay 
Monolayers of BHK cells were grown in 24-well plate until 80 % or 90 % 
confluency for DENV or WNV, respectively. Virus stock was thawed and 10-fold 
serial dilutions of the virus were made using virus diluent. Growth media in the plates 
were discarded and washed with virus diluent. One hundred μl of the diluted virus 
were added into triplicate wells and incubated at 37 oC for 1 hr with rocking at 15 min 
intervals. Virus diluent was used in control wells. After 1 hr absorption, excess 
viruses were removed and 1 ml of overlay medium (Appendix 2b) was added into 
each well. The plates were incubated at 37 oC for 3 (WNV) or 5 (DENV) days before 
they were stained with crystal violet (Appendix 2c) for at least 3 hr at room 
temperature. The plates were then washed thoroughly with water and dried before 
counting the plaques. 
 
2.2.3. Infection of cell monolayer for virus study 
Appropriate amount of BHK cells, HEK293 cells, 293FT cells or HeLa cells 
were seeded into T-25 flask according to Section 2.1.2. When the cells were ready for 
infection, cell culture supernatant was discarded and the monolayer was rinsed with 3 
ml virus diluent (Appendix 2a). Five hundred µl of virus suspension was used to 




infect the cell monolayer at multiplicity of infection (M.O.I.) of one. For mock-
infected cells, 500 µl of virus diluent was used. During the incubation at 37 oC, flasks 
were rocked at every 15 min to ensure even infection. After 1 hr incubation, 
remaining viruses were removed and washed with PBS before topping up with 5 ml of 
growth media supplemented with 2 % FCS. The infected cells were incubated at 
37 oC until the appropriate harvesting time. 
 
2.3. Molecular Techniques 
2.3.1. Construction of green fluorescent protein (GFP)-tagged Dengue virus 
(DENV)-2 capsid (C) protein and nuclear localization signal (NLS) motif 
plasmids 
DENV-2 (accession number: M29095) RNA was extracted using QIAmp® 
Viral RNA Mini kit (Qiagen, Germany) and the first strand cDNA was synthesized 
using SuperScriptTM III reverse transcriptase (Life Technologies, USA). The 
DENV-2 capsid (C) protein cDNA coding sequence (nucleotide 100-438) was then 
amplified using Advantage 2 polymerase mix (Clontech, USA). The DNA sequences 
of primers used, DENV2C (F) and DENV2C (R), are listed in Table 2.2. The PCR 
cycling profile was 2 min of initial denaturing step at 94 oC followed by 29 cycles of 
denaturation at 94 oC for 1 min, annealing at 55 oC for 30 sec and extension at 72 oC 
for 1 min. After 29 cycles, a final extension step was carried out at 72 oC for 7 min.  
The PCR products were separated using 2 % agarose gel (Appendix 3a) in 
Tris/Acetate/EDTA (TAE) buffer (Appendix 3b) and purified using QIAquick® gel 
extraction kit (Qiagen, Germany) according to the manufacturer’s protocol. The 
purified PCR products were then ligated with GFP Fusion TOPO vector (Life 
Technologies, USA) and the ligated product was incubated with TOP10 competent 




cells (Life Technologies, USA) on ice for 30 min. The plasmid map of GFP Fusion 
TOPO vector is shown in Figure 2.1. The expression of DENV C protein in 
mammalian cells is under the control of human cytomegalovirus (CMV) promoter. 
The cells were heat shocked at 42 oC for 45 sec and incubated on ice immediately for 
2 min. Super optimal broth with catabolic repressor (SOC) medium (Life 
Technologies, USA) was added to the competent cells and incubated at 37 oC shaker 
for 1 hr. Recovered competent cells were spread on Luria-Bertani (LB) agar plate 
(Appendix 3c) containing ampicillin antibiotic and incubated overnight at 30 oC 
incubator. Colony PCR was carried out to identify positive clones. Positive clones 
were incubated overnight in 2 ml of LB broth (Appendix 3d) containing ampicillin 
and the plasmid DNA were isolated using QIAprep Spin Miniprep kit (Qiagen, 
Germany).  
 
Figure 2.1: Plasmid map of GFP-tagged DENV C gene. DENV C gene is inserted 
into pcDNA3.1/CT-GFP-TOPO vector via TA cloning. The 3′ -A overhang on the C 
gene is ligated with the 3′ -T overhang on the linearized plasmid vector. Green 
fluorescent protein (GFP) is fused to the C protein at the C-terminus. The expression 
of this protein construct in mammalian cells is under the control of human 
cytomegalovirus (CMV) promoter. Bacteria transformed with this plasmid can be 
cultured in LB broth containing ampicillin antibiotic.  
 




Nuclear localization signal (NLS) motifs of DENV C proteins were also 
cloned into GFP Fusion TOPO vector via the same protocol using the constructed 
DENV-2 C plasmid as template. The sequences of DENV2NLS primers are shown in 
Table 2.2. Since the PCR products for NLS motifs only contain approximately 60 
nucleotides, the PCR products were used directly for ligation with the pcDNA3.1/CT-
GFP-TOPO vector. To visualize the molecular size of the NLS motif PCR products, 
8 % non-denaturing polyacrylamide gel (Appendix 3e) and Tris/Borate/EDTA (TBE) 
buffer (Appendix 3f) were used. Positive clones were sent for DNA sequencing to 
confirm the orientation of the insert and to check for mutation. 
 
Table 2.2: Primers used for generation of GFP-tagged DENV C protein and NLS 
motifs. Kozak sequences (translational start site) are underlined. DENV2 denotes 
Dengue virus serotype-2 while C and NLS denote capsid and putative bipartite 
nuclear localization signal, respectively. The numbers behind NLS refer to the amino 
acid positions in the C protein. F denotes forward primer while R denotes reverse 
primer. 
Name Sequence (5′-3′) 
DENV2C (F) CACCATGGATGACCAACGGAAAAA 
DENV2C (R) CCGCCATCACTGTTGGAAT 
DENV2NLS5-22 (F) CACCATGGGGCGGAAAAAGGCGAGAAAC 
DENV2NLS5-22 (R) CGCGGTTTCTCTCGCGTTT 
DENV2NLS85-101 (F) CACCATGGGGAGGAAAGAGATTGGAAGGA 
DENV2NLS85-101 (R) CAGTTCTACGTCTCCTGTT 
 
2.3.2. Site-directed mutagenesis 
QuickChange® II Site-Directed Mutagenesis kit (Stratagene, USA) was used 
for mutagenesis on the full-length DENV-2 C vector constructs according to the 
manufacturer’s protocol. Briefly, PfuUltra HF DNA polymerase was mixed with 
plasmid DNA template, forward primer, reverse primer, and dNTP mix. The 
sequences of forward and reverse primers for mutagenesis are listed in Table 2.3. The 
mixture was then subjected to mutagenesis cycling profile. An initial denaturing step 
was conducted at 95 oC for 30 sec, followed by 18 cycles of 30 sec of denaturing step 




at 95 oC, 1 min of annealing at 55 oC and 7 min of extension at 68 oC. Subsequently, 
DpnI restriction enzyme was added to digest the parental methylated DNA template 
before the final product was transformed into the supercompetent cells provided in the 
kit. Positive clones on LB agar plate (Appendix 3c) containing ampicillin antibiotic 
were cultivated and the plasmid DNA was isolated using QIAprep Spin Miniprep kit 
(Qiagen, Germany). Extracted plasmids were sent for sequencing to check for correct 
mutation and no other additional unwanted mutations. 
 
Table 2.3: Primers used for site-directed mutagenesis. mtC represents the mutation 
of putative NLS in the full-length capsid clone. The numbers stated denote the amino 
acid residue positions that were mutated to alanine. F denotes forward primer while R 
denotes reverse primer. 













2.3.3. Generation of FLAG-tagged Dengue virus (DENV)-2 capsid (C) protein 
plasmid 
To express FLAG-tagged C protein in mammalian system, DENV-2 C gene 
was cloned into pFLAG-CMV-3 mammalian expression vector (Sigma, USA). 
DENV-2 C gene was amplified from the DENV-2 cDNA obtained from Section 2.3.1 
using FlagDENCF2 and FlagDENCR primers (Table 2.4). A thrombin cleavage site 
was included at the N-terminus of C protein. The PCR products were electrophoresed 
in a 2 % agarose gel (Appendix 3a) and the correct band was excised for gel 
purification. The purified PCR product was then used as template for overlap 




extension-PCR to insert one more FLAG peptide at the N-terminus. FlagDENCF1 and 
FlagDENCR primers (Table 2.4) were used for this OE-PCR. Final PCR product was 
also purified via gel purification. Restriction enzymes HindIII and BamHI (New 
England Biolabs, USA) were used to cut the PCR product and pFLAG-CMV-3 vector 
at 37 oC for 4 hr. After PCR purification, ligation was performed using ligase 
(Promega, USA) according to the manufacturer’s protocol. Positive colonies were 
inoculated into LB broth (Appendix 3d) containing ampicillin and extracted plasmids 
were sent for DNA sequencing.   
 
Table 2.4: Primers used for cloning of FLAG-tagged DENV C protein. 
Restriction enzyme recognition sites are highlighted in BOLD and overlapping sites 
are underlined. F denotes forward primer while R denotes reverse primer. 
Name Description Sequence (5′-3′) 
FlagDENCF1 Forward primer with HindIII cut 





FlagDENCF2 Forward primer for priming out 
DENV C protein from DENV-2 
cDNA with thrombin cleavage 
site at the N-terminus and part of 




FlagDENCR Reverse primer for priming out 
DENV C protein from DENV-2 




2.3.4. Construction of biotinylated Dengue virus (DENV)-2 capsid (C) protein 
(pET28aDENVBioCap) plasmid 
To express biotinylated DENV C protein in bacterial system, 
pET28aDENVBioCap plasmid was constructed. DENV C gene was amplified from 
cDNA synthesized from DENV-2 RNA using SuperScriptTM III First-Strand 
Synthesis System (Life Technologies, USA). Primers Biotin_F, Biotin_C_F, 
Biotin_C_R, and C_R (Table 2.5) were used to join signal peptide gene (Cull & 
Schatz, 2000) and an enterokinase cleavage site with DENV C gene via overlap 




extension-PCR (OE-PCR). Gel-purified PCR products containing the joined 
fragments were subsequently ligated with expression vector, pET28a (Novagen, 
Germany) via Nhe I and Xho I cut sites. 6xHis tag and thrombin cleavage site were at 
the N-terminus of signal peptide followed by enterokinase cleavage site and DENV C 
protein was at the C-terminus. DNA sequencing was performed to verify the 
constructs.  
 
Table 2.5: List of primers used for pET28aDENVBioCap plasmid construction. 
Letters in BOLD are restriction enzyme recognition sites while underlined letters are 
overlapping PCR sites. F denotes forward primer while R denotes reverse primer. 
Primers Description Sequence (5′-3′) 
Biotin_F Forward primer for priming out 
signal peptide with Nhe I cut site 
CTAGCTAGCTCCGGCCTGA
ACGAC 
Biotin_C_F Forward primer for overlapping 




Biotin_C_R Reverse primer for overlapping 




C_R Reverse primer for priming out 
DENV C protein from DENV 





2.3.5. Cloning of Dengue virus (DENV)-2 capsid protein tagged with activation 
domain (DENVC-AD) and importin alpha protein tagged with DNA-binding 
domain (Impα-DBD) for mammalian-2-hybrid (M2H) assay 
To measure the binding efficiency between importin-α protein and various 
DENV C protein mutants, DENVC-AD and Impα-DBD plasmids were engineered. 
GFP-tagged DENV C proteins generated in Section 2.3.1 and mutants in Section 2.3.2 
were used as templates whereas primers M2HDenCF and M2HDenCR (Table 2.6) 
were used to prime out DENV C genes. PCR products were gel purified, cut and 
ligated with pFN10A (ACT) vector (Promega, USA) via Sgf I (GCGATCGC) and 




Pme I (GTTTAAAC) restriction enzyme sites. To obtain Impα-DBD, mRNA was first 
extracted from BHK cells using RNeasy® mini kit (Qiagen, Germany). cDNA was 
then synthesized using SuperScriptTM III First-Strand Synthesis System (Life 
Technologies, USA) and oligo(dT) primers. M2HImpαF and M2HImpαR primers 
(Table 2.6) were used to amplify importin-α gene from the cDNA. PCR product was 
gel purified, cut, and ligated with pFN11A (BIND) vector (Promega, USA). Positives 
clones were sent for DNA sequencing to verify the constructs and correct orientation. 
 
Table 2.6: Primers used for generating DENVC-AD and Impα-DBD plasmids. 
M2H denotes mammalian-2-hybrid while DenC and Impα represent DENV C protein 
and importin-α protein, respectively. F denotes forward primer while R denotes 
reverse primer. Restrictive enzyme sites are underlined.  







2.3.6. Transfection  
Baby Hamster Kidney (BHK) cells, Human Embryonic Kidney (HEK)-293 
cells, 293FT cells or HeLa cells were seeded into 6-well plate according to Section 
2.1.3 or onto coverslips in a 24-well plate according to Section 2.1.4 on the day before 
transfection. Vector constructs were transfected into the cells using Lipofectamine 
2000 (Life Technologies, USA). A mixture of 0.8 µg of plasmid DNA and 2 µl of 
Lipofectamine reagent was incubated in 250 µl of Opti-MEM (Gibco BRL, USA) for 
30 min at room temperature. Old media was discarded and the mixture was added into 
the wells for 5 hr incubation at 37 oC. After incubation, 1 ml of fresh RPMI-1640 
growth medium (Appendix 1a) was added and incubated at 37 oC in 5 % CO2 
incubator (Nuaire, USA) for 24 hr.  




2.3.7. Mammalian-2-hybrid (M2H) Assay 
Baby Hamster Kidney (BHK) cells were seeded on 24-well plates as described 
in Section 2.1.4. DENVC-AD and Impα-DBD plasmids that were generated in 
Section 2.3.6 were co-transfected into BHK cells together with reporter vector 
[pGL4.31(luc2P/GAL4UAS/Hygro) (Promega, USA)] using Lipofectamine 2000 
(Life Technologies, USA) as described in Section 2.3.6. Single transfection, positive 
controls (pACT-MyoD and pBIND-Id vectors) and negative controls (pACT and 
pBIND vectors) were also included. At 24 hr post-transfection, 5 x passive lysis 
buffer (PLB) provided in the dual-luciferase reporter assay kit (Promega, USA) was 
diluted and added into the wells to lyse the transfected cells. About 100 µl of 
Luciferase assay reagent II (LAR II) were mixed with 20 µl of cell lysates in a black 
flat-bottom 96-well plate. The firefly luciferase activity was measure using a 
luminometer (Promega, USA). Subsequently, 100 µl of Stop&Glo® reagent were 
added into the mixture. Renilla luciferase activity was measured. Mock-transfected 
cell lysates were used for measuring endogenous luminescence background, single-
transfected cell lysates were used for respective luciferase activity baseline, and co-
transfected cells were used to measure protein-protein binding efficiency. Renilla 
luciferase activity detected from the BIND-type vectors could be used to normalize 
transfection efficiency.  
 
2.3.8. Real-time polymerase chain reaction (PCR)  
Total RNA were isolated from transiently HEK293 transfected cells (Section 
2.3.6) using RNeasy® mini kit (Qiagen, Germany). First strand cDNA was then 
synthesized from 2 µg of total RNA using SuperScriptTM III First-Strand Synthesis 
System (Life Technologies, USA) and random hexamers. The first-strand cDNA was 




diluted by a factor of 100 and mixed with Fast SYBR® Green master mix (Life 
Technologies, USA). Each reaction well consists of 10 µl of Fast SYBR® Green (2x), 
1 µl of diluted cDNA, 0.4 µl of forward primer, 0.4 µl of reverse primer and 8.2 µl of 
diethylpyrocarbonate (DEPC)-treated water (Appendix 3g). The real-time PCR 
primers used in this project are listed in Table 2.7. Real-time PCR was carried out 
using ABI PRISM 7500 real-time PCR system (Applied Biosystems, USA). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as housekeeping 
gene. 
 
Table 2.7: Primers used for real-time PCR. F denotes forward primer while R 
denotes reverse primer.  




















2.3.9. Mutagenesis of Dengue virus (DENV) infectious clone 
 Dengue virus (DENV)-2 infectious clone, pDVWS601 (Gualano et al., 1998; 
Pryor et al., 2001), was a generous gift from Dr. Andrew Davidson, Bristol University, 
United Kingdom. Approximately 1.2 kb fragment containing C gene sequence was 
first cloned out from the infectious clone using DINBsrGIF and DINSphIR primers 




(Table 2.8). BsrG I and Sph I restriction enzyme recognition cut sites were at the 5′ 
and 3′ ends, respectively. This fragment was then ligated with pcDNA3.1/CT -GFP 
TOPO vector (Life Technologies, USA) to form a carrier plasmid. Mutations R(97-
100)A were then introduced on the carrier plasmid as described in Section 2.3.2 using 
DIN97F and DIN97R primers (Table 2.8). After confirming the presence of 
introduced mutations on the carrier plasmid by sequencing, the 1.2 kb fragment was 
excised using restriction enzyme BsrG I and Sph I (Promega, USA) and ligated back 
to the original infectious clone backbone using T4 DNA ligase (Promega, USA). 
Positive clones were sent for full plasmid sequencing to ensure no additional 
mutations.  
 
Table 2.8: Primers used for mutagenesis of DENV infectious clone. F denotes 
forward primer while R denotes reverse primer.  






2.3.10. In vitro synthesis of infectious RNA  
About 5 µg of full-length / mutant infectious clone of DENV were linearized 
with Xba I restriction enzyme (Promega, USA). The linearized DNA was purified 
using QIAquick® PCR purification kit (Qiagen, Germany) according to the 
manufacturer’s protocol. The purified linearized DNA was then used for in vitro 
synthesis of infectious RNA using T7 RibomaxTM large scale RNA production system 
(Promega, USA) and Ribo m7G Cap Analogue (Promega, USA) according to the 
manufacturer’s protocol. Briefly, the linearlized DNA was mixed with T7 reaction 
components and incubated at 37 oC for 4 hr. To obtain purified infectious RNA from 
the reaction, RNeasy® Mini kit (Qiagen, Germany) was employed. The infectious 




RNA was then transfected into BHK cells according to Section 2.3.6 and virus 
progeny was harvested from the supernatant for growth kinetic analysis.  
 
2.4. Microscopic Techniques 
2.4.1. Direct immuno-fluorescence microscopy of fixed cells 
Baby Hamster Kidney (BHK) cells were transfected with GFP-tagged vector 
constructs [full length C protein, NLS motifs and various NLS mutants] according to 
Section 2.3.6. At 24 hr post-transfection, the transfected cells were washed with 1 x 
PBS (Appendix 1e) and fixed with paraformaldehyde for 20 min at room temperature 
inside a fume hood. After fixation, 4’,6’-diamidino-2-phenylindole [(DAPI) (Life 
Technologies, USA)] were used to stain the cell nuclei and the coverslips were 
mounted on glass slides using Prolong® Gold antifade reagent (Life Technologies, 
USA).  The mounted samples were then viewed under an optical immunofluorescence 
microscope (IX-81, Olympus, Japan). A confocal microscope (C1si, Nikon, Japan) 
was used to analyze the z-axis planes and to obtain three-dimensional images of the 
transfected cells. 
 
2.4.2. Indirect immuno-fluorescence microscopy of fixed cells 
To study the localization of recombinant proteins, BHK cells or HeLa cells 
were transfected according to Section 2.3.6. For mock-transfected cells, only 
transfection reagent was added. At 24 hr post-transfection, transfected cells were 
fixed with 4 % paraformaldehyde for 20 min at room temperature. After 
permeabilization with 0.1 % Triton-X, 5 % skim milk or 1 % bovine serum albumin 
(BSA) in 1 x PBS (Appendix 1e) were used for blocking at 37 oC for 30 min. Primary 
antibody was diluted to 1.0 – 10 μg/ml in blocking buffer before it was used for 




binding at 37 oC. After 1 hr incubation, primary antibody was decanted and the 
coverslips were washed thrice with 1 x PBS (Appendix 1e). Secondary antibody 
[Alexa Fluor-488 or Alexa Fluor-594 antibodies (Life Technologies, USA)] was also 
diluted to optimal concentration in blocking buffer and [(DAPI) (Life Technologies, 
USA)] was used for nuclear staining. After 1 hr incubation at 37 oC, the coverslips 
were washed with 1x PBS (Appendix 1e) and mounted on glass slides using Prolong® 
Gold antifade reagent (Life Technologies, USA). The slides were ready for viewing 
with confocal microscope (C1si, Nikon, Japan) after sealing the sides of coverslips 
with nail polish. [Mouse anti-DIMT1L (ab69434) and rabbit anti-SRP19 (ab131239) 
antibodies were purchased from Abcam, UK; mouse anti-FLAG (F3165) and rabbit 
anti-FLAG (F7425) antibodies were from Sigma, USA; mouse anti-Dengue 4G2 
antibody (MAB10216) was purchased from Millipore, USA] 
 
2.4.3. Live cell imaging 
Time-lapse experiment was performed to visualize the localization of 
recombinant GFP-tagged DENV-2 C proteins in transfected BHK cells. Thirty-five-
millimetre glass-bottom dish (WillCo Wells, Netherland) was used in this experiment. 
The BHK cells were transfected with 4 μg of plasmid DNA and 10 µl of 
Lipofectamine reagent according to Section 2.3.6. At 8 hr post-transfection, the glass-
bottom dish was placed in Nikon Live Cell Imaging System (TE2000, Nikon, Japan) 
which contained a 37 oC incubation chamber with 5 % CO2. After allowing the cells 
to equilibrate in the chamber for 1 hr, phase contrast and GFP fluorescence was 
captured at every half an hour interval for a total of 40 hr. A video was then produced 
using the images.  
 




2.4.4. Effect of leptomycin B, H-89 dihydrochloride, and bisindolylmaleimide on 
Dengue virus (DENV) capsid (C) protein localization 
Leptomycin B [(LMB) (Merck, Germany)], inhibitor of chromosomal region 
maintenance 1 (CRM1)-mediated export pathway, was used to inhibit the exportation 
of C proteins. H-89 dihydrochloride and bisindolylmaleimide (Bis) which are 
inhibitors of protein kinase A (PKA) and protein kinase C (PKC), respectively, were 
used to study the role of phosphorylation on nuclear localization of DENV C protein. 
Baby Hamster Kidney (BHK) cells were seeded on coverslips in a 24-well plate and 
were transfected with recombinant C-GFP plasmid according to Section 2.3.6. After 
transfection, LMB, H-89 dihydrochloride and Bis drugs was added to a final 
concentration of 1 nM, 10 µM and 10 nM, respectively. The transiently-transfected 
cells were incubated at 37 oC in 5 % CO2 incubator for 24 hr. After 24 hr post-
transfection, the cells were fixed with cold methanol, followed by nuclear staining 
with DAPI and the coverslips were then mounted on glass slides with Prolong® Gold 
antifade reagent. The localization of C proteins was examined under fluorescence 
microscope (IX-81, Olympus, Japan). 
 
2.4.5. Co-localization analysis 
The signal intensities of the fluorochromes were analyzed with ImageJ 
software (http://rsbweb.nih.gov/ij/). Images of Alexa Fluor-488 and Alexa Fluor-594 
were cropped for co-localization analysis using the JACoP plugin (Bolte & 
Cordelieres, 2006). Cytofluorogram was generated and the post-thresholding 
Pearson’s coefficient was obtained. The cytofluorogram indicated the correlation of 
the two fluorochromes and the spread of the dots distribution with respect to the fitted 
line refered to the Pearson’s coefficient. Perfect co-localization yield a Pearson’s 




coefficient value of +1 while -1 showed a perfect inverse correlation. Zero Pearson’s 
coefficient value meant that there was no correlation. At least 20 different images of 
each interactor were analyzed to obtain the average value of Pearson’s coefficient and 
its standard deviation. 
 
2.5. Protein Techniques 
2.5.1. Protein expression 
2.5.1.1.  Competent cell strains screening for optimal protein expression 
pET28aDENVBioCap plasmid that was engineered in Section 2.3.4 was 
transformed into two bacterial competent cell strains [BL-21 (DE3) and BL-21-
CodonPlus] (Agilent Technologies, USA). Three colonies were picked and grown in 
20 ml Luria-Bertani (LB) broth (Appendix 3d) with 30 μg/ml kanamycin antibiotic. 
When the bacteria absorbance OD600nm reached 0.65, protein expression was induced 
with 1 mM isopropyl β-D-thiogalactoside (IPTG) overnight at 16 oC. On the 
following day, the bacteria absorbance OD600nm was measured again and 200 μl of 
equal bacteria density for both strains were used for expression level screening. 
Bacterial cells were pelleted down with centrifugation at 8,000 rpm for 15 min at 4 oC 
and resuspended with 100 μl protein sample buffer (Bio-Rad, USA) containing β-
mercaptoethanol. The samples were boiled for 10 min with constant vortexing at 
1 min interval. Insoluble substances were pelleted down with centrifugation for 2 min 









2.5.1.2.  Protein extraction 
pET28aDENVBioCap plasmid was transformed into BL-21-CodonPlus 
expression competent cells (Agilent Technologies, USA) and grown on LB agar 
(Appendix 3c) containing 30 μg/ml kanamycin. Selected clones were cultured in 1 L 
LB broth [(30 μg/ml kanamycin) (Appendix 3d)] at 30 oC until absorbance OD600nm of 
0.8. Expression of DENV C protein was induced with 1 mM isopropyl β-D-
thiogalactoside (IPTG) overnight at 16 oC. Bacterial cells were pelleted down with 
centrifugation at 8,000 rpm for 15 min at 4 oC. Pellet was then resuspended in 
resuspension buffer (Appendix 4a) and the suspension was clarified by centrifugation 
at 8,000 rpm for 20 min. The pellet was re-solubilized in resuspension buffer with 
Triton-X (Appendix 4b) and incubated at room temperature for 30 min. The lysate 
was subsequently centrifuged at 8,000 rpm for 20 min and washed with resuspension 
buffer (Appendix 4a). The inclusion bodies were lysed with lysis buffer (Appendix 4c) 
containing 8 M urea and EDTA-free protease inhibitor (Roche, Switzerland). It was 
incubated at 4 oC for 4 hr with gentle agitation. The lysate was subsequently clarified 
by centrifugation at 13,500 rpm for 20 min. Lysates collected from each step were 
analyzed as described in Section 2.5.3.1-2.5.3.3 and the final cell lysates were 
subjected to His-tag affinity purification as described in Section 2.5.2.1.  
 
2.5.2. Protein purification 
2.5.2.1.  His-tag affinity purification 
Bacterial lysate containing DENV C protein from Section 2.5.1.2 was 
incubated with nickel-nitrilotriacetic acid (Ni-NTA) resin (Bio-Rad, USA) for binding 
in a chromatography column overnight at 4 oC. Ten column volume of wash buffer 
(Appendix 4d) was used to wash away non-specific binding proteins. DENV C 




protein was eventually eluted out with elution buffer (Appendix 4e) in ten fractions. 
All the flowed-through, washed and eluted fractions were analyzed via SDS-PAGE 
(Section 2.5.3.1) stained with Coomassie-blue [Section 2.5.3.3 and Appendix 5d(i-iii)] 
and Western-blotting (Section 2.5.3.2).  
Eluates with DENV C proteins were combined for dialysis and refolding. 
Briefly, all eluates were pooled into a SnakeSkin dialysis membrane tubing (Thermo 
Scientific, USA) and 0.5 % of Tween-20 was added into the samples. The dialysis 
tubing was incubated in 1 L of 6 M urea for 6-12 hr at 4 oC and 250 ml of refolding 
buffer (Appendix 4f) was added into the solution at every 6-12 hr interval. When the 
final volume reached 3 L, the dialysis tubing was transferred into 2 L of 25 mM Tris 
and 150 mM NaCl buffer (pH 8.0) for 6 hr. Refolded DENV C proteins were 
collected from the dialysis tubing. Second round of purification was carried out using 
ion-exchange chromatography as described in Section 2.5.2.2. 
 
2.5.2.2.  Ion exchange chromatography 
Ion exchange chromatography column, ResourceTM Q/S 1 ml-packed size 
column (GE Healthcare, UK), was connected to fast protein liquid chromatography 
(FPLC) system (GE Healthcare, UK). For ResourceTM Q column, ten column volumes 
of Tris starting buffer (Appendix 4g) was used for equilibration until the UV baseline 
and conductivity were stable. Refolded DENV C protein was injected into the column 
and the flow rate was set to 0.5 ml/min. After the sample passed through the column, 
ten column volumes of 20 mM Tris (pH 8.0) was used to wash away all the unbound 
proteins. Ionically-bound proteins were eluted out with increasing concentration of 
sodium chloride to a final concentration of 1 M (100 %) using elution buffer 
(Appendix 4h). For ResourceTM S column, 2-[N-morpholino]ethanesulphonic acid 




(MES) starting buffer (Appendix 4i) was used for equilibration while MES elution 
buffer (Appendix 4j) was used to elute out the bound protein. All the fractions were 
analyzed via ELISA (Section 2.5.3.6) to determine the presence of biotinylated C 
protein. 
 
2.5.2.3.  Size-exclusion chromatography 
Superdex 75 10/300 GL chromatographic separation column (GE Healthcare, 
UK) was connected to FPLC system (GE Healthcare, UK). The column was washed 
with five column volumes of MilliQTM water to remove ethanol and equilibrated with 
two column volumes of filtered 1x PBS (Appendix 1e). When the UV baseline and 
conductivity were stable, samples with biotinylated DENV C protein from Section 
2.5.2.2 were injected into the column and the flow rate was set to 0.25 ml/min. Buffer 
used for this purification is filtered PBS. All the eluates were analyzed via ELISA 
(Section 2.5.3.6) to determine the presence of biotinylated C protein.   
 
2.5.3. Protein analysis 
2.5.3.1.  Sodium dodecyl sulphate-polyacrylamide gel (SDS-PAGE) 
Glycine gel was used for normal and large protein size analysis whereas 
tricine gel was used for small protein size analysis during protein expression and 
purification. A Tris-glycine polyacrylamide denaturing gel containing 12 % 
separating glycine gel [Appendix 5a(i) and 5a(iii)] and 5 % staking gel [Appendix 
5a(ii) and 5a(iv)] was cast.  The comb was removed and the gel was placed into a tank 
with glycine running buffer [Appendix 5a(iv-v)]. For Tris-tricine gel [Appendix 5b(i-
iii)], tricine-containing running buffers [Appendix 5b(iv-v)] were used. Samples were 
boiled for 5 min at 95 oC before loading into the wells. Electrophoresis of samples and 




pre-stained molecular marker (Fermentas, USA) was carried out at constant 120 V for 
1 ½ hr. The gel was then used for Western blot transfer [Section 2.5.3.2 and 
Appendix 5c(i-iv)] or stained with Coomassie blue [Section 2.5.3.3 and Appendix 
5d(i-iii)] / Silver staining [Section 2.5.3.4 and Appendix 5e(i-ii)].  
 
2.5.3.2.  Western-blotting 
Separated proteins in SDS-PAGE gels from Section 2.5.3.1 were transferred 
onto a polyvinylidene diflouride (PVDF) membrane using iBlot® Dry Blotting System 
(Life Technologies, USA) for 7 min. The membrane was then blocked with 5 % skim 
milk [Appendix 5c(i)] or 4 % bovine serum albumin (BSA) [Appendix 5c(ii)]  at 
room temperature for 1 hr before incubating it with appropriate primary antibody at 
4 oC overnight. After that, the membrane was washed with TBST [Appendix 5c(iii)] 
or PBST [Appendix 5c(iv)], followed by incubation with secondary antibody 
(conjugated with alkaline phosphatise or horseradish peroxidase) for 1 hr at room 
temperature. 5-bromo-4-chloro-3-indolylphosphate / p-nitro blue tetrazolium 
(BCIP/NBT) substrate (Chemicon, USA) or SuperSignal® West Pico 
chemiluminescent substrate (Thermo Scientific, USA) were added for bands 
visualization. For low concentration protein, SuperSignal® West Dura or Femto 
chemiluminescent substrate (Thermo Scientific, USA) were used. 
 
2.5.3.3.  Coomassie blue staining 
Separated proteins in SDS-PAGE gels were stained with Coomassie blue 
staining solution [Appendix 5d(i)] overnight. To accelerate the staining, it could be 
heated up in a microwave for 30 sec. To destain the background, destaining solution I 
[Appendix 5d(ii)] was used. When the destaining solution became blue, it was 




discarded and new destaining solution I was added. This process was repeated until 
the background was clear and the bands were obvious. At this stage, stained gel could 
be kept in destaining solution II [Appendix 5d(iii)] for photographing or dried using 
dual temperature SLAB 1125B gel dryer (Bio-Rad, USA). 
 
2.5.3.4.  Silver staining 
For low concentration protein, SDS-PAGE gels were stained with silver stain 
plus kit (Bio-Rad, USA) according to the manufacturer’s protocol. Briefly, gels were 
fixed with Fixative Enhancer solution [Appendix 5e(i)] with gentle agitation for 20 
min. After fixing, gels were washed thrice with 400 ml distilled water for 10 min each. 
After the last washing, Development Accelerator Solution [Appendix 5e(ii)] was 
added and waited for the bands to appear. When the desired staining intensity was 
reached, Development Accelerator Solution was discarded and 5 % acetic acid was 
added to stop the staining reaction. The stained gels were photographed or dried using 
gel dryer (Bio-Rad, USA). 
 
2.5.3.5.  Sample preparation for mass spectrometry 
Purified protein was electrophoresed through SDS-PAGE using 12 % Tris-
tricine polyacrylamide denaturing gel (Section 2.5.3.1) and stained with Coomassie 
blue [Section 2.5.3.3 and Appendix 5d(i)]. After removing the background of 
Coomassie-stained gel with destaining solution I [Appendix 5d(ii)]. DENV C protein-
corresponding band was excised from the gel and kept in eppendorf tube containing 
distilled water. Samples were submitted to Dr. Lim Yoon Pin, Department of 
Biochemistry, NUHS for mass spectrometry analysis. 
 




2.5.3.6.  Enzyme-linked immunosorbent assay (ELISA) 
Samples and standards were added into the wells of MaxiSorp plate 
(eBioscience, USA) in triplicate. The plate was covered with aluminum foil and 
incubated for 2 hr. All incubating and washing steps were carried out at room 
temperature. After washing with 1x PBST [Appendix 5c(iv)], blocking buffer 
[Appendix 5c(ii)] was added into each well and incubated for another hour. Next, 
streptavidin-horseradish peroxidase (HRP) enzyme conjugates (Millipore, USA) was 
diluted 20,000 times with blocking buffer and added into each well for 1 hr incubation. 
The plate was washed with 1x PBST [Appendix 5c(iv)] thrice to remove unbound 
conjugates and then substrate solution, tetramethyl benzidine [(TMB) (Promega, 
USA)], was added for development for 15 – 30 min at room temperature. 0.5 M 
H2SO4 solution was added to stop the reaction. The absorbance was measured 
immediately at 450 nm. 
 
2.5.3.7.  Enzyme-linked immunosorbent assay (ELISA)-based binding assay 
Pure proteins of the potential interacting partners were purchased from 
Abnova (USA) and 100 ng of the proteins were added into the wells of MaxiSorp 
plate (eBioscience, USA) in triplicates for coating overnight at 4 oC. After discarding 
the solution, 150 µl of blocking buffer [Appendix 5c(ii)] was added into each well and 
incubated for another hour at 37 oC. Next, 100 ng of purified biotinylated full-length 
DENV protein was added into the wells for binding and incubated for 1 hr at 37 oC. 
After washing with 1x PBST [Appendix 5c(iv)], 150 µl streptavidin-horseradish 
peroxidase (HRP) secondary antibodies (Millipore, USA) were added and incubated 
for 1 hr. The plate was washed with 1x PBST [Appendix 5c(iv)] to remove unbound 
conjugates and then 100 µl substrate solution, tetramethyl benzidine [(TMB) 




(Promega, USA)], was added for colour development. When necessary, 50 µl of 
0.5 M H2SO4 solution was added to stop the reaction. The absorbance was measured 
immediately at 450 nm. For reciprocal binding assay, DENV C protein was coated on 
the plates instead followed by the interacting partners. The bound proteins were 
detected by HRP-conjugated anti-glutathione S transferase (GST) antibody (Millipore, 
USA). 
 
2.5.3.8.  Functional binding assay for purified Dengue virus (DENV) capsid (C) 
protein with human Sec3 protein 
Pure Sec3 protein [(Abnova, Taiwan) (known interacting partner of flavivirus 
C protein (Bhuvanakantham et al., 2010))] was added into the wells of MaxiSorp 
plate (eBioscience, USA) for coating overnight at 4 oC. After washing with 1x PBST 
[Appendix 5c(iv)], blocking buffer [Appendix 5c(ii)] was added into each well and 
incubated for another hour. Purified DENV C protein was added into the well for 
binding at 37 oC for 1 hr. Next, streptavidin horseradish peroxidase (HRP) enzyme 
conjugates (Millipore, USA) was added and incubated for one more hour at 37 oC. 
After washing three times with 1x PBS (Appendix 1e), 100 μl TMB substrate 
(Promega, USA) was added for development and 50 μl of 0.5 M H2SO4 solution was 
added to stop the reaction when necessary. The absorbance was measured at 450 nm. 
 
2.5.3.9.  Co-immunoprecipiation 
Co-immunoprecipitation was carried out to study the interaction between 
DENV C protein and importins. Baby Hamster Kidney cells were seeded onto a 6-
well plate according to Section 2.1.3. When the cell confluency reached 
approximately 80-90 %, the cells were transfected with GFP-tagged C protein plasmid 




according to Section 2.3.6. At 24 hr post-transfection, cells were washed with 1 x PBS 
(Appendix 1e) and lysed with ice-cold mild lysis buffer provided in the µMACSTM 
GFP isolation kit (Miltenyi Biotec, Germany). The cell lysates were then incubated 
with anti-GFP magnetic microbeads overnight with constant rotation for enough 
binding before loading the mixture into μMACs separator column. After the cell 
lysates flowed through the column, Wash Buffer I and Wash Buffer II (Miltenyi 
Biotec, Germany) were used to rinse the column. Elution buffer was preheated to 
95 oC before loading it into the column to eluate out the bound proteins as 
immunoprecipitates. The eluates were then analyzed through SDS-PAGE (Section 
2.5.3.1) and Western-blotting (Section 2.5.3.2).  
 
2.6. Protoarray Screening 
ProtoArray® Human Protein Microarray PPI Complete Kit (Life Technologies, 
USA) was employed for protein-protein interaction study according to the 
manufacturer’s protocol. Briefly, the protein microarray was blocked with 5 ml of 
Blocking Buffer provided in the kit for 1 hr. The whole experiment was performed at 
4 oC. Six µg of purified biotinylated proteins (50 µg/ml) was used to probe the array 
and a LifterSlipTM coverlip was placed over the array slowly. The array was incubated 
for 90 min to allow enough binding time. Next, 5 ml of diluted Alexa Fluor® 647-
conjugated streptavidin secondary antibody (Life Technologies, USA) was added and 
incubated for another 90 min. After washing thoroughly with Wash Buffer provided 
in the kit, the array was dried via centrifugation at 200x g for 1-2 min at room 
temperature. Scanning of the array was done using GenePix® scanner (Molecular 
Devices Corporation, USA), a fluorescence microarray scanner, within 24 hr. 




Images of the array were analyzed with GenePix® Pro software (Life 
Technologies, USA) using the specific “.GAL” file downloaded from ProtoArray® 
Central. The “.GAL” file contains information on the identity and location of each 
spot on the microarray. The software acquired data by analyzing the pixel intensity of 
each spot after adjusting the grid and aligning all the features based on the “.GAL” 
file. The data acquired from the image can be further analyzed using ProtoArray® 
Prospector software to identify statistically significant interactors. The functions and 
subcellular locations of the interactors were analyzed via GeneCards 
(http://www.genecards.org), UniProt (http://www.uniprot.org), and The Gene 
Ontology (http://www.geneontology.org). Classification of the interactors was then 
performed based on the obtained information.   
 
2.7. Cell Cycle Analysis 
2.7.1. Fluorescence-activated cell sorting (FACS) 
Appropriate cell density of BHK, C6/36 and HEK293 cells were seeded in 
T-25 flask as described in Section 2.1.2. Two flasks (control and experiment) were 
used for each time-point. During virus infection as described in Section 2.2.3, 500 µl 
of virus [multiplicity of infection (M.O.I.) = one] was added into each experimental 
flask. To synchronize the infection, all flasks were incubated at 4 oC for 1 hr, followed 
by incubation at 37 oC for another 1 hr. During the incubation at 37 oC, flasks were 
rocked at every 15 min to ensure even infection. After 2-hr incubation, remaining 
viruses were removed and washed with 1 x PBS (Appendix 1e) before topping up 
with 5 ml of respective growth media supplemented with 2 % FCS. BHK and 
HEK293 cells were then incubated at 37 oC while C6/36 cells were incubated at 28 oC 
during the whole course of the experiment. Time course experiments for WNV 




infections were 2 hr, 4 hr, 6 hr, 8 hr, 10 hr, 12 hr and 24 hr while for DENV infections 
were 12 hr, 24 hr, 36 hr and 48 hr p.i. 
 At each time point, supernatant for the infected cells were kept to determine 
virus titers. Cells for both control and experimental flasks were trypsinized and spun 
down in 15 ml falcon tubes at 250 x g for 5 min at 4 oC. The cells were then 
resuspended in 0.5 ml ice-cold 1 x PBS (Appendix 1e) and fixed with 4.5 ml 70 % 
ice-cold ethanol. For staining, fixed cells were spun down again at 250 x g for 5 min 
and washed with ice-cold 1 x PBS (Appendix 1e) to remove excess ethanol. Cell 
pellets were then resuspended with 1 ml of propidium iodide staining solution 
(Appendix 6a) and incubated at 37 oC for 15 min. After staining, the cells were 
filtered with 41 µm filter cloth into mini-glass vials for flow cytometry. Fluorescence 
activated cell sorting (FACS) analysis was performed using Beckman Coulter Epics 
Altra (FACScan) machine in Clinical Research Center (CRC), National University of 
Singapore (NUS). Stained cells were excited with 488 nm laser line and the emitted 
light was detected through photomultiplier tube four (PMT4). Ten thousands cells 
were analyzed for each sample to create a cell cycle profile using the software, 
EXPO32 Version 2.0. WinMDI version 2.8 was used to further analyze the data to 
obtain the percentage of cells at each cell cycle phase. 
 
2.7.2. Effect of cell cycle synchronization on Dengue virus (DENV) replication 
Human Embryonic Kidney (HEK)-293 cells were seeded in T-25 flask as 
described in Section 2.1.2 and infected with DENV at M.O.I. of one according to 
Section 2.2.3. To synchronize the infection, all flasks were incubated at 4 oC for 1 hr, 
followed by incubation at 37 oC for another 1 hr. After 2-hr incubation, remaining 
viruses were removed and washed with 1 x PBS (Appendix 1e) before adding 5 ml of 




DMEM growth medium (Appendix 1c) supplemented with 2 % FCS and drugs. To 
arrest cell cycle at G1 phase, fresh growth media without FCS were used. Thymidine 
(4 mM) was used to synchronize host cell cycle at S-phase whereas nocodazole 
(100 ng/ml) was used to arrest cell cycle at G2- / M-phase. At 48 hr post-infection, 
supernatant of the infected cells were collected for virus titer quantitation whereas 
infected cells were harvested for FACS analysis according to Section 2.7.1.  
 
2.7.3. Cell cycle-polymerase chain reaction (PCR) array 
Human cell cycle RT2 Profiler PCR array kit (SABiosciences, Qiagen, 
Germany) was employed to screen for the cell cycle-related genes that were affected 
during DENV and WNV infection on HEK-293 cells. The HEK293 cells were 
infected with virus at M.O.I. = 1 as described in Section 2.7.1 with synchronization. 
At various post-infection time points, the total RNAs were extracted with RNeasy® 
mini kit (Qiagen, Germany). The RNA of infected cells and mock infected cells were 
reverse-transcribed into cDNA with the RT2 First-Strand kit provided. The 
synthesized cDNAs were then mixed with RT2 qPCR master mix containing SYBR 
Green and reference dye. The mixture was aliquoted carefully into a 96-well plate 
containing pre-dispensed gene specific primer sets. All the aliquoting steps were 
carried out in a dedicated clean PCR hood. After that, the plates were sealed and 
analyzed using ABI PRISM 7500 real-time PCR system (Applied Biosystems, USA). 
The gene expression profiling of virus-infected cells were analyzed using a kit-
specific Excel sheet template provided by SABiosciences, Germany. 
 




2.8. Effect of Signal Recognition Particle (SRP19) and DIM1 
Dimethyladenosine Transferase 1 Homolog (DIMT1) Genes Over-Expression on 
Dengue Virus (DENV) Replication 
Both SRP19 (Accession number: NM_003135) and DIMT1 (Accession 
number: NM_014473) clones were purchased from OriGene, USA. DNA sequencing 
was carried out to confirm the identity of the clones. Human Embryonic Kidney 
(HEK)-293 cells were seeded onto 6-well plate according to Section 2.1.3 and 
transfected with the plasmids using TurboFectin transfection reagent (OriGene, USA) 
according to Section 2.3.6. At 24 hr post-transfection, transfected cells were infected 
with DENV at M.O.I. = 1 according to Section 2.2.3. After 1 hr incubation, remaining 
viruses were discarded and washed with 1 x PBS (Appendix 1e) before topping up 
with 2 ml of growth medium (Appendix 1c) supplemented with 2 % FCS. At 24 hr 
post-infection, medium was harvested for plaque assay (Section 2.2.2) while total 
RNA and proteins were extracted for real-time PCR (Section 2.3.8) and Western-blot 
(Section 2.5.3.2) analyses, respectively. 
 
2.9. Effect of Signal Recognition Particle (SRP19) and DIM1 
Dimethyladenosine Transferase 1 Homolog (DIMT1) Genes Knock-Down on 
Dengue Virus (DENV) Replication 
Human shRNA constructs of SRP19 (Locus ID: 6728) and DIMT1 (Locus ID: 
27292) were purchased from OriGene, USA. There were four unique shRNA 
constructs for each gene. All four shRNA constructs were combined during 
transfection to target multiple splice variants. Scrambled shRNA constructs were 
included for negative control. Human Embryonic Kidney (HEK)-293 cells were 
seeded onto 6-well plate according to Section 2.1.3 and transfected with the shRNA 




constructs using TurboFectin transfection reagent (OriGene, USA) according to 
Section 2.3.6. At 24 hr post-transfection, transfected cells were infected with DENV 
at M.O.I. = 1 according to Section 2.2.3. At 24 hr post-infection, medium containing 
viruses was harvested for plaque assay (Section 2.2.2) whereas total RNA and 
proteins were extracted from the cells for real-time PCR (Section 2.3.8) and Western-
blot (Section 2.5.3.2) analyses, respectively. 
 
2.10. Software used in this study 
  Various bioinformatic software were used to: (1) check DNA sequences of the 
plasmid constructs; (2) predict putative binding domains with host proteins in C 
protein; and (3) analyze cell cycle data. The major software used were listed in 
Appendix 7. 
 
2.11. Statistical Analyses 
  Means, standard deviations, p-values, and 95 % confidence intervals were 
obtained using Microsoft Office Excel 2007. Student’s t test was performed to obtain 
p-values. 
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3.  Delineating the Nuclear Transport Mechanism of 
Dengue Virus (DENV) Capsid (C) Protein 
3.1. Introduction 
The nuclear localization of Dengue virus (DENV) capsid (C) protein was first 
reported by Bulich and Aaskov (1992) using anti-DENV-2 C protein monoclonal 
antibodies. Following this discovery, attempts have been made to decipher the 
important regions responsible for the nuclear localization of DENV C protein 
(Sangiambut et al., 2008; Wang et al., 2002). The exact mechanism of nuclear 
translocation of DENV C protein is still unknown. The aim of this chapter is to 
delineate the underlying molecular mechanism of transporting DENV C protein into 
host cell nucleus.  
 
3.2. Cloning of Green Fluorescent Protein (GFP)-Tagged Full-Length Dengue 
Virus (DENV) Capsid (C) Protein 
To examine the nuclear translocation ability of DENV C protein alone without 
the presence of other viral proteins, recombinant full-length DENV-2 C protein was 
cloned as fusion protein with GFP tag to ease the visualization under fluorescent 
microscope. After harvesting the DENV-2 virus, viral RNA was extracted and 
reverse-transcribed to cDNA which served as a template to amplify the full-length C 
gene. Figure 3.1 showed the molecular size of the C gene to be about 350 bp as 
indicated by the arrow. The amplified full-length C gene was purified and inserted 
into pcDNA3.1/CT-GFP-TOPO vector (Invitrogen, USA) via TA cloning strategy. 
Ligated plasmids were transformed into One Shot® TOP 10 chemically competent 
Escherichia coli cells (Invitrogen, USA). Positive clones were sent for DNA 
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sequencing to ensure that there was no mutation and correct orientation. The DNA 
and amino acid sequences of the DENV-2 C protein were shown in Appendix 8a. 
 
Figure 3.1: Cloning of full-length DENV C protein tagged with GFP. DENV C 
gene is primed out from the cDNA of DENV-2 (NGC) viral genome. The molecular 
size of DENV C gene is approximately 346 bp.  
 
3.3. Nuclear Localization of Green Fluorescent Protein (GFP)-Tagged Dengue 
Virus (DENV) Capsid (C) Protein 
Since C protein was cloned as GFP fusion protein, the localization of the 
proteins in the cells can be visualized directly under immuno-fluorescence microscope 
as green fluorescence. Plasmid DNAs were transfected into Baby Hamster Kidney 
(BHK)-21 cells (Section 2.3.6) on coverslips and fixed at 24 hr post-transfection 
before viewing under fluorescence microscope at 100 x magnification (Section 2.4.1). 
As shown in Figure 3.2(A), DENV full-length C protein indeed localized into 
the cell nuclei / nucleoli as bright green fluorescence in the 4’,6’-diamidino-2-
phenylindole (DAPI)-stained regions indicating the position of nuclei. To ensure the 
nuclear translocation phenomenon was not due to the presence of GFP protein, GFP 
control plasmid was also transfected into BHK cells. Figure 3.2(B) demonstrated that 
GFP proteins were evenly distributed throughout the whole cells. Mock-transfected 
cells were also included as negative controls [Figure 3.2(C)]. To further confirm the 
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nuclear localization ability was attributed by DENV C protein, FLAG octapeptide 
which was a small tag was fused at the C-terminus of C protein and indirect immuno-
fluorescence microscopy was carried out (Section 2.4.2). Likewise, bright green 
fluorescence was observed in the cell nuclei / nucleoli [Figure 3.2(D)]. To confirm the 
localization of DENV C protein is in the nucleoli, nucleolus marker, SYTO® 
RNASelect Green Fluorescence cell stain (Invitrogen, USA) was employed. DENV C 
protein indeed co-localized with nucleolus stain as indicated by Figure 3.2(E). Hence, 
these proved that nuclear localization of DENV C proteins was specific and it was 
purely caused by C protein itself, without the presence of other viral proteins. 
Figure 3.3 illustrated two-dimensional images of transfected cells. These 
images could not differentiate whether the GFP-tagged DENV C proteins were inside 
the nuclei or resided at the top or at the bottom of the nuclei. To further corroborate 
that C protein indeed localized into the nuclei / nucleoli, three-dimensional images 
were obtained using confocal microscope A1R+, in the SBIC-Nikon Imaging Centre, 
Biopolis, Singapore. Before constructing three-dimensional images, the emission 
spectrum of green fluorescence in the transfected samples was analyzed with NIS-
Elements Imaging software. As shown in Figure 3.3, green fluorescence outside the 
blue region was chosen and marked with a green box (1) so that only the green 
fluorescence was analysed. A spectrum graph was plotted and a distinct peak was 
detected between 500 to 550 nm. This peak coincided with that of the GFP signal 
from the known database. Thus, the spectrum analysis reaffirmed that the green 
fluorescence detected from GFP-transfected cells was specific and reliable. 




Figure 3.2: Immuno-fluorescence microscopic images of GFP-tagged DENV C 
protein. The localization of GFP fusion proteins is visualized under fluorescence 
microscope IX-81 (Olympus, Japan) using 100 x magnifications with oil immersion. 
DENV full-length C proteins (A) localize in the nuclei / nucleoli as indicated by the 
white arrows in the overlay image whereas GFP control (B) shows even distribution 
throughout the cytoplasm and nucleus. DAPI is used to stain the nuclei. Mock-
transfected cells (C) serve as negative controls. DENV C protein tagged with FLAG 
octapeptide (D) also localizes in the nuclei / nucleoli as indicated by white arrow. To 
confirm the localization of DENV C protein is in the nucleoli, SYTO RNASelect 
Green (E) is used to stain the nucleoli. DENV C protein co-localizes with nucleoli 
stain as indicated by the white arrow.  




Figure 3.3: Verification of green fluorescence detected in the transfected cell 
nucleus. Green fluorescence signal detected outside the blue region (nuclei) is marked 
with a green square box (1) and analysed. A peak between 500 and 550 nm is detected 
and it matches with a known GFP peak stored in the database. 
 
To construct three-dimensional images of the DENV C-transfected cells, z-
stack programme was employed to acquire the z-axis planes from the top of the nuclei 
to the bottom whereby the x- and y-axes were fixed. Three-dimensional image was 
then generated using the obtained z-axis images. Figure 3.4 showed the three-
dimensional volume views of the z-stacked images. A total of 105 planes was 
acquired with approximately 0.125 µm thickness for each plane. Both DAPI and 
green fluorescence channels were merged in the images.  
When the three-dimensional volume image was viewed from the top or XY 
surface, green fluorescence signals detected from the two DENV C-transfected cells 
were co-localized with the blue DAPI staining which were the nuclei [Figure 3.4(A)]. 
Likewise, when the volume view was rotated to the side or XZ surface, the green 
fluorescence signals were still seen together with the DAPI staining [Figure 3.4(B)]. 
When the volume image was viewed from an angle where all three x-, y-, and z-axes 
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were visible, the green fluorescence was again detected in the nuclei [Figure 3.4(C)]. 
To further substantiate that the green fluorescence detected was inside the nuclei and 
not on top, at the sides or at the bottom of the nuclei, a slice view (slice 35 from the 
top) of the three-dimensional image was shown [Figure 3.4(D)]. As indicated by the 
white crosses in Figure 3.4(D), green fluorescence signals were detected inside the 
nucleus, predominantly nucleolus, in all three XY, XZ and YZ planes. By going 
through the whole 105 planes from the top to the bottom of the nuclei, green 
fluorescence signals were not only detected around the nuclei, but also in the nuclei 
especially the nucleoli. Therefore, this result clearly demonstrated that DENV C 
proteins indeed localized in the nuclei / nucleoli.  
 




Figure 3.4: Three-dimensional images of DENV C-transfected cells showing the 
nuclear localization of C protein. Volume views of confocal microscopic images 
(105 planes; 13 µm depth) at XY plane (A), XZ plane (B), and XYZ angle show the 
co-localization of green fluorescence and blue DAPI staining. Slice view (D) of the 
three-dimensional image (slice 35 from the top) shows that DENV C protein indeed 
localizes in the nuclei / nucleoli as indicated by the white crosses. 
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3.3.1. Not all Dengue virus (DENV) capsid (C) proteins are in the nuclei  
As observed in Figures 3.3 and 3.4, green fluorescence was not only detected 
in the nuclei / nucleoli, substantial amount of green fluorescence signals were also 
seen in the perinuclear regions and a minority in the cytoplasm. Figure 3.5 showed the 
different localization patterns of DENV C protein observed under one field of view. 
The overlay image in Figure 3.5 illustrated that one of transfected cells showed 
complete nuclear localization as indicated by a white arrow whereas the other cell 
retained some green fluorescence at the perinuclear region as indicated by a yellow 
arrow. 
 
Figure 3.5: Localization of DENV C proteins in the nuclei and perinuclear 
regions. Immuno-fluorescence image shows two successfully GFP-tagged C protein-
transfected cells in which one of them shows complete nuclear localization as 
indicated by white arrow while the other cell shows fluorescence at both nuclei and 
the perinuclear region as indicated by yellow arrow. DAPI is used to stain the nuclei. 
 
This phenomenon raises a question as to whether all DENV C proteins are 
required to enter host cell nuclei during replication. It is possible that the C proteins 
detected at the perinuclear regions are newly-synthesized C proteins that are yet to be 
transported into the nuclei? To verify this, the same procedure of transfection (Section 
2.3.6) was carried out and the transfected cells were fixed at 24 hr and 48 hr post-
transfections. The number of cells showing green fluorescence in the nuclei only or all 
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other regions (nuclei, perinuclear regions, and cytoplasms) were tabulated and 
presented in Figure 3.6.  
It was noticed that the number of fluorescing cells at 48 hr post-transfection 
was much lower than 24 hr post-transfection. This could be due to the transfected 
cells undergoing apoptosis caused by over-expression of DENV C proteins. About 
100 transfected cells were counted and the percentage of cells showing nuclei 
localization only or all regions (nuclei, perinuclear regions and cytoplasms) were 
compared with that of 24 hr post-transfection. Figure 3.6 showed the percentage of 
cells demonstrating different localization patterns at 24 hr and 48 hr post-transfection. 
No significant difference was observed for both time points. Green fluorescence was 
still seen in the perinuclear regions and cytoplasms of transfected cells at 48 hr post-
transfection. This result showed that the amount of C proteins localized in the nuclei 
was not time dependent. As such, 24 hr post-transfection was used for all subsequent 
experiments that involved transfection of DENV C protein.   
 
Figure 3.6: Percentage of DENV C protein-transfected cells showing different 
localization patterns of C protein in the cells at two different time points. The 
percentage of cells showing complete nuclear localization at 24 hr post-transfection is 
not significantly different from 48 hr post-transfection. 
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3.3.2. Dengue virus (DENV) capsid (C) protein is not exported out from the 
nucleus 
 It was recently reported that C proteins were exported out of nucleus via 
chromosomal region maintenance 1 (CRM1)-mediated pathway (Oh et al., 2006). 
Hence, the fluorescence observed in the cytoplasm could be attributable to the 
exported C proteins from the nuclei. To examine this possibility, leptomycin B [(LMB) 
(Merck, Germany)], which is an inhibitor for CRM1-mediated export, was used to 
inhibit any possible exportation of recombinant C proteins.  
After transfection, LMB was added to a final concentration of 1 nM (Oh et al., 
2006). A total of at least 100 cells showing fluorescence in the nuclei only or in both 
nuclei and cytoplasm were counted. As shown in Figure 3.7, the proportion of 
complete nuclear localization of C protein in the LMB-treated cells was not 
significantly different from LMB-untreated cells. Hence, the green fluorescence 
observed at the cytoplasm of some cells was not due to the exported recombinant C 
proteins from the nuclei but more likely were GFP-tagged C proteins that were 
translated by ribosomes and remained in the cytoplasm. Taken together, these results 
(Section 3.3.1 and Section 3.3.2) suggested that not all C proteins were needed to be 
localized in the nuclei. The perinuclear C proteins could eventually be used for 
encapsidation of the progeny viral RNA. Cytoplasmic C proteins might interact with 
host proteins carrying out other non-structural functions. This would be investigated 
in subsequent chapters.  
 




Figure 3.7: Percentage of DENV C protein-transfected cells showing different 
localization patterns of C protein in the cells with or without the presence of 
leptomycin (LMB) inhibitor. Leptomycin inhibitor is used to inhibit chromosomal 
region maintenance 1 (CRM1)-mediated export to examine the distribution of C 
proteins in the transfected cells after treatment. The percentages of cells with only 
nuclear localization of C proteins for both treated and untreated groups are not 
significantly different. 
 
3.3.3. Nuclear localization of Dengue virus (DENV) (C) protein is not cell type-
specific  
 The examination of DENV C protein localization so far was carried out in 
BHK cells. To investigate whether nuclear localization of DENV C protein is cell-
type specific, similar direct immuno-fluorescence microscopic study protocol (Section 
2.4.1) was performed on other cell lines, namely human embryonic kidney (HEK)-
293 and HeLa cells. These two cell lines were used for other experiments throughout 
this project. Similar to BHK cells, nuclear localization of DENV C protein was also 
observed in human cell lines, namely HEK293 and HeLa cells. Distinct green 
fluorescence signals were still seen in the DAPI-stained nuclei, predominantly in the 
nucleoli. Hence, nuclear localization of DENV C protein was not cell type-specific 
and this observed phenomenon was in the absence of other viral factors. 




Figure 3.8: Nuclear localization of GFP-tagged DENV C protein in HEK293 (A) 
and HeLa (B) cells. The localization of DENV C protein is visualized under 
fluorescence microscope IX-81 (Olympus, Japan) using 100 x magnifications with oil 
immersion. Similar to BHK cells, DENV full-length C proteins also localize in the 
nuclei / nucleoli of HEK293 and HeLa cells. 
 
3.3.4. Live cell imaging of the localization of DENV C protein in the cell  
Nuclear localization of C protein was only captured at a fixed timing in other 
studies (Bulich & Aaskov, 1992; Tadano et al., 1989; Wang et al., 2002) so the whole 
process of nuclear translocation of C protein has not been fully described thus far. 
Therefore, it will be interesting to decipher the entire transportation process.   
To capture the whole process of nuclear translocation of C proteins, time-
lapsed live cell imaging technique (Section 2.4.3) was employed. BHK cells were 
transfected with full-length DENV C plasmid for 8 hr before the cell monolayer in the 
dish was viewed under Nikon Live Cell Imaging System (Nikon, Japan). Only one 
field of view was chosen to capture the time-lapsed images throughout the whole 
experiment. Green fluorescence and phase contrast images were acquired at every half 
an hour interval up to 40 hr post-transfections.  
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Figure 3.9 showed part of the overlay images of GFP fluorescence and phase 
contrast microscopy at every 1 hr interval from 21 hr post-transfection until 34 hr 
post-transfection. Localization of GFP-tagged C proteins was followed in one 
transfected cell as highlighted by the white arrows in Figure 3.9. Merged image at 
29 hr post-transfection was enlarged to illustrate the localization of intense green 
fluorescence in the nucleus as indicated by the yellow arrow. GFP-tagged C protein 
was observed in the nucleus from 21 hr post-transfection onwards after the green 
fluorescence signals were detected in the cytoplasm at 16 hr post-transfection.   
One interesting observation was that C protein-induced apoptosis was 
observed clearly at 32 hr post-transfection and the cell eventually rounded up at 34 hr 
post-transfection as highlighted by yellow circle in Figure 3.9. The blebbing 
appearance of the cell at 32 hr and 33 hr post-transfection was indicative of the 
occurrence of apoptosis (Majno & Joris, 1995). DENV C protein-induced apoptosis 
was captured live for the first time via time-lapsed live cell imaging. This result 
elucidated the observation in Figure 3.6 where lower number of transfected cells was 
observed at 48 hr post-transfection.  
 




Figure 3.9: Time-lapse experiment showing the localization of DENV C proteins 
in BHK cells. BHK cells are transfected with GFP-tagged DENV C plasmid before 
viewing using Nikon Live Cell Imaging System (Nikon, Japan). Green fluorescence 
and phase contrast images of the cells were captured at every half an hour interval. 
Images shown here are the overlay images of GFP fluorescence and phase contrast 
microscopy at every one hour interval from 21 hr to 34 hr post-transfection. Nuclear 
localization of C protein is followed in one transfected cell as indicated by white 
arrows. Faint green fluorescence is observed in the nucleus of the cell from 21 hr 
post-transfection onwards. The image at 29 hr post-transfection is enlarged for better 
view of the nuclear localized DENV C protein. DENV C protein-induced apoptosis is 
observed at 32 hr and 33 hr post-transfection.  
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Nevertheless, one major drawback in Figure 3.9 was that the nuclei were not 
clearly distinguishable from the cytoplasm. As a result, it could not indicate 
conclusively that the C proteins were indeed in the nuclei of the transfected cells. To 
rectify this problem, Hoescht 33258 (Sigma, USA) was chosen to stain the nuclei. 
Cytotoxicity test of Hoescht 33258 was carried out to ensure that this stain will not 
affect the physiology of BHK cells. Hence, different concentration of Hoescht 33258 
was added into 6-well plate to examine the effect of this stain on the living BHK cells. 
About 106 cells were seeded into each well and different amounts of Hoescht 33258 
(2 μg to 10 μg) was added. To examine whether Hoescht could stain all cell nuclei, 
immuno-fluorescence images of each well were taken at 24 hr and 48 hr post-
treatment. 
Figure 3.10 showed that 6 μg of Hoescht 33258 was sufficient to stain all the 
cell nuclei consistently at 24 hr post-transfection. The same intensity of blue 
fluorescence was also detected in the wells of 8 μg and 10 μg of Hoescht. Besides, 
Hoescht staining did not affect cell proliferation since the cell density was higher at 
48 hr post-transfection as compared to 24 hr post-transfection (Figure 3.10). Thus, 
Hoescht 33258 could be adopted as a suitable nuclear stain for live imaging in BHK 
cells. 
 




Figure 3.10: Nuclear staining of living BHK cells with Hoescht 33258. Immuno-
fluorescence images showing the nuclei of living BHK cells stained with different 
amount of Hoescht 33258 – 0 μg to 10 μg at 24 hr and 48 hr post-transfection. The 
intensity of blue signal is weak for 2 μg and 4 μg on both days. Similar intensity of 
blue fluorescence can still be detected for 6 μg, 8 μg and 10 μg at both timings. The 
density of cells at 48 hr post-transfection is higher than 24 hr post-transfection, 
indicating that Hoescht does not affect cell proliferation. 




After optimizing the amount of Hoescht 33258 used for nuclear staining, BHK 
cells were transfected with GFP-tagged DENV C plasmid and green fluorescence 
signals were tracked via time-lapsed fluorescence microscopy (Section 2.4.3). For this 
experiment, a new and more user-friendly microscope called BioStation (IM, Nikon, 
Japan) was used. Four different fields of view were chosen to capture the time-lapsed 
images throughout the whole experiment. Green fluorescence, Hoescht staining signal 
and phase contrast images were acquired at every half an hour interval up to 40 hr 
post-transfections. 
 As shown in Figure 3.11, cell nuclei were distinguishable from the cytoplasms 
in the merged images of phase contrast microscopy, Hoescht staining and GFP 
fluorescence microscopy. Faint green fluorescence signal was observed in the 
cytoplasm from 25 hr post-transfection onwards as highlighted by the white arrows. 
The green fluorescence accumulated gradually in the nucleus and concentrated in the 
nucleolus from 26.5 hr onwards. The entire nucleus fluoresced green with highest 
intensity at the nucleoli as highlighted by yellow arrows in the enlarged image (Figure 
3.11). Likewise, similar apoptotic event as observed in Figure 3.9 was also seen here. 
The DENV C protein-transfected cell blebbed and rounded up after accumulation of C 
protein in the nucleoli. 
 




Figure 3.11: Time-lapsed imaging of the nuclear localization of recombinant 
DENV C protein in Hoescht-stained BHK cells. The fluorescence images shown 
here are merged images of phase contrast microscopy, Hoescht staining and GFP 
fluorescence microscopy from 25 hr post-transfection to 29 hr post-transfection at half 
an hour interval. The yellow arrows indicate one of the transfected cells in which GFP 
fluorescence is seen clearly in the nucleus / nucleolus from 26.5 hr to 27.5 hr post-
transfection. The transfected cell at 27.5 hr post-transfection is enlarged and intense 
green fluorescence can be seen clearly in the nucleoli as indicated by white arrows. 
Cell blebbing occurs at 28 hr post-transfection and the cell is rounded up after that.    
 
Figure 3.11 provided more convincing evidence that the GFP-tagged DENV C 
proteins were indeed transported into the nuclei / nucleoli as green fluorescence 
signals were co-localized with the blue fluorescence emitted from Hoescht 33258-
stained nuclei in living cells. The entire transportation process of DENV C protein 
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from the cytoplasm into the nucleus followed by accumulation in the nucleoli was 
demonstrated successfully via this optimized live cell imaging technique in BHK cells. 
In addition, both Figure 3.9 and Figure 3.11 also illustrated that DENV C protein-
transfected underwent apoptosis confirming the results reported by other studies 
(Limjindaporn et al., 2007; Netsawang et al., 2010; Oh et al., 2006; Yang et al., 2008). 
 
3.4. Role of Nuclear Localization Signal (NLS) 
3.4.1. Prediction of functional nuclear localization signal (NLS) motifs 
After confirming the nuclear translocation ability of DENV C protein, the next 
objective of this study was to identify the essential amino acid residues responsible 
for the transportation. There were two contradicting evidences reported by Wang and 
colleagues (2002) and Mori and co-workers (2005). This discrepancy has not been 
resolved thus far. Hence, bioinformatics analysis of all four DENV serotypes was 
performed to screen for potential functional motifs involved in nuclear localization. 
 ScanProsite and MyHits were used to scan the full-length C proteins of all 
four DENV serotypes. Checking with two different bioinformatics software was to 
ensure that there was no discrepancy between software algorithms. Both software 
tools consistently predicted that there were two putative bipartite NLS motifs in all 
four DENV C proteins (Table 3.1). These two putative bipartite NLS motifs were 
located at the N-terminus (residues 5 to 22) and C-terminus (residues 85 to 100) of 
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Table 3.1: Putative bipartite NLS motifs of C protein in all four DENV serotypes. 
Basic residues in the left and right regions in the putative bipartite NLS motifs are 
shown in upper case letters; others are shown in lower case letter. NLS1 denotes 
putative NLS motif at the N-terminus of DENV C protein while NLS2 denotes 
putative NLS motif at the C-terminus.  
Serotypes NLS1 (residue 5-22) NLS2 (residue 85-100) Left Middle Right Left Middle Right 
DENV-1 RKK tgrpsfnml KRaRnR KK eissmlnimn RRKR 
DENV-2 RKK arntpfnml KReRnR RK     eigrmlniln RRRR 
DENV-3 RKK tgkpsinml KRvRnR KK     eisnmlsiin KRKK 
DENV-4 RKK vvrppfnml KReRnR RK eigrmlnilng RKR 
Consensus RKK 9 residues KR-RnR (R/K)2 10-11 residues (R/K)3-4 
 
This scanning result is different from the prediction of Wang and co-workers 
(2002) whereby three putative NLS motifs were predicted at positions 6-9, 73-76, and 
85-100 as shown in Figure 3.12(B). They demonstrated that only putative bipartite 
NLS motif at position 85-100, which was also predicted by ScanProsite and MyHits, 
was important in nuclear localization. Deletion of the first 45 amino acids from the N-
terminus of C protein and mutation of amino acids at position 73-76 did not affect the 
nuclear localization (Wang et al., 2002). However, ScanProsite and MyHits predicted 
that there was another putative bipartite NLS motif from the amino acid residues 5-22, 
which was within the first 45 amino acids from the N-terminus of C protein.  
Both predicted bipartite NLS motifs (Table 3.1) were well conserved in all 
four DENV serotypes. Conservation of amino acid sequences in both regions implied 
that NLS1 and NLS2 could be functionally important. Thus, experiment was carried 
out to examine the functionality of both putative NLS1 (residues 5 to 22) and NLS2 
(residues 85 to 100) as predicted by the software. 
 




Figure 3.12: Schematic diagram of full-length DENV C protein and putative 
NLS motifs. (A) ScanProsite and MyHits predict that there are two putative bipartite 
NLS regions in the DENV C protein, namely NLS1 from residues 5 to 22 and NLS2 
from residues 85 to 100. (B) NLS motifs predicted by Wang and colleagues (2002). 
There are two predicted monopartite NLS motifs located from residues 6 to 9 and 
from residues 73 to 76 while one bipartite NLS motif is located from residues 85 to 
100. Residue 42 and 43 are also found to be essential amino acids for nuclear 
localization of C protein (Mori et al., 2005). 
 
3.4.2. Cloning of green fluorescent protein (GFP)-tagged nuclear localization 
signal (NLS) motif plasmids 
To determine the nuclear translocation role of both putative bipartite NLS 
motifs, NLS1 (amino acid 5 to 22) and NLS2 (amino acid 85 to 100) fragments were 
cloned as fusion proteins with GFP as previously described in Section 3.2. The GFP-
tagged full-length DENV C plasmid generated in Section 3.2 was used as template to 
amplify the two putative NLS fragments.  
Since the size of both putative NLS motifs was too small (approximately 
60 bp) to be eluted out during gel purification, this purification step was bypassed and 
the PCR products were used directly for ligation with the pcDNA3.1/CT-GFP-TOPO 
vector. To minimize the chances of ligating the vector with the full-length C template, 
the amount of template used to amplify NLS fragment was minimized to 30 ng. 
Ligated vectors were transformed into One Shot® TOP 10 chemically competent 
Escherichia coli cells and ten colonies were randomly picked for colony PCR.  
Figure 3.13 shows the molecular sizes of the C gene, NLS1 and NLS2 
fragments in 8 % non-denaturing polyacrylamide gel with Tris/Borate/EDTA (TBE) 
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buffer (Appendix 3e and 3f). The full-length C gene was about 350 bp while NLS1 
and NLS2 were about 60 bp as indicated by the arrows.  
 
Figure 3.13: Gel electrophoresis image of NLS1 and NLS2 fragments. Eight 
percent non-denaturing polyacrylamide gel is used to resolve small NLS fragments 
which are about 60 bp as indicated by arrow. Full-length DENV C gene, which is 
approximately 350 bp, is also included for reference.  
 
DNA sequencing was carried out to confirm the DNA insert and its orientation.  
The amino acid sequences for the insertion were checked with ExPASy (Expert 
Protein Analysis System) - Translate tool to confirm the insertion was in frame with 
the vector. Appendix 8 (b-c) showed the DNA sequences of NLS1 and NLS2 
plasmids together with the conceptual translation of the DNA sequences. 
  
3.4.3. Immuno-fluorescence microscopy study on NLS clones 
 Generated NLS1 and NLS2 plasmids were transfected into BHK cells 
(Section 2.3.6) on coverslips and fixed at 24 hr post-transfection (Section 2.4.1). The 
localization of GFP-tagged putative NLS motifs was visualized under fluorescence 
microscope IX-81 (Olympus, Japan) at 100 x magnification. As shown in Figure 3.14, 
both NLS 1 (A) and NLS2 (B) motifs were indeed functional as bright green 
fluorescence could be detected in the DAPI-stained nuclei. The pattern of localization 
observed for NLS motifs was similar to full-length C protein [Figure 3.2(A)]. This 
indicated that DENV C protein contained another functional bipartite NLS motif at 
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the N-terminus from residues 5 to 22 in addition to the reported NLS motif at the C-
terminus from residues 85 to 100 (Wang et al., 2002). Both functional NLS motifs 
were responsible for the nuclear localization of DENV C proteins. 
 
Figure 3.14: Immuno-fluorescence images of GFP-tagged putative NLS motifs. 
The localization of putative NLS motifs is visualized under fluorescent microscope 
using 100 x magnifications with oil immersion. DAPI is used to stain the nuclei. Both 
NLS1 (A) and NLS2 (B) motifs localize in the nucleoli as indicated by white arrows 
in the merged images. 
 
The immuno-fluorescence images shown in Figure 3.14 were representatives 
of the majority population observed. As previously demonstrated in Section 3.3.1, not 
all C protein-transfected cells exhibited complete nuclear localization. To determine 
the role of NLS motifs in bringing GFP tag into nuclei / nucleoli, the number of cells 
showing complete or partial nuclear localization was counted manually under the 
microscope. At least 100 transfected cells were tabulated for each clone.  
Figure 3.15 showed that there was approximately 70 % of the full-length C 
protein-transfected cells showed complete nuclear localization. However, less than 40 % 
of NLS1 motif-transfected cell and approximately 50 % NLS2 motif-transfected cells 
showed green fluorescence at the nuclei only. This result could possibly be explained 
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that NLS motif alone was not as effective in bringing GFP tags into the nuclei as 
compared to full-length C protein. Nonetheless, NLS2 motif was slightly more 
efficient in nuclear translocation compared to NLS1 motif.  
 
Figure 3.15: Percentage of NLS motif-transfected cells showing different 
localization patterns in the cells. Full-length C protein is also included for 
comparison. The percentage of NLS motif-transfected cells showing complete nuclear 
localization at 24 hr post-transfection is significantly lower than full-length C protein-
transfected cells (P=0.001). Higher percentage of NLS2-transfected cells shows 
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3.5. Delineating Pivotal Amino Acid Residues for Nuclear Localization of 
Dengue Virus (DENV) Capsid (C) Protein 
3.5.1. Single site-directed mutagenesis of capsid (C) protein 
Wang and co-workers (2002) demonstrated that NLS2 from residues 85 to 100 
was crucial for nuclear localization of DENV C protein using truncated clones. 
However, deletion of amino acid domains may affect proper folding of C protein. To 
overcome this flaw, site-directed mutagenesis was performed in this study on selected 
amino acid residues to minimize the negative impact on protein folding.  
 It was demonstrated structurally that bipartite NLS bound to its receptor 
protein via its basic amino acid clusters (Fontes et al., 2000). As such, the binding 
ability of NLS-containing proteins to its transporting proteins would be affected if the 
basic residue clusters were disrupted. With this information, basic residues of bipartite 
NLS1 (amino acids 5 to 22) and NLS2 (amino acids 85 to 100) on full-length 
recombinant C proteins were substituted with alanine residue. In addition, residues 42 
and 43 were also mutated to alanine to examine whether these mutations would also 
abrogate the nuclear localization of DENV-2 C proteins as reported by Mori and 
colleagues (2005). The mutated amino acid sequences of all the mutants generated for 
this experiment were shown in Figure 3.16. DNA sequencing was carried out to 
ensure that there was no extra mutation. The DNA and protein sequences of all the 
mutated clones were included in Appendix 8 (d-h).  
 
 




Figure 3.16: Schematic diagram showing the positions of mutation on different 
mutated clones. Basic residues of bipartite NLS and residues 42-43 on full-length C 
protein are mutated to alanine to examine the importance of the residues for nuclear 
localization of DENV C proteins.  
 
 As shown in Figure 3.17, different mutations on NLS affected the nuclear 
localization ability of C protein to varying degrees. Transfected cells with R5A & 
K6A mutant clearly showed higher cytoplasmic fluorescence as compared to normal 
C protein [Figure 3.2(A)]. The green fluorescence could be detected in the nuclei as 
well as the cytoplasm. Figure 3.17(B) showed that only sparse green fluorescence 
signals were detected in the nuclei for mutant K17A & R18A. Most of the C proteins 
were at the perinuclear region. Mutations on residues 42 and 43 did not completely 
abrogate the nuclear localization of C proteins as bright GFP fluorescence was still 
clearly observed in the nuclei / nucleoli with some green fluorescence at the 
perinuclear region [Figure 3.17(C)]. As for R85A & K86A mutant, intense GFP 
fluorescence was observed at the nuclei clusters and also well-defined perinuclear 
membrane region [Figure 3.17(D)]. Mutation on the second basic residue cluster at 
the C-terminus of NLS2, from residues 97 to 100, resulted in most severe outcome. 
Nuclear localization was abolished and transfected cells showed cytoplasmic 
localization of C proteins only [Figure 3.17(E)]. Therefore, not all four basic-residue 
clusters contributed equally to the translocation of C protein into the nucleus. 




Figure 3.17: Determination of the key amino acid residues responsible for 
nuclear localization of C protein. The immuno-fluorescence images represent the 
majority localization pattern shown by the respective mutated clones. Green 
fluorescence is clearly visualized in the cytoplasm for R5A & K6A (A). K17A & 
R18A mutants (B) show intense GFP fluorescence in the perinuclear region with 
lower intensity of fluorescence in the nuclei. G42A & P43A (C) also show intense 
GFP fluorescence in the nuclei with low intensity of fluorescence in the cytoplasm. 
Whereas intense GFP fluorescence is observed in the nuclei clusters of R85A & 
K86A (D) transfected cells with weak cytoplasmic fluorescence but with well-defined 
nuclear membrane staining. R(97-100)A mutant (E) is the only clone that show no 
nuclear translocation of C proteins. The green fluorescence is observed at the 
perinuclear regions as well as the cytoplasm. Wild type C protein without mutation (F) 
is included as control. 
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To determine the degree of involvement of the amino acid residues in nuclear 
localization of DENV C protein, at least 100 transfected cells showing complete, 
partial or abolished nuclear localization were counted under the microscope. Figure 
3.18 provided evidence that single-site mutations on the NLS motifs of full-length C 
protein negatively affected the nuclear translocation of C protein to different degrees. 
The percentages of R5A & K6A (42 %), K17A & R18A (38 %), G42A & P43A 
(45 %) and R85A & K86A (33 %) mutants showing complete nuclear localization 
were significantly lower than full-length C protein (70 %) in Figure 3.15. In other 
words, these mutations induced partial blockage to the nuclear localization of C 
proteins. In contrast, mutations at amino acid residues 97 to 100 resulted in complete 
abrogation of nuclear localization of C proteins as no green fluorescence was 
observed in the nuclei [Figure 3.17(E) and Figure 3.18].  
Approximately 13 % of the cells exhibited localization of GFP-C protein in 
the nuclei and perinuclear regions. The fluorescence was markedly more pronounced 
in the perinuclear regions and cytoplasm. Besides, it was observed that the second 
basic-residue cluster in both bipartite NLS motifs appeared to be more important than 
the first basic-residue cluster [Figure 3.17(A, B, D and E) and Figure 3.18]. Taken 
together, it could be inferred that among four basic-residue clusters in bipartite NLS1 
and NLS2 motif, amino acid residues 97 to 100 in NLS2 motif were the most pivotal 
residues responsible for nuclear translocation of DENV C protein.  
 




Figure 3.18: Percentage of transfected cells showing different localization of GFP 
fusion proteins for different clones. Mutants R5A & K6A, K17A & R18A, G42A & 
P43A and R85A & K86A show a mixture of complete and partial nuclear localization 
except mutant R(97-100)A exhibiting minority of partial and majority of non-nuclear 
localization. 
 
3.5.2. Multiple site-directed mutagenesis of C protein 
The results so far were not sufficient to justify the need and pre-existence of 
two bipartite NLS motifs if only amino acid residues 97 to 100 were needed for 
nuclear translocation. Thus, further characterization of the involvement of NLS1 and 
NLS2 motifs in the nuclear localization of C proteins was investigated. To further 
examine the role of NLS motifs, multiple site-directed mutagenesis were performed 
on double basic-residue clusters [R5A & K6A & K17A & R18A and R85A & K86A 
& R(97-100)A] and all four basic residue clusters simultaneously (∆all) as shown in  
Figure 3.19.  
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To generate double mutation sites, single-site mutant clones generated in 
Section 3.5.1 were used as templates. Primers for mutation on residues 17 & 18 were 
used on R5A & K6A plasmid to produce R5A & K6A & K17A & R18A clone. While 
primers for mutation on residues 85 & 86 were used on R(97-100)A plasmid to 
generate R85A & K86A & R(97-100)A clone. This procedure was repeated until all 
four basic residues clusters were mutated to generate ∆all clone [R5A & K6A & 
K17A & R18A & R85A & K86A & R(97-100)A]. The DNA sequences and the 
conceptual translation of these mutant sequences are included in Appendix 8 (i-k). 
 
Figure 3.19: Schematic diagram of clones with multiple mutations. Both basic-
residue clusters in each NLS motif are mutated to alanine to study the effect of NLS 
mutation on the full-length C protein. 
 
 
Figure 3.20(A) indicated that double mutations on both the basic-residue 
clusters of NLS1 motif (R5A & K6A & K17A & R18A) did not abolish the nuclear 
localization of C proteins completely. Bright green fluorescence clusters were still 
seen in the nuclei / nucleoli of the transfected cells with more accumulation at the 
perinuclear regions. On the other hand, double-sites mutations on NLS2 motif [R85A 
& K86A & R(97-100)A] [Figure 3.20(B)] showed the same effect as with single-site 
mutation on the second basic-residue cluster [R(97-100)A] [Figure 3.17(E)]. The 
nuclear localization of C protein was completely absent in all the transfected cells. 
Likewise, no green fluorescence signal was detected in the nuclei / nucleoli of 
transfected cells when all the basic-residue clusters were mutated (∆all) [Figure 
3.20(C)]. DENV C proteins were only seen in the perinuclear regions or cytoplasm.  




Figure 3.20: Immuno-fluorescence images of clones with multiple mutations. 
Both basic-residue clusters in each NLS motif are mutated to alanine. Green 
fluorescence clusters are still observed in the nuclei although NLS1 motif namely 
R5A & K6A & K17A & R18A (A) is mutated. Nuclear localization of C protein is 
completely abolished when NLS2 motif namely [R85A & K86A & R(97-100)A (B)] 
is mutated. No green fluorescence appears in the nuclei when all basic residue clusters 
of both NLS motifs are mutated in ∆all (C).  
 
Cell count was also performed to quantify the effect of mutations on nuclear 
translocation of C proteins. Alanine replacement on both basic-residue clusters of 
NLS1 motif (R5A & K6A & K17A & R18A) reduced the number of cells showing 
complete nuclear localization to about 40 % as shown in Figure 3.21. This percentage 
was not much different from the single-site mutation on the basic-residue cluster of 
NLS1 motif (Figure 3.18). On the other hand, the percentage of transfected cells 
showing partial nuclear localization of C protein was further reduced from 
approximately 13 % to 7 % when residues 85 & 86 were also mutated on R(97-100)A 
clone (Figure 3.21). The effect of nuclear import abrogation was even more 
pronounced when all basic-residue clusters of NLS1 and NLS2 motifs were mutated 
to alanine residues. None of the transfected cells (0 %) exhibited nuclear localization 
of C protein for ∆all mutant [R5A & K6A & K17A & R18A & R85A & K86A & 
R(91-100)A] (Figure 3.21).  




Figure 3.21: Percentage of transfected cells showing different localization 
patterns of mutated C proteins. Green fluorescence still can be detected in the 
nuclei even though both basic residue clusters are mutated in NLS1 (R5A & K6A & 
K17A & R18A). The effect of mutation on NLS2 [R85A & K86A & R(97-100)A] is 
more drastic where 93 % the transfected cells show cytoplasmic localization of C 
proteins. The nuclear localization of C protein is completely abolished when both the 
bipartite NLS motifs are mutated ∆all [R5A & K6A & K17A & R18A & R85A & 
K86A & R(97-100)A]. 
 
In summary, Sections 3.4 and 3.5 indicated that bipartite NLS1 motif is 
functional. However, it contributed a minor role in translocating the DENV C proteins 
into the nuclei. Based on the percentages of ∆all and [R85A & K86A & R(97 -100)A] 
in Figure 3.21, bipartite NLS1 motif might only contribute an additional  7 % towards 
enhancing the nuclear localization of C proteins when bipartite NLS2 motif was 
present and functional. As such, this could also explain why deletion of 45 amino 
acids from the N-terminus did not abolish the nuclear localization of C protein as 
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published by Wang and colleagues (2002). The results from this study further 
revealed that amino acid residues 97 to 100 were sufficient to abolish nuclear 
localization of DENV C proteins. Simultaneous mutations on all basic-residue 
clusters of both bipartite NLS motifs could completely abolish the C protein nuclear 
transportation. The data so far corroborated that there were two functional bipartite 
NLS motifs in DENV C proteins in which NLS2 motif, particularly residues 97-100, 
played the major role in nuclear translocation with NLS1 motif (residues 5 to 22) 
having a minor role in the process. 
 
3.6. Effect of R(97-100)A Mutations on Dengue Virus (DENV) Replication 
 To examine whether mutations on residues 97-100 of DENV C protein will 
have any effect upon DENV virus replication, alanine substitutions were introduced 
on those residues in the DENV-2 infectious clone, pDVWS601 (Gualano et al., 1998; 
Pryor et al., 2001), as described in Section 2.3.9. After confirming there was no 
additional mutation on the mutant infectious clone, in vitro transcription was 
performed on the linearized full-length and mutant infectious clones (Section 2.3.10) 
to generate infectious RNA. The infectious RNA of full-length and mutant infectious 
clones was then transfected into BHK cells according to Section 2.3.6 to produce 
virus progeny. At various post-transfection time courses, supernatant of the 
transfected BHK cells were harvested for growth kinetic analysis and immuno-
fluorescence microscopy (Section 2.4.2) was carried out to detect the expression of 
viral proteins in the transfected BHK cells.  
Figure 3.22(A) showed that the in vitro transcribed RNA of full-length [(IC) 
(i)] and mutant [(IC97) (ii)] infectious clones was infectious because the expression of 
DENV envelope (E) proteins were detectable by anti-DENV 4G2 antibody (Henchal 
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et al., 1982) as indicated by white arrows. However, unlike the full-length infectious 
clone (IC), mutant infectious clone (IC97) was unable to produce viable infectious 
virus particles as indicated by the growth kinetic and plaque assay data in Figure 
3.22(B). Similar to West Nile virus (WNV) C protein (Bhuvanakantham et al., 2009), 
this result implicated that nuclear translocation of DENV C protein was a crucial 
event during the life cycle of DENV. Hence, nuclear phase of flavivirus C protein is 
important and warrants further investigation. 
 
Figure 3.22: Effect of R(97-100)A mutations on DENV replication. (A) Expression 
of envelope protein is detected using anti-DENV 4G2 antibody, followed by anti-
mouse Alexa Fluor-594 secondary antibody. Overlay images of DAPI (nuclei) and red 
fluorescence indicates that viral protein synthesis is taking place inside the transfected 
cells for both the full-length [(IC) (i)] and mutant [(IC97) (ii)] infectious clones as 
indicated by the white arrows. (B) Supernatant of the infectious RNA-transfected cells 
is harvested at various time points for growth kinetic analysis. Viable virus progeny 
from IC can be detected via plaque assay but IC97 mutant fails to produce detectable 
level of viable virus particles.     
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3.7. Importins-α/β Imports Dengue Virus (DENV) Capsid (C) Protein into 
Nucleus 
3.7.1. Identifying nuclear transporting partner of Dengue virus (DENV) capsid 
(C) protein 
After identifying the important residues responsible for the nuclear 
localization of DENV C protein, this project continued to unravel the host interacting 
partner of C protein involved in the nuclear entry process. Importin proteins are well-
studied nuclear transport factors that bind to NLS-bearing proteins. Importin-α protein 
is known to bind to NLS motif and acts as a bridge to importin-β protein that brings 
the whole complex to nuclear pore complex (NPC) for translocation. However, 
importin-β protein is also able to transport some NLS-containing proteins directly 
without the aid of importin-α protein (Gorlich & Mattaj, 1996). Hence, it is intriguing 
to examine whether the nuclear localization of C protein is mediated by importin-α or 
importin-β protein. 
 Co-immunoprecipitation (co-IP) was carried out to pull down GFP-tagged C 
proteins from DENV C-transfected cell lysate using anti-GFP antibodies conjugated 
to magnetic beads. The C protein of WNV was also included in this study as a 
positive control since WNV C protein was shown to interact with importin-α protein 
(Bhuvanakantham et al., 2009). GFP control plasmid was included as negative control. 
The pulled-down C proteins and any C protein-interacting proteins were resolved in 
SDS-PAGE and the presence of importin-α/β protein was detected by anti-importin-α 
and anti-importin-β antibodies (Sigma, USA). The presence of C proteins in the cell 
lysates and eluates was detected using anti-GFP antibody (Santa Cruz, USA).  
As shown in Figure 3.23(A), immunoprecipitation was successful because 
GFP bands were observed after pull-down. No band was detected in mock-transfected 
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cells (Lanes 4 and 8) indicating that the GFP antibody was specific. Figure 3.23(B) 
indicated that there was a novel interaction between DENV C protein and importin-α 
protein. Bands were observed in Lanes 5 and 6 where DENV and WNV C proteins 
were co-immunoprecipitated using anti-GFP antibodies as indicated by arrows. 
Similar bands were not seen in Lanes 7 and 8 where GFP-control plasmid and 
Lipofectamine 2000 were used.  
It implied that C protein and not GFP tag interacted specifically with importin-
α protein. Hence, this result demonstrated that DENV C protein also interacted with 
importin-α protein, just as WNV C protein. However, no bands were observed from 
Lane 5 to Lane 8 when anti-importin-β antibody was used for detection [Figure 
3.23(C)]. This indicated that there was no direct interaction between DENV C 
proteins or GFP tag with importin-β protein. Lanes 1 to 4 (Figure 3.23) showed the 
endogenous importin-β proteins in the cell lysates before pull-down. This result 
showed that nuclear localization of DENV C proteins was mediated by importin-α/β 










Figure 3.23: Interaction between C protein and importin-α/β proteins. (A) Anti-
GFP antibody is used to detect the presence of GFP-tagged C proteins and GFP 
control. Pull-down is successful because GFP bands can be observed from Lanes 5 to 
7. (B) Anti-importin-α antibody is used to detect for the presence of importin-α 
protein in Western-blot. Bands are observed in Lanes 5 and 6 as indicated by arrows 
but not in Lanes 7 and 8 implying that DENV and WNV C proteins interacted with 
importin-α protein. (C) The same samples are loaded into another gel in the same 
order but anti-importin-β antibody is used for Western-blot. No bands can be 
observed from Lanes 5 to 8. Lanes 1-4 show the endogenous importin-α/β in the cell 
lysates. (Lanes 1 & 5 – DENV C protein; Lanes 2 & 6 – WNV C protein; Lanes 3 & 7 
– GFP control; Lanes 4 & 8 – Mock-transfected cells; co-IP – co-immunoprecipitation; 
WB – Western blot ). 
 
To further confirm the interaction between DENV C and importin-α proteins, 
reciprocal co-IP was carried out using anti-importin-α antibodies conjugated to 
magnetic beads. Anti-GFP antibodies were used to detect the presence of DENV C 
protein in the eluates. In addition to full-length DENV C protein, various NLS 
mutants (G42A & P43A, R85A & K86A, R(97-100)A, and R85A & K86A & R(97-
100)A) were also included to study the interacting domain of DENV C protein with 
importin-α protein. Since R5A & K6A and K17A & R18A mutants did not impose 
great impact on the nuclear translocation of DENV C protein as shown in Figure 
3.17(A and B), they were not included in this co-IP study. ∆NLS mutant in which the 
C-terminal DENV C protein from residues 85 onwards was removed, was generated 
and included in this experiment.  
Figure 3.24(A) demonstrated that co-IP using anti-importin-α antibodies was 
also successful as importin-α bands were observed after pull-down. Besides, co-IP 
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using anti-importin-α antibodies was much better than anti-GFP antibodies (Figure 
3.23) because more intense bands were observed in the eluates when anti-GFP 
antibodies were used for detection. Surprisingly, the binding between mutant R(97-
100)A and importin-α protein was not affected at all because band was still observed 
in Lane 5 after co-IP. This was contradictory with the immuno-fluorescence 
microscopy data in Figure 3.17(E).  
Densitometry analysis using ImageJ software revealed that the binding affinity 
between DENV C protein and importin-α protein was only affected for mutant 
R85A&K86A&R(97-100)A. There was approximately 50 % reduction in the band 
intensity as shown by Figure 3.24(B). However, the nuclear translocation of mutant 
R85A&K86A&R(97-100)A was completely abolished under immuno-fluorescence 
microscopy [Figures 3.20(B) and 3.21]. The binding between importin-α and DENV 
C proteins was only abrogated when NLS2 motif was removed completely from the 
full-length C protein (ΔNLS) [Figure 3.24(A and B)].  
The result of ∆NLS mutant (Figure 3.24) tallied with WNV C protein 
(Bhuvanakantham et al., 2009) whereby the binding between importin-α and WNV C 
proteins were completely abolished when the NLS motif at the C-terminus was 
removed. These results implied that NLS2 motif was essential for the binding of 
DENV C protein to importin-α protein but the binding strength did not rely merely on 
the basic residues clusters of NLS motif. Alanine substitution mutagenesis on the 
basic residues clusters did not completely abolish the binding ability of DENV C 
protein to importin-α protein.  
 




Figure 3.24: Co-immunoprecipitation study on various NLS mutants and 
importin-α protein. (A) Various mutated clones are pulled down with anti-importin-
α antibody and detected with anti-GFP antibody. Faint bands are still observed in 
most of the mutants except ΔNLS where the entire C-terminus (residues 85-114) is 
removed from full-length C protein (Lane 1 – mock-transfected; Lane 2 – full-length 
C protein; Lane 3 – G42A & P43A mutant; Lane 4 – R85A & K86A mutant; Lane 5 – 
R(97-100)A mutant; Lane 6 – R85A & K86A & R(97-100)A; Lane 7 – ∆NLS mutant). 
(B) Densitometry analysis using ImageJ software. The GFP band intensities are 
normalized against respective importin-α band intensity for each clone. Relative 
density is calculated by using full-length DENV C protein as the baseline.  
 
3.7.2. Determining binding strength of DENV C protein and importin-α 
Other than densitometry analysis on Western-blot results, mammalian-2-
hybrid (M2H) assay (Section 2.3.7) was also carried out to quantify the binding 
strength between DENV C and importin-α proteins. Importin-α gene was amplified 
from BHK total RNA and cloned into pFN11A (BIND) vector so that importin-α 
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protein would be fused to the C-terminus of GAL4 DNA-binding domain. Whereas, 
DENV-2 C gene was amplified from GFP-tagged C protein plasmid and ligated with 
pFN10A (ACT) vector so that DENV C protein would be at the C-terminus of VP16 
transcriptional activation domain. If DENV C protein bound to importin-α protein, 
VP16 activation domain and GAL4 DNA-binding domain would be brought together 
resulting in transcriptional activation of a firefly luciferase reporter gene as shown in 
Figure 3.25. Firefly luciferase enzyme could be measured easily via luciferase assay 
and a luminometer. Renilla luciferase enzyme would also be expressed for 
normalization of the transfection efficiency of both vectors.  
 
 
Figure 3.25: Illustration of mammalian-2-hybrid concept. Importin-α protein is 
fused with GAL4 DNA-binding domain while DENV C protein is fused with VP16 
activation domain. When DENV C protein binds to importin-α protein, firefly 
luciferase reporter gene will be activated. 
 
Figure 3.26 showed the importin-α gene (A) and full-length DENV C gene (B) 
were ligated with pFN11A (BIND) and pFN10A (ACT) vectors, respectively. The 
DNA sequences and the conceptual translation of the sequences of both genes were 
included in Appendix 8 (l-m). 
 




Figure 3.26: Cloning of importin-α (A) and full-length DENV C (B) genes into 
mammalian-2-hybrid vectors. Importin-α and DENV C genes are approximately 
1587 bp and 342 bp, respectively as indicated by the arrows.  
 
Subsequently, M2H assay was performed to measure the binding strength of 
full-length DENV C protein and mutated proteins with importin-α protein. Mutants 
R5A&K6A&K17A&R18A (DM1), R85A&K86&R(97-100)A (DM2) and Δall 
(DM1M2) were also generated from the mutated clones produced in Section 3.5.2. 
Figure 3.27(A) showed that the binding strength of DENV C protein with importin-α 
protein was reduced to about 50 % when NLS1 motif was mutated (DM1). The 
binding strength was further reduced to 20 % when NLS2 motif was mutated (DM2) 
and less than 20 % when both NLS1 and NLS2 motifs were mutated (DM1M2). 
Figure 3.27(B) showed the relative protein expression level in all the samples. The 
transfection efficiency among all the samples was quite equal.  
 




Figure 3.27: Mammalian-2-hybrid assay on the binding strength of importin-α 
protein with full-length DENV C and mutated proteins. (A) The relative 
Firefly/Renilla activities of full-length DENV C protein and C protein mutants [DM1 
(R5A&K6A&K17A&R18A), DM2 (R85A&K86&R(97-100)A) and DM1M2(Δall)] 
are measured and plotted. An arbitrary value of 1 is set for the binding efficiency of 
full-length DENV C protein and importin-α association. The binding efficiency 
between C protein and importin-α is reduced up to 50% for DM1 mutant (P=0.008) 
and 80% for DM2 (P=0.0008) and DM1M2 (P=0.0007) mutants. (B) To normalize 
the transfection efficiency among all the samples, Renilla luciferase activities are 
measured. The protein expression levels among all the samples are similar..   
 
 Taken together, Section 3.7 corroborated the fact that importin-α protein was 
the transporting partner of DENV C protein and both NLS motifs were vital for the 
binding to importin-α protein. NLS2 motif was the main interacting domain of DENV 
C protein but either one of the basic-residues clusters was sufficient for the binding to 
importin-α protein.  
 
3.8. Role of Phosphorylation in Nuclear Localization of Dengue Virus (DENV) 
Capsid (C) Protein 
Increasing evidence showed that phosphorylation was the key regulator in 
controlling the binding of importin-α protein to its targeting partners for nuclear 
translocation (Bian et al., 2007; Jans et al., 2000; Lu & Ou, 2002). Recently, 
Bhuvanakantham and her colleagues (2010) demonstrated that nuclear localization of 
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WNV C protein was regulated by protein kinase C (PKC)-mediated phosphorylation. 
Thus, it was hypothesized that nuclear localization of DENV C protein would be 
regulated similarly by phosphorylation process. Bioinformatic analyses using NetPhos 
2.0 and Eukaryotic Linear Motif (ELM) predicted that DENV C protein was indeed a 
phosphoprotein that could be phosphorylated by various kinases as shown in Table 
3.2. Similarly, two different bioinformatics software were used to ensure that there 
was no discrepancy between software algorithms. 
 
Table 3.2: Putative phosphorylation sites on DENV C protein. Putative 
phosphorylation sites are underlined and respective protein kinases acting on the 
putative phosphorylation sites are shown. 
Enzymes Position Amino Acid Sequences 




Protein Kinase B 
(PKB) 
20-28 RNRVSTVQQ 
Protein Kinase C 
(PKC) 
 30-32  TKR 
71-73 TIK 
 
 As shown in Table 3.2, five putative phosphorylation sites were predicted and 
DENV C protein could potentially be phosphorylated by all three protein kinases 
(Protein Kinase A, B and C) for different purposes. It was reported that 
phosphorylation was also involved in regulating the binding of viral RNA to C protein 
(Cheong & Ng, 2011; Law et al., 2003). Therefore, the five putative phosphorylation 
sites may not be solely responsible for nuclear localization but also for viral RNA 
interaction. To investigate if the putative phosphorylation site(s) was/were essential in 
regulating the nuclear localization of DENV C protein, site-directed mutagenesis was 
carried out to mutate all these five putative phosphorylation sites to alanine (Figure 
3.28). The DNA sequences and the conceptual translation of the sequences of all the 
mutated clones were included in Appendix 8 (n-r).  






Figure 3.28: Schematic diagram of clones with mutation on putative 
phosphorylation site. Single site-directed mutagenesis is carried out on the five 
putative phosphorylation site of full-length DENV C protein.  
 
After obtaining the phosphorylation-site mutated clones, the effect of the 
mutations on nuclear localization of DENV C protein was examined under 
fluorescence microscope. As shown in Figure 3.29, most of the putative 
phosphorylation sites did not affect the nuclear localization of C proteins as green 
fluorescent was still observed in the nuclei for mutant T25 [Figure 3.29(A)], T30 
[Figure 3.29(B)], S34 [Figure 3.29(C)], and T101 [Figure 3.29(E)]. The result 
indicated that phosphorylation site at residue 71 (T71A) [Figure 3.29(D)] may have a 
functional role in regulating nuclear translocation of DENV C protein as green 
fluorescence was detected mostly at the perinuclear regions with residual fluorescence 
in the nuclei. 
According to Table 3.2, residue 71 is a putative phosphorylation site by 
protein kinase C (PKC). Hence, the role of PKC in mediating nuclear translocation of 
DENV C protein was investigated. Baby Hamster Kidney (BHK) cells seeded on 
coverslips were transfected with GFP-tagged C protein plasmid and treated with PKC 
inhibitor bisindolylmaleimide (Bis) according to Section 2.4.4.  
 




Figure 3.29: Effect of mutations on the putative phosphorylation sites of DENV 
C protein. Distinct green fluorescence signals are still detected in the nuclei for 
mutants T25A (A), T30A (B), S34A (D) and T101A (E). Only T71A (D) exhibits 
higher concentration of green fluorescence at the perinuclear regions with residual 
fluorescence in the nuclei.  
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As shown in Figure 3.30(A), majority of the green fluorescence was observed 
in the cytoplasm after treatment with PKC inhibitor. DENV C protein was unable to 
enter nuclei when the phosphorylation activity by PKC was inhibited. However, when 
protein kinase A (PKA) inhibitor, H-89 dihydrochloride, was used [Figure 3.30(B)], 
no effect was observed as compared to non-treatment [Figure 3.30(C)]. Bright green 
fluorescence was still seen in the nuclei / nucleoli of transfected cells. Hence, the 
effect of PKC inhibitor on nuclear localization of C protein was specific. 
 
 
Figure 3.30: Role of protein kinase C on nuclear localization of DENV C protein. 
BHK cells are transfected with C-GFP plasmid and treated with (A) 
bisindolylmaleimide [(Bis) (PKC inhibitor)] and (B) H-89 dihydrochloride (PKA 
inhibitor). Majority of DENV C protein appears in the cytoplasm after treatment with 
Bis. However, PKA inhibitor has no effect on the nuclear localization of C protein 
because intense green fluorescence is still observed in the nuclei / nucleoli, which is 
similar to that of without treatment (C). 
 
The result from this chapter allowed the understanding of the translocation 
mechanism of DENV C protein into the cell nucleus and a molecular mechanism 
model is proposed as shown in Figure 3.31. The first step is phosphorylation of 
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residue 71 of DENV C protein by protein kinase C. The phosphorylated DENV C 
protein proceeds to interact with importin-α protein via NLS2 motif of DENV C 
protein before engaging with importin-β protein allowing the DENV C-importinα-
importinβ complex to translocate into the nucleus. NLS1 motif (residue 5-22) of 
DENV C protein enhances this nuclear translocation either by helping NLS2 motif to 
bind more strongly to importin-α protein or by facilitating the binding of importin-β 
to importin-α protein. 
 
Figure 3.31: Proposed model of nuclear transportation of DENV C protein. 1. 
DENV-2 C protein is phosphorylated by protein kinase C at amino acid residue 71. 2. 
Phosphorylated form of C protein is recognized by importin-α protein. Importin-α 
protein binds to phosphorylated C protein at bipartite NLS2 motif. NLS1 motif 
enhances the binding between C protein and importin-α protein. 3. Importin-β protein 
binds to importin-α protein and brings the whole complex into the nucleus.   
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Nuclear translocation of C protein is an essential step during the replication of 
DENV. However, the roles of nuclear localization of DENV C protein are not 
resolved thus far. Investigating the non-structural roles of C protein in the nucleus will 
allow better understanding of the pathogenesis of flavivirus. The subsequent chapters 
will unravel this missing puzzle to understand the significance of DENV C protein 
nuclear phase during flavivirus replication.  




4.  Expression and Purification of Dengue Virus (DENV) 
Capsid (C) Protein 
4.1. Introduction 
Other than delineating the molecular mechanism of nuclear translocation of 
Dengue virus (DENV) capsid (C) protein, another main objective of this project was 
to unravel novel non-structural roles of DENV C protein in the nucleus. High-
throughput screening for novel interacting partners of DENV C protein using 
ProtoArray® technology of human protein microarray was selected. Therefore, highly 
purified DENV C protein was obligatory before the screening can proceed. In this 
chapter, various challenges that were encountered and ways to overcome them during 
the expression and purification of DENV C protein to use on the ProtoArray® 
technology were described. 
 
4.2. Expression and Purification of Dengue Virus (DENV) Capsid (C) Protein 
in Mammalian System 
4.2.1. Molecular cloning of FLAG-tagged dengue virus (DENV) capsid (C) 
protein 
 In order to generate recombinant DENV C protein in a protein folding 
environment that is closer to the wild-type viral C protein, mammalian amino (N)-
terminal FLAG stable expression kit (Sigma, USA) was chosen. DENV C protein is a 
small protein comprising 114 amino acids with molecular weight of approximately 12 
kDa. Thus, FLAG peptide which is an octapeptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-
Lys) would be an ideal tag as its small molecular size would be highly unlikely to 
affect the folding of DENV C protein. pFLAG-CMV-3 vector was selected because it 
contained a preprotrypsin (PPT) leader sequence that would result in secretion of the 




FLAG fusion protein into culture media. Hence, a stable cell line expressing FLAG 
fusion protein can be generated and the recombinant proteins can be easily harvested 
continuously from the culture media. 
 Figure 4.1 showed the molecular cloning of FLAG-tagged full-length DENV 
C protein using pFLAG-CMV-3 vector. To increase the binding strength of FLAG 
fusion protein during purification step, an additional FLAG peptide was included at 
the N-terminus of DENV C protein. A thrombin cleavage site was inserted in between 
DENV C protein and FLAG peptides for tags removal after purification. To insert the 
thrombin cleavage site and an additional FLAG peptide, overlap extension-PCR (OE-
PCR) technique was employed using two overlapping forward primers (Section 2.3.3; 
Table 2.4). The final PCR product was cloned into pFLAG-CMV-3 vector via HindIII 
and BamHI restrictive enzyme recognition sites. Positive clones were sent for DNA 
sequencing to ensure the insert was in frame with the vector and no extra mutation. 




Figure 4.1: Cloning of FLAG-tagged full-length DENV C protein. An additional 
FLAG peptide is included at the upstream of DENV C gene before the thrombin (Tb) 
cleavage site. The final PCR product is ligated into pFLAG-CMV-3 vector at the 
downstream of preprotrypsin (PPT) leader sequence and FLAG peptide.  




4.2.2. Pilot screening of FLAG-tagged full-length dengue virus (DENV) capsid 
(C) protein expression 
 After obtaining FLAG-tagged DENV C protein plasmid, pilot screening was 
performed to examine its expression in 293FT cells. 293FT cell line is a fast-growing 
variant of human embryonic kidney (HEK)-293 cell line stably-expressing the SV40 
large T antigen. Comparatively, 293FT cell line showed higher transfection efficiency 
than normal HEK293 cells. Thus, 293FT cell line was chosen for large-scale protein 
expression. 
 293FT cells were transfected with FLAG-tagged DENV C protein plasmid in 
a 6-well plate and both the supernatant and cell lysates were harvested at 24 hr post-
transfection. Anti-FLAG antibody was used to detect the presence of DENV C protein 
in the culture media and cell lysate. Unfortunately, DENV C protein was not detected 
in the culture media as shown in Figure 4.2. Most of the DENV C proteins still 
remained in the cells as band could only be observed in the cell lysate but not in the 
culture media (Figure 4.2).  
 
Figure 4.2: Pilot screening of FLAG-tagged DENV C protein expression in 
293FT cells. The presence of DENV C protein in the culture media (CM) and cell 
lysates (LY) is detected using anti-FLAG antibody in Western-blot. FLAG-tagged C 
protein can only be detected in the cell lysates. 
 




 Possible reasons for the absence of FLAG-tagged DENV C protein in the 
culture media could be due to the low concentration of DENV C protein in the media 
or the insufficient time for protein expression. To examine these possibilities, another 
round of transfection was carried out in a 6-well plate and both the supernatant and 
cell lysates were harvested at 24 hr and 48 hr post-transfection. The 2-ml culture 
media was concentrated ten times to 200 µl via Vivaspin (Sartorius, Germany). 
Western-blot was performed to detect the presence of DENV C protein in all samples 
using anti-FLAG antibody.  
Figure 4.3 illustrated that the level of expression of DENV C protein was 
higher at 24 hr post-transfection than 48 hr post-transfection as the band intensity for 
24 hr post-transfection was thicker. It was noticed under upright light microscope that 
the number of cells at 48 hr post-transfection decreased significantly as compared to 
24 hr post-transfection. This could be due to cell apoptosis triggered by C protein as 
previously observed in Section 3.3.4 (Figures 3.9 and 3.11). A very faint band was 
observed in the ten-time concentrated culture media at 24 hr post-transfection and no 
band was detectable in the ten-time concentrated culture media at 48 hr post-
transfection. This showed that the preprotrypsin leader sequence was not functional 
because DENV C protein was not secreted into the culture media. This could be 
attributed to the two bipartite nuclear localization signal (NLS) motifs that were 
present on the DENV C protein as described in Section 3.4. 
 





Figure 4.3: Detection of FLAG-tagged DENV C protein in the 293FT cell lysates 
and culture media. The presence of DENV C protein in both the concentrated culture 
media (10 x CM) and cell lysates (LY) harvested at 24 hr and 48 hr post-transfection 
are detected using anti-FLAG antibodies. Band detected in the LY at 24 hr post-
transfection is much more intense than that at 48 hr post-transfection. A very faint 
band is detected in the 10 x CM at 24 hr post transfection and no band is observed at 
48 hr post transfection. 
 
 
4.2.3. Immunoprecipitation of FLAG-tagged dengue virus (DENV) capsid (C) 
protein in the cell lysates 
 Although the above attempts to express and secrete FLAG-tagged DENV C 
protein into the culture media were not successful, immunoprecipitation was still 
carried out using the cell lysates to examine the functionality of FLAG tags. One T-75 
flask of 293FT cells with 80 % confluency was transfected with FLAG-tagged DENV 
C protein plasmid and the cell lysates were harvested at 24 hr post-transfection. Cell 
lysates were then incubated with anti-FLAG M2 affinity gel (Sigma, USA) overnight 
at 4 oC with constant rotating. Unbound proteins were collected as flow-through and 
the resin with bound FLAG fusion proteins was washed thrice with cold PBS 
(Appendix 1e) to remove any nonspecific binding proteins. FLAG fusion proteins 
were eluted out by competition with 3x FLAG peptides (Sigma, USA). 





Figure 4.4: Immunoprecipitation of FLAG-tagged DENV C proteins in 293FT 
cell lysates. (A) The presence of DENV C proteins in the cell lysate (LY), flow-
through (FT), washed samples (W) and eluate (E) are detected via Western-blot using 
rabbit anti-FLAG antibody. DENV C protein-corresponding bands can be detected in 
LY, FT and E fractions. (B) SDS-PAGE gel stained with Coomassie-blue. Multiple 
intense bands are observed in the LY and FT fractions. Although only one band is 
detected in Western-blot, multiple faint bands are seen in the E fraction. The 
molecular weights of the E bands are estimated based on their relative mobility. (C) 
Estimated band sizes of various possible oligomers of DENV C protein are drawn. 
Only dimer and tetramer are reported thus far as highlighted in red. The molecular 
weight of DENV C protein monomer is approximately 18 kDa in SDS-PAGE.   




 As shown in Figure 4.4 (A), there were still significant amounts of DENV C 
proteins in the flow-through (FT). This could be due to either the binding of FLAG-
tagged DENV C protein to the resin was not strong enough or all the anti-FLAG 
antibodies were fully occupied and thus the FLAG fusion proteins detected in the FT 
were excessive proteins. No FLAG fusion proteins were detected in the Wash (W) 
fractions so the binding of FLAG-tagged DENV C proteins to anti-FLAG antibody 
was specific and with high affinity [Figure 4.4 (A)].  
Despite the thick band as detected via Western-blot in Figure 4.4 (A), SDS-
PAGE analysis followed by staining with Coomassie blue indicated that DENV C 
protein-corresponding band was not distinctively seen in lysate (LY) and FT fractions 
[Figure 4.4 (B)]. Instead, many intense bands were seen in those fractions. As for the 
eluate (E) fraction, multiple faint bands were observed. This was unanticipated 
because at least 4 µg of FLAG fusion proteins should be eluted out if all anti-FLAG 
antibodies were occupied during the binding step. One possible explanation for the 
multiple bands in the eluate was that they could be the different oligomers of DENV 
C protein. However, this postulation was not supported by the molecular sizes of the 
bands detected in the eluate [Figure 4.4 (B)] as compared to the estimated molecular 
weights of various possible oligomers [Figure 4.4 (C)]. On top of that, except 
monomer and dimer, all other possible oligomers [Figure 4.4 (C)] were not detected 
in the Western-blot [Figure 4.4 (A)]. Therefore, the multiple bands should be 
attributable to unspecific proteins from the cell lysate or some DENV C protein-
interacting partners that were co-immunoprecipitated out during elution. To remove 
or decrease these non-specific bands, more stringent washing buffer was necessary.  
All the results thus far indicated that mammalian N-terminal FLAG stable 
expression kit was not suitable for expression and purification of large-scale DENV C 




protein. The FLAG-tagged DENV C protein was not secreted out into the culture 
media. It was also not feasible to generate 293FT cell line stably expressing DENV C 
protein because C protein would trigger cell apoptosis as previously described in 
Sections 4.2.2 and 3.3.4. Moreover, the amount of immunoprecipitated FLAG-tagged 
DENV C proteins from one T-75 flask of transfected 293FT cells was very low. 
Therefore, it was not cost-effective to use this system for large-scale production of 
purified DENV C protein. Nonetheless, the results showed that FLAG-tagged DENV 
C protein was suitable for immunoprecipitation or co-immunoprecipitation studies. 
 
4.3. Expression and Purification of Dengue Virus (DENV) Capsid (C) Protein 
in Bacterial System 
 To overcome the quantity issue, the alternative bacterial system was used to 
achieve higher yield for subsequent experiments. An optimized bacterial system for 
expression and purification of viral proteins was developed in the laboratory 
(Krupakar et al., 2012; Tan et al., 2010).  
 
4.3.1. Engineering of biotin acceptor peptide (BAP) into dengue virus (DENV) 
capsid (C) plasmid, pET28aDENVBioCap 
To perform high-throughput screening for novel interacting partners using 
ProtoArray platform, a suitable tag must be engineered onto DENV C protein for easy 
detection with high sensitivity. Biotinylation has been widely used to date for 
purification, detection, diagnostic, protein-protein interaction studies, imaging studies, 
and other molecular studies (Chapman-Smith & Cronan, 1999a; de Boer et al., 2003; 
Howarth & Ting, 2008; Postel et al., 2011; Qi & Katagiri, 2011). One of the 
advantages of using biotinylated protein is that the detection sensitivity of the 




biotinylated protein is greatly enhanced by the high affinity and specificity between 
biotin and streptavidin (Bayer & Wilchek, 1990).  
Besides, biotin is a very small molecule (molecular weight = 244.31) so it is 
unlikely to affect the structure and function of DENV C protein. To ensure that the 
BAP will not result in any steric hindrance to the protein conformation, a secondary 
structure prediction was performed. As shown in Figure 4.5, the predicted secondary 
structures of DENV C protein with and without BAP do not differ from each other. 
As such, biotin was chosen to be the suitable tag for detection and a biotin acceptor 




Figure 4.5: Secondary structure prediction of biotinylated DENV C protein 
(BNC) and unbiotinylated C protein (UBNC). The prediction shows that biotin 
acceptor peptide (BAP) insertion does not affect the overall secondary structure 
formation when BAP is added to the N-terminus of C protein. Alpha helices are 
represented in gray, rounded rectangles. Beta sheets are represented in black, regular 
rectangles. 
 
To engineer pET28aBioCap plasmid, nucleotides from 100 to 438 in DENV-2 
genome (GeneBank accession number: M29095) was cloned out from its cDNA, 
whereas the BAP sequence was amplified from a template provided by Dr. Krupakar 
Parthasarathy, Department of Microbiology, NUS. The template containing a BAP 
sequence was synthesized based on the published sequence (Cull & Schatz, 2000) 
followed by an enterokinase cleavage site. Both fragments were joined together 
through overlapping extension-PCR (OE-PCR) method as illustrated in Figure 4.6 (A). 
Figure 4.6 (B) showed the first and second fragments, C1 and C2, which contained 




BAP sequence and DENV C gene, respectively. Since C1 fragment was 
approximately 90 bp only, PCR purification was carried out instead of gel purification 
to minimize loss of PCR product. Both fragments were then joined together using 
primers Biotin_F and C_R (Table 2.5 in Chapter 2) to obtain C3 fragment.  
 
Figure 4.6: Cloning of pET28aDENVBioCap plasmid via overlapping extension 
PCR (OE-PCR) technique. (A) Schematic diagram showing OE-PCR technique. 
The 3′ overhang of biotin acceptor peptide (BAP) fragment is complementary to the 5′ 
overhang of DENV C gene fragment. As such, primers B and C are complementary to 
each other. Both fragments are joined together with primers A and D. (B) DNA gel 
electrophoresis of C1 fragment (BAP sequence, enterokinase cleavage site and some 
overlapping sequence from the 5′ overhang of C2 fragment) and C2 fragment (DENV 
C gene with some overlapping sequence from the 3′ overhang of C1 fragment) which 
are approximately 90 bp and 369 bp, respectively. Both fragments are joined together 
to generate C3 final product with C1 fragment at the N-terminus followed by C2 
fragment. Final product is about 432 bp as indicated by arrow. 




After gel purification, the final product was ligated with bacterial expression 
vector, pET28a, via Nhe I and Xho I cut sites. pET28a vector contained a 6 x His tag 
and a thrombin cleavage site at the upstream of the multiple cloning site. Hence, the 
recombinant full-length DENV C construct (pET28aDENVBioCap) contained 2 tags 
(6 x His tag and BAP) at the N-terminus and 2 different enzyme cleavage sites 
(thrombin cleavage site and enterokinase cleavage site) for tags removal when 
necessary. The 6 x His tag was used for affinity chromatography purification while 
BAP was the signal peptide for biotinylation. Schematic representations of the final 
vector construct and recombinant protein are shown in Figure 4.7 (A) and (B), 
respectively. Five successfully transformed bacterial colonies were picked for colony 
PCR screening and DNA sequencing was performed to verify the constructs. The 
final DNA and protein sequences are shown in Appendix 8(t). DENV C protein 
without BAP was also constructed for comparison purposes. 
 
Figure 4.7: Schematic representation of pET28aDENVBioCap construct. (A) 
Plasmid vector map of pET28aDENVBioCap construct. (B) Final construct of 
recombinant protein generated. 6 x His tag is at the N-terminus followed by thrombin 
cleavage site and biotin acceptor peptide (BAP). Enterokinase cleavage site is 
included at the downstream of BAP. 6 x His tag is used for affinity purification while 
BAP is the signal peptide for biotinylation. 




4.3.2. Pilot screening of Dengue virus (DENV) capsid (C) protein expression 
To express DENV C protein, an optimal expression competent bacterial strain 
is requisite because 14 rare codons were detected in the full-length DENV C protein 
DNA sequence (Table 4.1). This raised a concern for protein expression because 12 % 
of the total 115 codons were rare codons. To screen for the optimal bacterial 
expression competent cell, pET28aDENVBioCap plasmid was transformed into BL-
21 (DE3) and BL-21-CodonPlus. BL-21 (DE3) is a common bacterial strain for high 
expression of recombinant protein while BL-21-CodonPlus is a bacterial strain 
specifically engineered for expression of protein with rare codons.  
 
Table 4.1: Rare codon analysis of full-length DENV C protein. Rare codons are 
highlighted in BOLD and underlined.  
Rare Codons Number 
Arg (AGG, AGA, CGA) 12 
Leu (CTA) 1 
Ile (ATA) 1 
Pro (CCC) 0 
Full-length DENV C DNA sequence: 
atg aat aac caa cga aaa aag gcg aga aat acg cct ttc aat atg 
ctg aaa cgc gag aga aac cgc gtg tcg act gta caa cag ctg aca 
aag aga ttc tca ctt gga atg ctg cag gga cga gga cca tta aaa 
ctg ttc atg gcc ctg gtg gcg ttc ctt cgt ttc cta aca atc cca 
cca aca gca ggg ata ctg aag aga tgg gga aca att aaa aaa tca 
aaa gcc att aat gtt ttg aga ggg ttc agg aaa gag att gga agg 
atg ctg aac atc ttg aac agg aga cgc aga act gca ggc atg atc 
att atg ctg att cca aca gtg atg gcg taa 
 
 The expression of DENV C protein was indeed much higher in BL-21-
CodonPlus strain. As indicated in Figure 4.8 (A), an obvious band corresponding to 
the recombinant full-length DENV C protein was detected in the bacterial cell lysate 
of IPTG-induced CodonPlus strain but not in the BL-21 (DE) strain. The molecular 
weight of DENV C protein was approximately 18 kDa as indicated by arrow.  
However, Western-blot analysis using anti-His antibody revealed that DENV 
C protein was expressed in both BL-21 (DE) and BL-21-CodonPlus strains because C 




protein-corresponding bands were detected in the bacterial cell lysates of both strains 
[Figure 4.8 (B)]. Nonetheless, the observed bands were much thicker in BL-21-
CodonPlus strain as compared to BL-21 (DE) strain, indicating that the expression 
level of DENV C protein was much higher in BL-21-CodonPlus strain. This result 
corroborated that DENV C protein indeed required special bacterial strain for efficient 
protein translation. Therefore, BL-21-CodonPlus strain was used for expression of 
DENV C protein subsequently.  
 
Figure 4.8: Pilot expression screening of DENV C protein. Two expression 
competent cell systems were tested, namely BL-21 (DE3) and BL-21-CodonPlus. The 
presence of C protein band in the IPTG-induced bacterial cell lysate, as indicated by 
arrow, is detected via SDS-PAGE stained with Coomassie blue (A) and Western blot 
(B) using anti-His antibody. The expression level of C protein in BL-21-CodonPlus 
competent cells is superior because the band intensity is much higher than that of 
normal BL-21 (DE3) competent cells. 
 
After pilot expression screening using pET28aDENVBioCap plasmid, DENV 
C protein without biotin acceptor peptide (BAP) was also expressed in BL-21-
CodonPlus competent cells for comparison purposes. Bacterial cell lysates containing 
DENV C proteins with and without BAP were analyzed via Western-blot using anti-
His antibody. As shown in Figure 4.9, bands were observed in both DENV C proteins 
with and without BAP, implicating that both clones were expressing well in the BL-




21-CodonPlus strain. Recombinant DENV C protein with BAP showed higher 
molecular weight than that without BAP.  
 
Figure 4.9: Expression of DENV C protein with and without BAP. Western-blot 
analysis using anti-His antibody shows that both DENV C proteins with and without 
BAP are expressing well in BL-21-CodonPlus competent cells. The molecular weight 
of DENV C protein with BAP is higher than that without BAP. 
 
Besides detecting the proteins of interest using anti-His antibody, horse radish 
peroxidase-conjugated streptavidin antibody (Millipore, USA) was used to detect 
biotinylated proteins. Before using this streptavidin antibody for Western-blot, 
optimization was required. 
 
4.3.3. Optimization of Western-blot for biotinylated protein 
To optimize Western-blot protocol for horse radish peroxidase (HRP)-
conjugated streptavidin antibody, commercially-available biotinylated (BN) and 
unbiotinylated (UBN) maltose-binding protein [(MBP) (GeneCopoeia, USA)] were 
purchased. Unlike anti-His antibody, usual Western-blot protocol (Section 2.5.3.2) 
using 5 % skim milk in TBST [Appendix 5c(iii)] as blocking buffer and antibody 
diluents was not suitable for streptavidin antibody. As shown in Figure 4.10 (A), BN 
MBP-corresponding band was not observed and the background was very high. This 




problem was successfully solved when 4 % bovine serum albumin (BSA) in PBST 
[Appendix 5c(iv)] was used as blocking buffer and antibody diluents. BN MBP-
corresponding band was not only seen clearly as indicated by arrow, the background 
was also very clean. Similar band was not observed in UBN lane. This optimized 
Western-blot protocol was used to detect biotinylated DENV C protein subsequently. 
 
Figure 4.10: Optimization of Western-blot protocol for biotinylated proteins. (A) 
Western-blot using streptavidin-horse radish peroxidase (HRP) antibody and 5 % 
skim milk in TBST as blocking buffer and antibody diluents. Biotinylated (BN) 
maltose-binding protein (MBP) is not detected and the background is very high. 
Unbiotinylated (UBN) MBP is also included as negative control for biotinylation. (B) 
When 4 % bovine serum albumin (BSA) in PBST is used as blocking buffer and 
antibody diluents, the background becomes very clean and MBP-corresponding band 
is observed in BN lane and not in UBN lane. 
 
4.3.4. Discovery of endogenous biotinylation in BL-21-CodonPlus competent 
cells 
After optimizing the Western-blot protocol for streptavidin antibody using 
commercial maltose-binding protein (MBP), the biotinylation status of DENV C 
proteins with and without biotin acceptor peptide (BAP) was examined via the same 
Western-blot protocol. Before any in vitro biotinylation process using biotin ligase 
enzyme, no bands should be observed.  




Surprisingly, DENV C protein with BAP was found biotinylated even before 
in vitro biotinylation process. As shown in Figure 4.11, thick band could be observed 
in the BAP-containing DENV C protein when streptavidin HRP antibody was used. 
Similar band was not detected in DENV C protein without BAP. This result suggested 
that DENV protein with BAP were biotinylated endogenously in BL-21-CodonPlus 
competent cells. 
 
Figure 4.11: DENV C protein with biotin acceptor peptide (BAP) is biotinylated 
endogenously. Band is observed in the DENV C protein with BAP when horse radish 
peroxidase (HRP)-conjugated streptavidin antibody is used for Western blot. Similar 
band is not seen in the DENV C protein without BAP. 
 
 It was postulated that bacterial BL-21-CodonPlus competent cells might 
contain biotin holoenzyme synthetase BirA gene that encoded for biotin ligase protein 
in their genome. To investigate the reason behind endogenous biotinylation, BirA 
gene sequence was analyzed using BLAST software and the result showed that BL-21 
strains indeed possessed BirA gene in their genome (Table 4.2). Besides, it was also 
reported that biotin molecules were present in the Luria-Bertani (LB) broth (Tolaymat 
& Mock, 1989). As a result, proteins engineered with BAP could be directly 
expressed and biotinylated in BL-21 strains cultivated in LB broth without the extra in 
vitro enzymatic biotinylation step. This discovery would be valuable for protein 




engineering that requires site-specific biotinylation in bacterial system with simple 
steps. Proteins that required site-specific biotinylation could be produced easily by 
just simple overlap extension-PCR (OE-PCR) followed by expression in Escherichia 
coli BL-21 strains without the need of an additional in vitro biotinylation step.     
 
Table 4.2: Competent cells identified through BLAST analysis of BirA gene. 
Competent Cells Accession Number Features 
BL-21 (DE3) AM946981 Bifunctional biotin-[acetyl-CoA-
carboxylase] ligase and transcriptional 
repressor 





4.3.5. Purification of biotinylated Dengue virus (DENV) capsid (C) protein 
4.3.5.1. Extraction of Dengue virus (DENV) capsid (C) protein under denaturing 
condition 
After confirming the expression and biotinylation status of DENV C proteins, 
large scale production of bacterial culture was carried out. Initial attempt was to 
perform all the extraction and purification steps in native form so that the protein 
structure could be preserved without the need of refolding. However, the extraction of 
DENV C protein from the bacterial cells via sonication under native condition was 
not effective. The solution was still very cloudy and huge amount of cell pellet was 
formed even after sonicating for 15 min in ice (30 sec “ON”, 30 sec “OFF”, and 45 % 
amplitude).  
As shown in Figure 4.12, no band was observed when non-denaturing buffer 
(20 mM Tris, 300 mM NaCl and 10 mM Imidazole) was used. However, DENV C 
protein-corresponding band was observed when the cell pellet was solubilized in 
denaturing buffer (20 mM Tris, 300 mM NaCl, 8 M urea and 10 mM Imidazole) 




without sonication. This result suggested that the recombinant full-length DENV C 
proteins were trapped in inclusion bodies. As such, 8 M urea was used to lyse the 
bacterial cell pellet and affinity chromatography purification was performed under 
denaturing condition.  
 
Figure 4.12: Extraction of DENV C protein under non-denaturing and 
denaturing conditions. Bacterial cell lysate after sonication (LY) and 8 M urea-
solubilized pellet (Urea) are analyzed via Coomassie blue (A) and Western-blot using 
anti-His antibody (B). A thick band can only be observed in the 8M urea-solubilized 
pellet fraction, implying that DENV C proteins are trapped in the cell pellet.  
 
4.3.5.2. Purification of Dengue virus (DENV) capsid (C) protein via affinity 
chromatography 
To purify His-tagged proteins via affinity chromatography, bacterial cell 
lysates containing DENV C protein in 8 M urea was incubated with nickel-
nitrilotriacetic acid (Ni-NTA) resin. 6 x His tag at the N-terminal recombinant full-
length DENV C protein bound to the resin and unbound proteins were removed 
during washing with 20 mM imidazole. To ensure most of the unbound proteins were 
washed away, ten column volumes of wash buffer (20 mM Tris, 300 mM NaCl, 8 M 
urea and 20 mM Imidazole) were used. The bound proteins were eluted out with 
500 mM imidazole.  




Figure 4.13 (A) showed that many non-specific bands were observed in the 
eluates of DENV C protein, especially in the second eluate fraction. This could be due 
to the highly positively-charged property of DENV C protein. Nonetheless, Western-
blot analysis using anti-His antibody [Figure 4.13 (B)] and streptavidin antibody 
[Figure 4.13 (C)] confirmed that most of the DENV C proteins were eluted out 
starting from fractions E2 until E10. Interestingly, a faint DENV C protein dimer-
corresponding band was observed in fraction E2 when anti-His antibody was used 
[Figure 4.13 (B)]. Similar band was not observed when streptavidin antibody was 
used [Figure 4.13 (C)]. This was surprising because elution buffer contained 8 M urea 
whereas sample loading buffer contained sodium dodecyl sulfate (SDS) detergent and 
reducing reagent (β-mercaptoethanol). If the band was indeed DENV C protein dimer, 
the interaction between two DENV C protein monomers must be very strong. 
Unfortunately, the corresponding band was not obvious in Coomassie blue-stained 
SDS gel for mass spectrometry analysis. Besides, there were many non-specific bands 
in that fraction. Therefore, second round of purification was required for DENV C 
protein.  
 
4.3.5.3. Aggregation issue during stepwise dialysis and concurrent refolding of 
partially purified Dengue virus (DENV) capsid (C) protein 
Before further purification, partially purified DENV C proteins from eluates 
E2 to E10 were pooled together for step-wise dialysis and concurrent refolding. This 
would remove 8 M urea and 500 mM imidazole in the elution buffer. However, it was 
noticed that significant amount of full-length DENV C protein precipitated out after 
refolding. DENV C proteins could be detected in both the refolding solution as well 
as in the precipitates. This problem could be due to the hydrophobic C-terminus of 




DENV C protein resulting in easy aggregation and caused major loss in amounts 
during refolding and dialysis. 
 
Figure 4.13: Purification of DENV C protein via affinity chromatography under 
denaturing condition. IPTG-induced bacteria is lysed in denaturing buffer containing 
8 M urea and the lysate (L) is incubated with nickel-charged resin overnight. Next, the 
resin is packed in a column and the flow through (FT) is kept for SDS-PAGE. 20 mM 
imidazole is used to wash away the unbound proteins (W) and 500 mM imidazole is 
used to elute the C protein in ten fractions (E1-10). SDS-PAGE is carried out and 
stained with Coomassie blue (A). Fraction E2 shows the most intense band as 
indicated by an arrow but there are also many contaminants in the eluates. Western 
blot is also performed for the samples using anti-His antibody (B) and streptavidin 
HRP secondary antibody (C). C protein-corresponding bands can be observed from 
Fractions E2 until E10. The band intensity is the highest in fraction E2 and decreases 
until Fraction E10. A faint band corresponding to C protein dimer is observed in 
Fraction E2 as indicated by an arrow when anti-His antibody is used. 
 




Initial attempt was to resolubilize the precipitates using different types of 
detergent. Six different reagents, namely Triton-X, Tween-20, NP-40, CHAPS {3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate}, digitonin and glycerol, 
were tested. Each of these reagents was added to the resuspension buffer (25 mM Tris 
and 150 mM NaCl, pH 8.0) and was used to resolubilize the precipitates of DENV C 
protein. After resolubilization, the mixture was spun down and both the supernatant 
and pellet were analyzed via SDS-PAGE and Western-blot. If the precipitate was 
resolubilized successfully, DENV C protein should be detected in the supernatant. 
However, the band corresponding to DENV C protein was not observed in all the 
supernatants [Figure 4.14 (A) and (B)]. They were still present in the pellets. 
 
 
Figure 4.14: Resolubilization of DENV C protein aggregate using various 
detergents. Different detergents are used to resolubilize DENV C protein aggregates 
after dialysis and refolding. The presence of C protein is detected via Coomassie blue 
staining (A) and Western-blot using anti-His antibody (B). No band is observed in the 
supernatant fraction. DENV C proteins are still trapped in the pellet as indicated by 
the arrows. (Lane 1 – dialyzed sample; Lane 2 – No detergent; Lane 3 – Triton X; 
Lane 4 – Tween-20; Lane 5 – NP40; Lane 6 – CHAPS; Lane 7 – Digitonin; Lane 8 – 
Glycerol) 
 




 Another attempt was to resolubilize the aggregates of DENV C protein using 
different pH. The pH of resuspension buffer (25 mM Tris and 150 mM NaCl) was 
adjusted with 5 M hydrochloric acid to obtain pH 3 to 9 while 5 M sodium hydroxide 
was used to prepare pH 11 to 13.3. Figure 4.15 (A) showed that no proteins were 
resolubilized as no band is detected in all the supernatants from pH 3 to 10. Multiple 
bands were still seen in the pellets but not the supernatant. However, it was found that 
DENV C protein aggregate resolubilized in extreme alkaline condition. Bands were 
seen in the supernatant starting from pH 12 to 13 [Figure 4.15 (B) – Lanes 2 and 3]. 
Nonetheless, smear was observed when pH 13.3 was used to resolubilize the 
aggregate (Lane 4). Significant amount of DENV C proteins were rescued from the 
aggregate by using resuspension buffer with pH 12.  
 
Figure 4.15: Resolubilization of DENV C protein aggregate using different pH. 
(A) DENV C protein aggregate is solubilized using solubilization buffer with 
different pH (Lane 1 – dialyzed sample; Lane 2 – pH 3; Lane 3 – pH 4; Lane 4 – 
pH 5; Lane 5 – pH 6; Lane 6 – pH 7; Lane 7 – pH 8; Lane 8 – pH 9; Lane 9 – pH 10). 
C protein is still in the pellet as no band is observed in the supernatant. (B) DENV C 
protein aggregate solubilizes in extreme alkaline solution as bands can only be 
observed in buffer with pH 12 and pH 13 (Lane 1 – pH 11; Lane 2 – pH 12; Lane 3 – 
pH 13; Lane 4 – pH 13.3). 
 




Although the optimal condition of resuspension buffer to resolubilize DENV 
C protein aggregate was found, extreme alkaline condition was absolutely not suitable 
for protein storage and other downstream experiments. The quality of resolubilized 
DENV C protein was also questionable. Instead of resolubilizing the protein 
aggregates, method was developed to prevent protein aggregation during dialysis and 
refolding step. Recently, it was discovered in this laboratory that addition of 0.05 % 
Tween-20 into samples during dialysis and refolding would not only prevent protein 
aggregation but also enhance efficient refolding (Krupakar et al., 2012).  
With the addition of 0.05 % Tween-20 into denatured DENV C protein 
samples, protein aggregation was indeed reduced significantly. No obvious 
precipitation was observed and the solution was clear after stepwise dialysis and 
concurrent refolding. Protein aggregation problem was solved successfully. Refolded 
DENV C protein was then subjected to a second round of purification to obtain highly 
purified DENV C protein. 
 
4.3.5.4. Second purification of full-length Dengue virus (DENV) capsid (C) 
protein via ion exchange chromatography 
The partially purified refolded DENV C protein was further purified using ion 
exchange chromatography-fast protein liquid chromatography system (IEX-FPLC). 
Ion exchange chromatography was chosen because DENV C protein was a highly 
positively-charged protein. Theoretically, cation-exchanger column, Resource MonoS, 
should be used. However, it was found that biotinylated DENV C protein was not 
eluted out at a specific concentration of sodium chloride (NaCl). As shown in Figure 
4.16 (A), minimal amount of proteins was eluted out slowly in an increasing gradient 
and reached a plateau from 700 mM of NaCl onwards.  




Analysis of the samples via enzyme-linked immunosorbent assay (ELISA) 
using streptavidin-horse radish peroxidase (HRP) antibody also showed that 
biotinylated DENV C protein was eluted out slowly and reached a steady state after 
700 mM of NaCl [Figure 4.16 (B)]. No distinct peak was observed in any elution 
fractions. This result indicated that Resource MonoS column was not suitable for 
separating DENV C protein from residual contaminants.  
 
Figure 4.16: Cation exchange chromatography purification of DENV C protein 
using Resource MonoS column. (A) Dialysed and refolded DENV C proteins after 
affinity chromatography are injected into Resource MonoS ion exchange 
chromatography column. Bound proteins are eluted out using increasing concentration 
of sodium chloride until final concentration of 1 M. However, there is no obvious 
peak during the elution steps except a small increase of UV absorbance when the 
concentration of NaCl reaches 400 mM (40 %). (B) The presence of C protein is 
detected by ELISA using streptavidin HRP antibody. An increasing amount of 
biotinylated DENV C protein is detected during elution and it reaches plateau at 
approximately 70 % of NaCl (700 mM NaCl). 
 




Better separation was instead obtained when anion-exchanger, Resource 
MonoQ, column was used. This could be due to the presence of biotin acceptor 
peptide (BAP) in the DENV C protein conferring its ability to bind to positively-
charged beads. As indicated by Figure 4.17, biotinylated full-length DENV C protein 
bound perfectly to Resource MonoQ column. Although there was high UV 
absorbance detected in the flow through fractions, no biotinylated proteins were 
detected by ELISA in the flow through. The high UV absorbance was mainly 
contributed by the unbound proteins. In other words, most of the residual 
contaminants detected in Figure 4.13 were separated from biotinylated full-length 
DENV C protein in Resource MonoQ column.  
As shown in Figure 4.17 (A), one high peak was detected when the NaCl 
concentration reached approximately 350 mM (35 %) during elution while there was 
another small peak detected at the elution concentration of 100 mM of NaCl (10 %). 
These peaks were confirmed to be biotinylated proteins as detected by ELISA using 
streptavidin HRP antibody [Figure 4.17 (B)]. In summary, the result showed that 
anion exchange chromatography was able to further separate most of the residual 
contaminants from DENV C protein after affinity chromatography.  
 
4.3.5.5. Third purification of biotinylated full-length Dengue virus (DENV) 
capsid (C) protein via size-exclusion chromatography 
To avoid any other contaminants that may have similar charge as biotinylated 
DENV C protein, eluates corresponding to the high UV absorbance peak after anion 
exchange chromatography were injected into size-exclusion chromatography (SEC), 
Superdex 75 10/300 GL column. It was previously reported that SEC could not be 
used to estimate the molecular weight of DENV C protein because there were many 




unspecific interaction between the gel matrix and C protein (Jones et al., 2003). 
Nevertheless, it is still a useful method to further isolate the proteins of interest from 
other possible residual contaminants based on the molecular weight differences.  
 
 
Figure 4.17: Anion exchange chromatography purification of DENV C protein 
using Resource MonoQ column. (A) Dialysed and refolded DENV C proteins after 
affinity chromatography are injected into Resource MonoQ ion exchange 
chromatography column. Bound proteins are eluted out using increasing concentration 
of sodium chloride until final NaCl concentration of 1 M. One high peak can be 
observed when the sodium chloride concentration reaches 350 mM. (B) The identity 
of the peak is confirmed to be biotinylated DENV C protein as detected by ELISA 
using streptavidin HRP antibody. 
 
 




After size-exclusion chromatography, three peaks were observed in the 
chromatogram [Figure 4.18 (A)]. The highest peak (first peak) was observed at 
approximately 33 ml elution volume followed by two very small peaks (second and 
third peaks) at about 63 ml and 70 ml elution volumes, respectively. As shown in 
Figure 4.18 (B), only the first peak was identified to be the biotinylated DENV C 
protein since the fractions detected with high absorbance in ELISA using streptavidin 
HRP antibody coincided with the first peak in the elution profile. No absorbance was 
detected in ELISA for the second and third peaks observed in the chromatogram 
[Figure 4.18 (A)]. Besides, bands could only be seen from the sample in the first peak 
when detected by Western-blot using anti-His antibody and streptavidin antibody. 
Hence, pure biotinylated full-length DENV C protein was in the first peak. To further 
validate the identity of this purified protein, the eluted protein from the first peak was 
sent directly for matrix-assisted laser desorption/ionization-time of flight (MALDI-
TOF) mass spectrometry analysis.  
Mass spectrometry analysis confirmed that the purified protein obtained from 
the first peak of SEC was indeed DENV C protein. Table 4.3 showed all the peptide 
sequences identified via MALDI-TOF analysis.  
 
Table 4.3: MALDI-TOF mass spectrometry analysis of purified DENV C protein. 
Fragment Peptide Sequence Calculated (Da) Measure (Da) Error (Da) 
81-89 FSLGMLQGR 1007.52 1007.49 -0.03 
104-116 FLTIPPTAGILKR 1425.87 1425.8 -0.07 
148-161 TAGMIIMLIPTVMA 1476.77 1476.78 0.01 
70-78 VSTVQQLTK 1002.56 1002.57 -0.01 
57-64 NTPFNMLK 963.48 963.49 0.01 
138-144 MLNILNR 872.49 872.48 -0.01 
93-102 LFMALVAFLR 1179.68 1179.69 0.01 
 
 





Figure 4.18: Size exclusion chromatography purification of DENV C protein 
using Superdex 75 column. The eluates from the anion-exchange chromatography 
with the highest absorbance in ELISA are combined and inserted into size exclusion 
chromatography for further purification. Three peaks are observed in the 
chromatogram (A). The high peak is identified to be DENV C protein as a band with 
corresponding molecular weight can be detected in Western blot when anti-His 
antibody and streptavidin-horse radish peroxidase antibody are used. This is further 
confirmed with ELISA using streptavidin HRP antibody (B). 
  
4.4. Functional Study of Purified Biotinylated Full-Length Dengue Virus 
(DENV) Capsid (C) Protein 
4.4.1. High in vivo biotinylation efficiency in BL-21-CodonPlus competent cells 
After validating the identity of the highly purified biotinylated full-length 
DENV C protein, it was of paramount importance to examine the functionality of the 
purified protein and the tags. Purified full-length DENV C protein contained 2 tags at 




the N-terminus, namely 6 x His tag and biotin acceptor peptide (BAP). To attach a 
biotin molecule onto BAP either in vivo or in vitro, bacterial biotin ligase BirA was 
required (Chapman-Smith & Cronan, 1999b). However, DENV C protein with BAP 
was found biotinylated endogenously in BL-21-CodonPlus competent cells (Section 
4.3.4).  
To compare the biotinylation efficiency in BL-21-CodonPlus cells, the same 
amount of purified biotinylated DENV C protein and commercial biotinylated 
maltose-binding protein (MBP) were coated on the ELISA plate and streptavidin-
horse radish peroxidase (HRP) antibody was used for detection. Assuming that the 
coating efficiencies are the same between DENV C and MBP proteins, the absorbance 
detected via ELISA should be proportional to the number of coated protein molecules 
and inversely proportional to the power of 2/3 of its molecular size. Hence, the larger 
the protein, the lesser the proteins can be coated on the plate. 
 
 
The molecular weight of MBP is approximately 42.5 kDa while DENV C 
protein has an approximate mass of 15.4 kDa. Assuming that each protein molecule 
carries only one biotin molecule which will bind to only one streptavidin HRP 
complex, the absorbance of MBP should be roughly two times lower than purified 
DENV C proteins for the same protein concentration.  
As shown in Figure 4.19 (A), the absorbance of purified biotinylated DENV C 
protein indeed showed approximately two times higher when compared to the 
commercial biotinylated MBP. The same phenomenon was also observed when the 
biotinylated proteins were pulled down by streptavidin-magnetic beads and detected 
via direct ELISA [Figure 4.19 (B)]. The absorbance of eluted biotinylated DENV C 




protein was two times higher than that of eluted biotinylated MBP. No significant 
absorbance was detected for unbiotinylated DENV C and MBP proteins.  
This result further supported that engineering an additional BAP onto a protein 
could result in site-specific endogenous biotinylation with high efficiency in 
Escherichia coli BL-21-CodonPlus competent cells, without the need of an extra in 
vitro enzymatic or chemical conjugation step. This strategy could produce 
biotinylated proteins which had equal quality as the manufactured biotinylated MBP. 
 
Figure 4.19: Biotinylation efficiency of purified full-length DENV C protein. (A) 
30 ng of biotinylated (BN) and unbiotinylated (UBN) maltose-binding proteins (MBP) 
and DENV C proteins are coated on ELISA plate and streptavidin-horse radish 
peroxidise (HRP) antibody is used to detect the presence of biotinylated proteins. 
Both BN MBP and DENV C protein show high absorbance at 450 nm as compared to 
UBN proteins. (B) Biotin-streptavidin binding assay also shows that only BN proteins 
bind to streptavidin-magnetic beads and are detected in the eluates. No absorbance is 
detected in the eluates of UBN proteins. 
 
4.4.2. Purified full-length Dengue virus (DENV) capsid (C) protein is functional 
After determining the functionality of biotin tag in purified DENV C protein, 
it was essential to ensure that full-length DENV C protein was functional before it 
was used for any further studies. According to recent findings in this laboratory, West 
Nile virus (WNV) and DENV C proteins were found to interact with human Sec3 
exocyst protein (Bhuvanakantham et al., 2010). Thus, the functionality of purified 
DENV C protein was examined by revisiting the interaction between biotinylated 
DENV C protein and Sec3 protein using ELISA. Pure Sec3 protein (Abnova, Taiwan) 




was coated overnight on ELISA plate and purified biotinylated DENV C protein was 
used as the probe. Bound DENV C proteins were detected with streptavidin-horse 
radish peroxidise antibody. As shown in Figure 4.20, statistically significant 
absorbance was detected in Sec3 protein-coated wells but not in bovine serum 
albumin (BSA)-coated wells. Thus, the purified full-length DENV C protein did 
interact with Sec3 protein. This corroborated that the purified biotinylated full-length 
DENV C protein was indeed functional and could be used for downstream studies. 
 
Figure 4.20: Functional assay of purified biotinylated full-length DENV C 
protein. The functionality of DENV C protein is examined via binding assay with 
Sec3 protein which is known to interact with flaviviral C protein in host cells. Pure 
Sec3 protein is coated onto ELISA plate and purified full-length DENV C protein is 
added into the well for binding. Bovine serum albumin (BSA) is used as negative 
control. Significant absorbance is detected using streptavidin-horseradish peroxidase 
antibody in the wells with Sec3 protein coated (Sec3-DENVC) but not with BSA 
(BSA-DENVC). *p-value<0.05 
 
In summary, the purification of non-truncated, full-length DENV C protein 
was successful. To obtain highly purified DENV C protein, an optimized sequential 
purification protocol (affinity chromatography  anion exchange chromatography  
size exclusion chromatography) was established. This sequential purification strategy 
could produce approximately 1 mg of purified full-length DENV C protein from 1 L 
of bacterial culture. With this highly purified biotinylated full-length DENV C protein, 
it was possible to use ProtoArray® technology-based protein microarray to discover 
novel interacting partners of DENV C protein (Chapter 5). 




5.  High-Throughput ProtoArray Screening for Novel 
Interacting Partners of Dengue Virus Capsid Protein 
5.1. Introduction 
Using the purified biotinylated full-length Dengue virus (DENV) capsid (C) 
protein generated in Chapter 4, high-throughput screening (HTS) was carried out to 
identify novel interacting partners of DENV C protein. Numerous protein-protein 
interaction (PPI) techniques have been developed for drug discovery and 
identification of novel interacting partners for hallmark proteins in a pathway or 
disease. For HTS of novel interacting partners, yeast two-hybrid, bacteria two-hybrid, 
pull-down assay, tandem affinity purification, and phage display are commonly used 
(Lievens et al., 2010; Petschnigg et al., 2011; Williamson & Sutcliffe, 2010; Wright 
et al., 2010). To date, chip-based technologies are expanding and more sophisticated 
screening technologies have been developed (Heeres & Hergenrother, 2011; Katz et 
al., 2011; Tomizaki et al., 2010; Torres et al., 2010). In this Chapter, protein 
microarray from Life Technologies, namely ProtoArray® Human Protein Microarray 
PPI Complete Kit, was employed for HTS study of novel DENV C protein-interacting 
partners. 
 
5.2. Description of ProtoArray® Technology-Based Protein Microarray 
ProtoArray® Human Protein Microarray PPI Complete Kit contains more than 
9000 purified functional human proteins printed on a glass slide. The purified human 
proteins encompass various cellular kinases, enzymes, nuclear proteins, signalling 
proteins and other important cellular proteins as stated in Table 5.1. All these proteins 
are cloned based on open reading frame (ORF) selected from Invitrogen’s Ultimate 
human ORF clone collection. They are expressed as N-terminal glutathione S 




transferase (GST) or 6x His-tag fusion proteins via baculovirus-based expression 
system and purified under non-denaturing conditions to preserve their native protein 
structures.  
 
Table 5.1: Content and classifications of human proteins coated on ProtoArray 
glass slide. Some of the proteins belong to more than one class. 
Class Number of protein on Array 
Protein kinases (unique) 268 
Protein kinases (including domains, splice 
variants, and mutants) 776 
Transcription factors 328 
Membrane proteins 2635 
Nuclear proteins 2252 
Signal transduction 1526 
Secreted proteins 192 
Cell communication 1687 
Metabolism 3862 
Cell death 505 
Protease / peptidase activity 219 
    
There are two tags on the purified full-length Dengue virus (DENV) capsid (C) 
protein, namely 6x His tag and biotin tag (Chapter 4). Since most of the human 
proteins printed on the array are tagged with 6x His tag or GST tag, anti-His and anti-
GST antibodies cannot be used as the detection reagent. As such, biotin tag was opted 
for the detection target in this screening. The strong binding affinity and specificity 
between biotin and streptavidin also helped in high detection sensitivity. Therefore, 
streptavidin-Alexa Fluor® 647 antibody was chosen as the detection reagent as it 
yielded very good signal to noise ratio. 
All the purified functional human proteins were printed in duplicate on a 
nitrocellulose-coated 1 inch x 3 inch glass slide in a temperature- and humidity-
controlled environment to ensure quality consistency. As shown in Figure 5.1, a 
protein microarray comprises 48 subarrays containing 484 spots (22 x 22 formats) in 
which each spot has a median diameter of approximately 110 μm. Alexa Fluor® 647 




antibodies are coated in each subarray as reference spots for proper alignment with 
microarray protein identity data file during data acquisition. Decreasing concentration 
of BioEaseTM (biotin) positive control proteins are also printed in each subarray to 
ensure the streptavidin-Alexa Fluor® 647 antibody used is functional and the probing 
is properly performed. 
 
Figure 5.1: Image of scanned ProtoArray glass slide. There are 48 subarrays in 
total and one of the subarrays is enlarged. Each subarray contains 484 spots (22 rows 
x 22 columns). Four pairs of antibody spots labelled with Alexa Fluor 647 in each 
subarray are used as the reference spots for orientation and alignment analysis. 
Decreasing concentration of biotins is included as positive controls for streptavidin-
Alexa Fluor® 647 antibody probing. 
 
 Figure 5.2 showed the workflow of ProtoArray screening. About 10 µg of 
purified biotinylated full-length Dengue virus (DENV) capsid (C) protein (50 µg/ml) 
was used as probe for binding with the human proteins. Bound DENV C proteins 
were detected using streptavidin-Alexa Fluor® 647 antibody. The entire experiment 
was carried out at 4 oC to ensure protein integrity. After scanning the microarray glass 
slide via a fluorescence microarray scanner – Axon GenePix 4000B scanner, data 
acquisition was carried out using GenePix® Pro software and the specific “.GAL” file 




that defined the array grid. Data analysis was done using ProtoArray® Prospector 
software to analyze the pixel intensity information and to identify statistically 
significant interactors. 
 
Figure 5.2: Workflow of ProtoArray screening. Purified biotinylated DENV C 
protein is used to probe the protein microarray and the bound protein complexes are 
detected with streptavidin-Alexa Fluor® 647 antibody. The fluorescence signal 
intensity of each spot is measured via Axon GenePix 4000B scanner and data 
acquisition is carried out using GenePix® Pro software. Statistically significant 
interactors are identified via ProtoArray® Prospector software. 
 
This high-throughput screening (HTS) method allowed identification of direct 
protein-protein interaction in a robust and cost-effective manner. More than 9000 
human proteins can be screened within one day without any additional cloning steps 
or cultivation of micro-organism. This technology has been employed to identify 
potential biomarkers and to map protein-protein interactome for better understanding 
or discovery of novel pathways in diseases (Fenner et al., 2010; Le Roux et al., 2010; 
Virok et al., 2011). This is the first time this technology was employed for virus-host 
interaction study. 




5.3. Screening of Novel Interacting Partners for Dengue Virus (DENV) 
Capsid (C) Protein via ProtoArray® Technology-Based Protein Microarray 
After data acquisition, data analysis was carried out using ProtoArray® 
Prospector software to identify statistically significant interacting partners. As shown 
in Figure 5.3, there were a total of 578 potential DENV C protein-binding partners 
detected to have z-score value of one or greater. Z-score indicates how far and in what 
direction the sample’s value deviates from the distribution’s mean in units of standard 
deviations. The larger the z-score, the more statistically significant the identified 
interacting partner. Protein interactors with z-score value greater than 3 (Z>3; 
P<0.002) and with coefficient of variation (CV) for the two fluorescence signals less 
than 0.5, were deemed to be statistically significant. After filtering some of the protein 
interactors without known functions and with biotin-binding property, 31 significant 
potential DENV C protein-interacting partners were identified as shown in Table 5.2.  
 
Figure 5.3: Number of identified protein interactors with z-score value of one or 
greater. Z-score cut-off value of 3 is taken to be statistically significant interactors for 
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Table 5.2: Significant interacting partners of DENV C protein identified using z-score cut-off value of 3. Interactors with coefficient of 
variation (CV) value larger than 0.5 for the fluorescence signals from the duplicate are excluded. 
No. Identity Symbol Database ID Array ID Signal Intensity CV Z-score Function 
1. Cortactin CTTN NM_138565.1 B39R03C15 3076.5 0.03517 13.41837 Regulate and organize actin 
cytoskeleton  
2. SLAIN motif family, 
member 2 





IGBP1 NM_001551.1 B09R16C19 1938 0.02043 8.17845 Binds to surface IgM receptor and may 
involve in the activation signal 
transduction pathway 
4. Choline kinase alpha CHKA NM_001277.1 B46R09C15 1738 0.03743 7.25795 Catalyzes the phosphorylation of 
ethanolamine and plays a role in 
phosphatidylcholine biosynthesis.  
5. DIM1 
dimethyladenosine 
transferase 1 homolog 
(S. cerevisiae) 




UBE2S BC004236.2 B38R06C13 1353.5 0.00366 5.4883 Catalyzes 'Lys-11'-linked 
polyubiquitination on the anaphase 
promoting complex/ cyclosome 
(APC/C) substrates  
7. AF4/FMR2 family, 
member 4 
AFF4 BC025700.1 B06R09C07 1251 0.06896 5.01654 Regulates transcriptional activity 
8. WAS / WASL 
interacting protein 
family, member 1 
WIPF1 BC002914.1 B48R20C19 1159 0.02562 4.59312 Control the organization of actin 
cytoskeleton 
9. Aurora kinase A AURKA BC006423.1 B06R10C09 1158 0.04519 4.58851 Cell cycle-regulated kinase regulates 
microtubules formation and stabilizes 
spindle poles during mitosis 
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No. Identity Symbol Database ID Array ID Signal Intensity CV Z-score Function 
protein 1 response pathway  
11. Additional sex combs 
like 1 (Drosophila) 
ASXL1 BC064984.1 B28R18C13 1072 0.04485 4.1927 Regulates transcriptional activity  




BC022270.1 B12R15C09 1031.5 0.13642 4.0063 Activates p53/TP53 via CDKN2A-
dependent and CDKN2A-independent 
pathways 
13. Calcium channel, 
voltage-dependent, 
beta 1 subunit 
CACNB1 NM_000723.3 B16R04C21 1017.5 0.12162 3.94187 Increases peak calcium current, 
modulates G protein inhibition, and 
shifts the voltage- dependent activation 
and inactivation.  
14. Spermidine / spermine 
N1-acetyltransferase 
family member 2 
SAT2 NM_133491.2 B44R08C07 1008.5 0.00351 3.90044 Catalyzes the acetylation of 
polyamines 
15. Eukaryotic translation 
initiation factor 1A, X-
linked 
EIF1AX NM_001412.2 B38R18C19 997 0.15461 3.84751 Enchances ribosome dissociation into 
subunits and stabilizes the binding of 
Met-tRNA(I) to 40S ribosomal 
subunits 













Mediates the assembly of signal 
recognition particle  
17. Calcium / calmodulin-
dependent protein 
kinase II alpha 
CAMK2A NM_171825.2 B13R15C19 969 0.11238 3.71865 Involved in hippocampal long-term 
potentiation by switching calmodulin-
dependent activity to calmodulin 
independent 
18. Piccolo (presynaptic 
cytomatrix protein) 
PCLO BC001304.1 B21R10C01 929 0.02740 3.53455 Involved in the organization of 
synaptic active zone and synaptic 
vesicle trafficking 
19. Nuclear speckle 
splicing regulatory 
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No. Identity Symbol Database ID Array ID Signal Intensity CV Z-score Function 
protein 1 
20. NIMA (never in 
mitosis gene a)-related 
kinase 7 
NEK7 NM_133494.1 B12R18C09 918.5 0.19169 3.48622 Controls initiation of mitosis  
21. Checkpoint suppressor 
1 / Forkhead box N3 
CHES1 / 
FOXN3 
NM_005197.2 B40R19C13 918 0.27730 3.48392 Transcriptional repressor involved in 
DNA damage-inducible cell cycle 
arrests at G1 and G2 phases 
22. Rtf1, Paf1/RNA 
polymerase II complex 
component, homolog 
(S. cerevisiae) 
RTF1 NM_015138.2 B44R16C19 882.5 0.02484 3.32053 Regulates transcriptional activity 
23. Microtubule-
associated protein 2 
MAP2 NM_031845.1 B40R07C17 875 0.03879 3.28601 Function unclear. Thought to be 
involved in microtubule assembly and 
stabilizing the microtubules against 
depolymerization 
24. Potassium channel 
tetramerisation domain 
containing 18 
KCTD18 NM_152387.2 B06R19C19 856 0.02313 3.19857 Molecular determinants for subfamily-
specific assembly of alpha-subunits 
into functional tetrameric voltage-
gated potassium channels 
25. Cyclin B3 CCNB3 NM_033671.1 B17R08C03 853.5 0.05385 3.18706 Involved in cell cycle control 
26. Eukaryotic translation 
initiation factor 1A, Y-
linked 
EIF1AY BC005248.1 B29R12C05 852.5 0.12691 3.18246 Enchances ribosome dissociation into 
subunits and stabilizes the binding of 
Met-tRNA(I) to 40S ribosomal 
subunits 
27. Vaccinia related 
kinase 1 
VRK1 NM_003384.1 B43R08C03 845 0.17406 3.14794 Serine / Threonine kinase that is 
involved in regulating cell 
proliferation and prevent the 
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No. Identity Symbol Database ID Array ID Signal Intensity CV Z-score Function 
28. Protein kinase C, iota PRKCI NM_002740.1 B17R10C07 841 0.00504 3.12953 Calcium-independent and 
phospholipid-dependent serine/ 
threonine kinase involved various 
cellular processes 
29. WD repeat domain 5 WDR5 NM_017588.1 B29R10C09 840.5 0.01598 3.12723 Involved in histone modification and 
acetylation of histone H3 




PSRC1 NM_032636.2 B40R12C17 822 0.02925 3.04208 Regulates mitotic spindle and involved 
in p53 / TP53-regulated growth 
suppression 
31. Elongation factor 1 
homolog (ELF1, S. 
cerevisiae) 
ELOF1 NM_032377.2 B38R06C11 816.5 0.00260 3.01677 Maintains proper chromatin structure 
in actively transcribed regions 
 
 




5.3.1. Functional classification of the interacting partners 
The list of identified interacting partners in Table 5.2 can be grouped into five 
main categories as shown in Figure 5.4. Four proteins are involved in signaling 
activities such as B cell activation (IGBP1), synaptic signaling (CAMK2A and PCLO) 
and signaling pathway activation (PRKCI). Another category is metabolic processing 
like phosphatidylcholine biosynthesis (CHKA) and acetylation of polyamines (SAT2). 
Six protein interactors are categorized into intracellular trafficking. Most of them are 
with high z-score values. Cortactin (CTTN), for example, is the top in the list with z-
score value of 13.41837. Other proteins that are involved in intracellular trafficking 
are SLAIN2, WIPF1, CACNB1, MAP2 and KCTD18 proteins.  
Two main categories of the novel interacting partners are cell cycle control and 
regulation of transcriptional and translational activities. In cell cycle control, further 
classification can be made into cell cycle arrest (CHES1 and CCNB3), DNA repair 
(RAD51AP1), mitotic spindle organization (AURKA, NEK7 and PSRCI), p53 
pathway (CDKN2AIP and VRK1) and polyubiquitination (UBE2S). Some of the 
protein interactors are involved in apoptotic pathway which is also a regulatory 
pathway for cell cycle arrest. For instance, AURKA and VRK1 are essential serine / 
threonine kinases involved in stabilizing p53 protein while CDKN2AIP is one of the 
activators of p53 pathway. 
Ten protein interactors are pertaining to the regulation of host transcriptional 
and translational activities. AFF4, ASXL1, RTF1, ELOF1 and WDR5 proteins are 
involved in transcriptional activity regulation while EIF1AX and EIF1AY proteins are 
translation initiators. Other transcriptional and translational activities include 
messenger RNA (NSRP1) and ribosomal RNA (DIMT1) processing and targeting 
proteins to membrane for translation (SRP19). 
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Figure 5.4: Functional classification of the interacting partners of DENV C protein. The function of each interacting protein is analysed and 
classified. Cell cycle and regulation of transcription and translation are the two major categories of DENV C protein-interacting partners. 
  




5.3.2. Compartmentalization of the interacting partners 
To unravel the non-structural roles of DENV C protein in the nucleus, novel 
protein interactors compartmentalized in the nucleus were identified. Hence, the 
localization of each protein interactor was studied and illustrated in Figure 5.5 (A). 
The list of the identified interacting partners of DENV C protein was quite well-
dispersed throughout the cell nucleus and cytoplasm. Approximately 55 % of the 
identified proteins localized in the nucleus while the other half was distributed in the 
cytoplasm [Figure 5.5 (B)]. This was exciting because a comprehensive list of DENV 
C protein-nuclear interactors involved in the virus replication was identified from this 
ProtoArray® high-throughput screening. 
Among all the nuclear proteins, five of them (SRP19, DIMT1, AFF4, RFT1, 
and CDKN2AIP) were from the nucleolus compartment. These five proteins deserve 
further investigation because DENV C protein was found localized predominantly in 
the nucleoli as previously shown in Figures 3.2-3.4 (Chapter 3).  
The cytoplasmic interacting proteins with DENV C proteins are PCLO, NEK7, 
VRK1, CTTN, MAP2, and SLAIN2 proteins which are related to cytoskeleton. Five 
proteins (CACNB1, KCTD18, CAMK2A, PCLO and PRKCI) are localized in the 
plasma membrane while four proteins (WIPF1, PCLO, CAMK2A, and PRKCI) are in 
the transport vesicles.  
Some of the proteins are localized in several compartments in the cells. For 
instance, PRKCI (protein kinase C-iota type) is a calcium-independent and 
phospholipid-dependent protein kinase found in the cytoplasm, plasma membrane, 
endosome and nucleus. PRKCI protein carries various important physiological roles 
such as cell differentiation and polarity, cell survival, and regulation of microtubule 
dynamics in the early secretory pathway (Suzuki et al., 2003). From Figure 5.5, it 




showed that DENV C protein has many opportunities to interact with large arrays of 
proteins in both nucleus and cytoplasm. 
 
Figure 5.5: Localization of DENV C protein-interacting partners identified via 
ProtoArray® platform. (A) The cellular localization of each individual protein is 
shown. Some of them localize in more than one cellular compartment. Majority of the 
DENV C protein-interacting partners localize in the nucleus followed by cytoplasm. 
(B) The total proteins in each cellular compartment are also calculated and charted. 
 
5.4. Non-Structural Role of Dengue Virus (DENV) Capsid (C) Protein in the 
Nucleus 
To delineate the significance of nuclear localization of DENV C protein 
during virus replication, a list of identified interacting partners that localize in the 
nucleolus compartment were chosen for further investigation. Five nucleolar proteins 
(SRP19, DIMT1, AFF4, RFT1, and CDKN2AIP) mainly involved in the regulation of 




transcriptional and translational activities and cell cycle control categories (Figure 5.4) 
were examined. 
 
5.4.1. Role of Dengue virus (DENV) capsid (C) protein in cell cycle arrest 
5.4.1.1. Validation of the binding between Dengue virus (DENV) capsid (C) 
protein and identified interacting partners 
Before investigating the roles of DENV C protein in cell cycle arrest, the 
binding between the identified interacting partners and DENV C protein was first 
verified via enzyme-linked immunosorbent assay (ELISA). Among the five nucleolar 
proteins, only cyclin-dependent kinase inhibitor 2A interacting protein (CDKN2AIP 
or CARF) is involved in cell cycle control and p53 pathway. The other four proteins 
(SRP19, DIMT1, AFF4, and RFT1) were examined later in Section 5.4.2. 
To expand the investigation of the role of DENV C protein in cell cycle 
control, more nuclear interactors that are also related to cell cycle control and p53 
pathway (CHES1 and VRK1 proteins) were included. The role of DENV C protein in 
p53 pathway was examined because of the involvement of C protein in activating p53 
pathway as previously reported in WNV by Bhuvanakantham and colleagues (2010). 
Cyclin B3 (CCNB3) protein was also chosen for further validation since eukaryotic 
linear motif (ELM) analysis revealed that there are putative cyclin binding motifs on 
DENV C proteins as shown in Table 5.3. From the putative cyclin binding motifs on 
DENV C protein, it was noticed that DENV-1 was similar to DENV-3 whereas 
DENV-2 was similar to DENV-4. Such phenomenon was also observed in the DENV 
sequence analyses done by Khan and colleagues (2008). 
 
 




Table 5.3: Putative cyclin binding sites of Dengue virus capsid proteins identified 
via eukaryotic linear motif (ELM) analysis 
Serotype Accession Number Positions Amino Acid Sequence 
DENV-1 NP_722457.2 35-38 KGLL 55-59 RFLAI 
DENV-2 NP_739581 55-59 RFLTI 90-94 RMLNI 





   
Commercially-available pure proteins were purchased and coated on ELISA 
plate. Purified biotinylated full-length DENV C protein that was produced from 
Chapter 4 was used as probe for binding and streptavidin-horseradish peroxidise 
(HRP) antibody was used to detect the presence of bound DENV C proteins. As 
shown in Figure 5.6 (A), all four proteins showed significant higher absorbance as 
compared to bovine albumin serum (BSA), implicating that these four identified 
interacting partners indeed bound to full-length DENV C protein in an ELISA-based 
platform. Human Sec3 and Sec6 proteins were used as positive and negative controls, 
respectively, for binding with DENV C protein in this experiment [Figure 5.6 (B)]. 
This result corroborated that DENV C protein was involved in cell cycle arrest and 
p53 pathway. 





Figure 5.6: Verification of the binding between identified interacting partners 
and DENV C protein via ELISA. (A) Commercially-available proteins of the 
identified protein interactors of DENV C protein are coated on MaxiSorp 96-well 
plate in triplicates. Purified biotinylated DENV C proteins are added into the wells for 
binding and bound proteins are detected via streptavidin-horseradish peroxidase 
(HRP) secondary antibody. The absorbance is measured at 450 nm. All four protein 
interactors show high absorbance as compared to bovine albumin serum (BSA). (B) 
Sec3p and Sec6p proteins are used as positive and negative controls, respectively, for 
binding with DENV C protein. *p-value < 0.05 
 
 
5.4.1.2. Dengue virus (DENV) capsid (C) protein arrested cell cycle at S-phase 
 Since the validated protein interactors were related to cell cycle arrest, 
investigation was carried out to examine the role of DENV C protein in cell cycle 
arrest. Green fluorescent protein (GFP)-tagged DENV C protein was transfected into 
human embryonic kidney (HEK)-293 cells (Section 2.3.6) and the cells were 
harvested for fluorescent-activated cell sorting (FACS) analysis (Section 2.7.1) at 
12 hr, 24 hr, 36 hr, and 48 hr post-transfection. GFP control was included as negative 




control. First gating was applied to the transfected cells expressing GFP. Cell cycle 
profile of the green fluorescing cells was subsequently analyzed.  
 Figure 5.7 showed the cell cycle profiles of DENV C protein-transfected cells 
and GFP control-transfected cells at 12 hr, 24 hr, 36 hr, and 48 hr post transfection. 
The percentage of cells in each cell cycle phase was counted and plotted in Figure 5.8. 
As shown in Figure 5.8, the percentage of cell population in S-phase was significantly 
higher in DENV C protein-transfected cells as compared to GFP control-transfected 
cells at 24 hr (P=0.0142) and 48 hr (P=0.0063) post-transfection. On the other hand, 
the percentage of DENV C protein-transfected cells at G1-phase was lower than 
control cells. It was also observed that the percentage of DENV C protein-transfected 
HEK293 cells in G2- / M-phase was lower than mock-transfected cells at 36 hr post-
transfection (P=0.0227). Hence, this result implicated that DENV C protein promoted 
cell cycle progression from G1- to S-phase.  





Figure 5.7: Cell cycle profile of DENV C protein-transfected and GFP control-
transfected HEK293 cells. Propidium iodide is used to stain the nuclei and cell cycle 
phases are analyzed via fluorescent-activated cell sorting (FACS). R1 – Apoptotic 
cells; R2 – G1-phase; R3 – S-phase; R4 – G2- / M-phase. 
   





Figure 5.8: Cell cycle arrest induced by DENV C protein on HEK293 cells. 
HEK293 cells are transfected with GFP-tagged DENV C protein and GFP control 
plasmids. Cell cycle profiles of the GFP expressing cells are analyzed via FACS. The 
values here are the averages of two independent experiments. S-phase cell cycle arrest 
is observed in DENV C protein-transfected cells at 24 hr and 48 hr post-transfection. 
*p-value < 0.05; **p-value < 0.01 
 
5.4.1.3. Cell cycle arrest during wild type flavivirus infection 
To investigate whether DENV C protein-induced cell cycle arrest is real in 
wild-type DENV infection, FACS (Section 2.7.1) was carried out to analyze the cell 




cycle profile of DENV-infected cells. HEK293 cells were infected with DENV-2 at 
multiplicity of infection (M.O.I.) of one. All the cells were infected synchronously at 
4 oC before they were incubated at 37 oC. This synchronization step is essential to 
ensure all cells were infected at the same time. Infected cells were fixed at every 12 hr 
interval with cold ethanol. All the fixed cells were stained with propidium iodide and 
cell cycle analyses were carried out using flow cytometer.  
Figure 5.9 demonstrated that similar S-phase cell cycle arrest was observed in 
DENV-infected HEK293 cells and this cell cycle arrest occurred as early as 12 hr 
post-infection (p.i.). As compared to mock-infected cells at S-phase, significant higher 
amount of DENV-infected was observed at 12 hr (P=0.022), 36 hr (P=0.0187) and 
48 hr (P=0.008) p.i. Concurrently, the percentage of infected HEK293 cells in G1-
phase was significantly lower than mock-infected cells (P=0.008). In addition, G2- / 
M-phase arrest was also observed in the DENV-infected cells. Percentage of DENV-
infected cells in G2- / M-phase was higher than mock-infected cells at 24 hr p.i. 
(P=0.004) and 48 hr p.i. (P=0.002). This cell cycle arrest time points correlated well 
with the exponential and peak of the virus growth curve as shown in Figure 5.10.  
Thus, cell cycle arrest by DENV C protein was confirmed in wild-type virus infection 









Figure 5.9: Cell cycle arrest induced by DENV on HEK293 cells. The percentage 
of cells in each cell cycle phase is counted and averaged from three independent 
experiments. Significant higher population of DENV-infected cells is arrested in S-
phase and G2- / M-phase at 48 hr post infection (p.i.) as compared to mock-infected 
cells. *p-value < 0.05; **p-value < 0.01 
 





Figure 5.10: Growth curve of DENV-2 in C6/36 cells. Mosquito C6/36 cells are 
infected with DENV-2 and the supernatant is harvested at various time courses for 
virus titer quantitation via plaque assay. Virus titer drops initially and starts increasing 
exponentially from 12 hr p.i. onwards until 48 hr p.i. The virus titer drops again from 
91 hr p.i. onwards.   
 
West Nile virus (WNV) C protein was also reported to localize in host cell 
nucleus during infection (Bhuvanakantham et al., 2009). To examine whether WNV 
C protein has similar role in controlling cell cycle or this cell cycle arrest is only 
specific to DENV, similar experiment was carried out using West Nile virus (WNV).  
The only difference in the protocol was that cell cycle analyses were performed at 
every 2 hr interval instead of 12 hr because WNV reaches virus peak production faster 
than DENV. One complete life cycle for DENV is about 48 hr whereas WNV needs 
approximately 24 hr. Since the replication cycle of WNV was fast, emphasis of this 
study was on the first 12 hr. 
As shown in Figure 5.11, WNV also arrested HEK293 cells at S-phase during 
infection. The percentage of WNV infected-cell populations at S-phase was indeed 
significantly higher (P=0.0001) than mock-infected cells at 24 hr p.i. Unlike DENV-
infected HEK293 cells, WNV-infected cell population at G2- / M-phase was lower 
than mock-infected cells. Therefore, both flaviviruses, DENV and WNV, arrested 
HEK293 cells at S-phase during replication but only DENV further promoted cell 
cycle progression from S- to G2- / M-phase in HEK293 cells.  





Figure 5.11: S-phase cell cycle arrest induced by WNV on HEK293 cells. The 
percentage of cell populations in each cell cycle phase is plotted after analysis via 
FACS. At 24 hr p.i., significant higher population of WNV-infected cells is at S-phase 
as compared to mock-infected cells. However, infected cell population in G2- / M-
phase is lower than mock-infected cells. *p-value < 0.05; **p-value < 0.01 
 
5.4.1.4. Flavivirus-induced cell cycle arrest is cell-type specific 
To further investigate if this flavivirus-induced cell cycle arrest is cell line and 
virus specific, cell cycle profile of DENV- and WNV-infected Baby Hamster Kidney 
(BHK) cells and C6/36 mosquito cells were also examined. Figure 5.12 showed that 
DENV also arrested BHK cells at S-phase during replication. The percentage of 




infected cells at S-phase was significantly higher than mock-infected cells at 12 hr 
(P=0.0162), 24 hr (P=0.0343), 36 hr (P=0.0138), and 48 hr (P=0.007) p.i. 
Concurrently, the percentage of infected cells at G1-phase was lower than mock-
infected cells at 36 hr (P=0.00673) and 48 hr (P=0.00168) p.i. Hence, this result 
implicated DENV also promoted BHK cell cycle progression from G1- to S-phase. 
Nevertheless, unlike HEK293 cells, G2- / M-phase arrest was not observed in DENV-
infected BHK cells. The percentage of DENV-infected BHK cells in G2- / M-phase 
was, on the other hand, lower than mock-infected cells. This indicated that DENV 
arrested BHK cells at S-phase and thus resulted in decreased G2- / M-phase cells 
population.  
As for WNV-infected BHK cells, S-phase cell cycle arrest was also observed 
during infection. Figure 5.13 showed that the population of infected cells at S-phase 
was significantly higher than mock-infected cells from 8 hr p.i. onwards. At the same 
time, the percentage of infected cells at G1-phase was significantly lower than mock-
infected. Therefore, WNV also promoted cell cycle progression from G1- to S-phase 
in BHK cells. The effect of S-phase cell cycle arrest by WNV on BHK cells was 
much more obvious and earlier than that of WNV on HEK293 cells (Figure 5.11).  In 
addition, G2- / M-phase cell cycle arrest was also observed in WNV-infected BHK 
cells at 24 hr p.i. This G2- / M-phase cell cycle arrest was similar to DENV infection 
on HEK293 cells (Figure 5.9). This confirmed that both DENV and WNV induced 
similar cell cycle arrest at S- and G2- / M-phases so that the cells were still at the 
replicating stage for better virus replication. 





Figure 5.12: Cell cycle arrest induced by DENV on BHK cells. The percentage of 
DENV-infected BHK cells at S-phase is also significantly higher than mock-infected 
cells. On the other hand, the percentage of DENV-infected BHK cells at G1-phase is 
significantly lower than mock-infected cells. *p-value < 0.05; **p-value < 0.01 
  





Figure 5.13: Cell cycle arrest induced by WNV on BHK cells. The percentage of 
WNV-infected BHK cells at S-phase is significantly higher than mock-infected cells 
from 8 hr p.i. onwards while the percentage of infected cells at G1-phase is 
significantly lower than mock-infected cells for the same time points. G2- / M-phase 
cell cycle arrest is also observed at 24 hr p.i.  
 
 
However, unlike mammalian cells, cell cycle arrest induced by flavivirus on 
C6/36 mosquito cells was different. Cell cycle arrest was also observed for DENV 
infection as shown in Figure 5.14 but DENV arrested C6/36 at G2- / M-phase instead 
of S-phase. As compared to mock-infected cells, higher percentage of DENV-infected 




C6/36 cells remained in G2- / M-phase, especially at 48 hr p.i. (P=0.048). On the 
other hand, the percentage of infected cells at G1-phase was lower than mock-infected 
cells (P=0.047) whereas no significant difference was observed between DENV-
infected and mock-infected cells in S-phase. This demonstrated that DENV arrested 
mammalian cells at S-phase but arrested mosquito cells at G2- / M-phase.  
To examine if G2- / M-phase arrest also occurred in WNV-infected C6/36 
cells, similar experiment was performed. In contrast, no significant differences were 
observed between WNV-infected and mock-infected C6/36 cells. The percentages of 
cells at each cell cycle phase were similar for both WNV-infected and mock-infected 
cells as shown in Figure 5.15. This implied that WNV arrested BHK cells at S-phase 
but WNV did not affect the cell cycle of insect cell line, C6/36.  
 
 




   
Figure 5.14: Cell cycle arrest induced by DENV on C6/36 cells. The population of 
C6/36 cells in S-phase between DENV-infected and mock-infected does not differ 
significantly. However, the percentage of DENV-infected cells at G1-phase is 
significantly lower than mock-infected cells at 48 hr p.i. On the other hand, higher 
number of DENV-infected cells are arrested at G2- / M-phase as compared to mock-
infected cells 48 hr p.i. * p-value < 0.05. 
 




   
Figure 5.15: Cell cycle arrest induced by WNV on C6/36 cells. No significant 
difference is observed in any cell cycle phase between WNV-infected and mock-
infected cells.  
 
 The wild-type virus infection results supported that flaviviruses indeed 
induced cell cycle arrest during replication. Both DENV and WNV induced S-phase 
arrest in HEK293 and BHK cells but DENV arrested C6/36 cells at G2- / M-phase 
whereas WNV did not affect the cell cycle of C6/36 cells.  




5.4.1.5. Effect of cell cycle arrest upon Dengue virus (DENV) infection 
 Since flavivirus induced cell cycle arrest at S-phase during infection, it was 
hypothesized that S phase was more favourable for flavivirus replication. To examine 
the effect of each cell cycle phase on DENV infection, HEK293 cells were arrested at 
each cell cycle phase using various drugs (Section 2.7.2) and infection was performed 
on the cell cycle synchronized cells. The effect of the cell cycle arrest on DENV 
replication was examined by quantitating the virus titer in the supernatant via plaque 
assay (Section 2.2.2) at 48 hr post-infection. HEK293 cells were chosen for further 
downstream experiments because both BHK and HEK293 cells were arrested 
similarly by DENV and WNV at S-phase during infection.  
 Figure 5.16 (A) showed the cell cycle profiles of all the treated cells at 48 hr 
post-infection. As compared to no treatment control (i), serum starvation was able to 
arrest the cells at G1-phase (ii). 40 mM thymidine (Thy) was used to arrest cell cycle 
at S-phase (iii) whereas 100 ng/ml nocodazole (Noco) was able to arrest cell cycle at 
G2- / M-phase (iv). DENV production was significantly reduced by up to 2 log when 
the host cell cycle was arrested at G1-phase [Figure 5.16 (B)]. There was no 
significant difference in virus titer when the cells were arrested at S-phase and G2- / 
M-phase. To rule out the possibility of cytotoxicity that in turn led to virus titer 
reduction, cytotoxicity assay was carried out. As shown in Figure 5.16 (C), the 
treatments did not show any significant cytotoxicity effect as compared to no 
treatment control. Hence, this result demonstrated that G1-phase was not favourable 
for DENV replication. Figures 5.7 to 5.15 implicated that DENV promoted host cell 
cycle progression to S-phase during infection to favour its replication.  





Figure 5.16: Effect of cell cycle arrest on DENV infection. (A) HEK293 cells are 
synchronized in different cell cycle phases using various treatments. (i) Growth media 
supplemented with 2 % fetal calf serum (FCS) is used as no treatment control. (ii) 
Serum starvation (0%) is used to arrest cells at G1-phase. 40 mM thymidine (Thy) is 
used for S-phase arrest while (iv) 100 ng/ml nocodazole (Noco) is used for G2- / M-
phase arrest. (B) Virus titer in the supernatant is quantitated via plaque assay at 48 hr 
post-infection. As compared to no treatment control (2%), no significant difference in 
virus titer is observed after treatment with Thy and Noco. However, DENV 
production is significantly reduced in cells arrested at G1-phase. (C) Cell cytotoxicity 
assay is carried out to examine the toxicity of the treatments. No significant 
cytotoxicity effect is observed in all the treatments as compared to no treatment 
control. (R1 – dead cells; R2 – G1-phase; R3 – S-phase; R4 – G2- / M-phase) 
*p-value < 0.05 




5.4.1.6. Effect of DENV infection on cell cycle-related genes 
 Since the ProtoArray® (Figure 5.6) and FACS analyses (Figure 5.7-5.15) 
results implicated that flaviviruses arrested host cell cycle during infection to aid their 
replication, further investigation was carried out to examine the changes in cell cycle-
related genes expression level during infection. In order to have a comprehensive list 
of cell cycle-related genes, Human Cell Cycle PCR array from SABiosciences was 
employed (Section 2.7.3). A total of 84 key genes pertaining to cell cycle regulation 
can be screened simultaneously in one single 96-well plate. Important genes that 
regulate transitions between each cell cycle phase, checkpoints and arrest are included 
in the PCR array. HEK293 cells were infected with DENV at M.O.I. of 1 and the total 
RNA was harvested at 48 hr post-infection (p.i.) for PCR array analysis. A more 
stringent fold change cut-off value (> 3) was considered significant difference to 
prevent false positive. 
3D PCR array profile (A) and scatter plot (B) in Figure 5.17 revealed that 
there were three significantly up-regulated genes in the DENV-infected cells as 
compared to mock-infected cells at 48 hr post-infection. The identity and functions of 
the up-regulated genes was illustrated in Table 5.4. 
Table 5.4: Cell cycle-related genes that are up-regulated during DENV infection 
Symbols Gene Name Fold Change Functions 
GADD45A Growth arrest and 
DNA-damage-
inducible, alpha 
5.89 Main regulator of p38/JNK 
pathway, mediating G2- / M-
checkpoint in response to 
environmental stress via p53-
dependent and -independent 
mechanisms 
HERC5 Hect domain and 
RLD 5 
4.92 Ubiquitin E3 ligase that mediates 
ISGylation of protein targets 
CDKN2B Cyclin-dependent 
kinase inhibitor 
2B (p15, inhibits 
CDK4) 
3.68 A CDK inhibitor that prevents cell 
cycle G1-phase progression by 
interrupting the binding of cyclin 
D to CDK4 or CDK6 




   
Figure 5.17: PCR array analysis of DENV-infected cells. HEK293 cells are 
infected with DENV at M.O.I. of 1 and total RNA is extracted from the infected cells 
for PCR array analysis at 48 hr post-infection. 3D profile (A) and scatter plot (B) 
show that three genes are significantly up-regulated in DENV-infected cells at 48 hr 
post-infection. The purple lines in scatter plot indicate the significant fold-change in 
the gene expression level threshold which is more than 3. 
 
ProtoArray® identified four cell cycle-related interacting partners (CCNB3, 
CDKN2AIP, CHES1 and VRK1) of DENV C protein while PCR array discovered 
three more genes (GADD45A, HERC5 and CDKN2B) that were up-regulated during 
DENV infection. Hence, to examine the gene expression levels of all these seven 
genes in DENV-infected cells at 48 hr post-infection, real-time PCR (Section 2.3.8) 




was carried out. As shown in Figure 5.18 (A), there was only a slight increase in 
CHES1 gene level as compared to mock-infected cells. Nevertheless, significant 
increase was observed in all other genes at 48 hr post-infection. To examine whether 
these genes up-regulation was specific to DENV laboratory strain only, DENV-2 
clinical isolate from Singapore (05K4137) with low passage number (Passage 3) was 
used to infect HEK293 cells. At 48 hr post-infection, it was observed that all seven 
genes were significantly up-regulated [Figure 5.18 (B)]. In summary, DENV 
promoted cell cycle progression during infection to favour its replication and seven 
cell cycle-related genes (GADD45A, HERC5, CDKN2B, CCNB3, CDKN2AIP, 
CHES1, and VRK1) were up-regulated. Among these seven genes, CCNB3, CHES1, 
CDKN2AIP and VRK1 were found to have direct interaction with DENV C protein. 
   
Figure 5.18: Gene expression level of identified interacting partners of DENV C 
protein during DENV infection. HEK293 cells are infected with DENV and total 
RNA is harvested for real-time PCR analysis at 48 hr post-infection. Both DENV-2 
laboratory strain (A) and clinical isolate (B) up-regulate all seven genes during 
infection. The up-regulation is also observed in clinical isolate-infected cells.  




5.4.2. Role of Dengue virus (DENV) capsid (C) protein in regulating host 
transcriptional and translational activity 
5.4.2.1. Validation of the binding between Dengue virus (DENV) capsid (C) 
protein and identified interacting partners 
Other than cell cycle control, regulating host transcriptional and translational 
activities was another main category of the identified interacting partners of DENV C 
protein. Among the five nucleolar proteins, four (SPR19, DIMT1, AFF4 and RFT1) 
of them (Figures 5.4 and 5.5) are pertaining to regulation of transcriptional and 
translational activities. These proteins may be useful for DENV viral proteins 
biogenesis. Before examining the role of the four nucleolar proteins, the binding 
between these proteins (SRP19, DIMT1, AFF4 and RFT1) and DENV C protein were 
first validated via enzyme-linked immunosorbent assay (ELISA). 
Commercially-available pure proteins were purchased from Abnova (USA) 
and coated on ELISA plate (Section 2.5.3.7). Bovine serum albumin (BSA) was also 
coated on the ELISA plate as negative control. Purified full-length biotinylated 
DENV C protein (Chapter 4) was then added into the well as probe for binding. 
Bound DENV C protein was detected by streptavidin-horseradish peroxidase (HRP) 
antibody. As shown in Figure 5.19, all four identified interacting partners bound to 
DENV C protein. Significant higher absorbance was observed in all four nucleolar 
proteins as compared to BSA. Hence, DENV C protein interacted with AFFT, DIMT1, 
RFT1, and SRP19 proteins in an ELISA-based platform. 





Figure 5.19: Validation of the binding between DENV C protein and interacting 
partners identified via ProtoArray® platform. Pure AFF4, DIMT1, RFT1, and 
SRP19 proteins are coated on MaxiSorp 96-well plate and purified biotinylated 
DENV C protein is used as probe. Bound C protein is detected by streptavidin-
horseradish peroxidase secondary antibody. As compared to negative control, bovine 
serum albumin (BSA), significant higher absorbance is detected for all four 
interacting partners. 
 
Among these four nucleolar proteins, DIMT1 and SRP19 were chosen for 
further investigation because purified proteins and working antibodies are 
commercially available. DIMT1 is an 18S ribosomal RNA (rRNA) dimethylase that 
specifically dimethylates adenosines of 18S rRNA in the 40S ribosomal particle. 
SRP19 is a ribonucleoprotein that facilitates targeting specific protein to endoplasmic 
reticulum during protein translation.  
To further confirm the interaction between DENV C protein and DIMT1 / 
SRP19 proteins, a reciprocal ELISA binding assay was carried out by coating DENV 
C protein on the ELISA plate and glutathione S-transferase (GST)-tagged DIMT1 and 
SRP19 proteins were used as probes. The bound complexes were then detected by 
HRP-conjugated anti-GST antibodies. As demonstrated by Figure 5.20, the reciprocal 
ELISA binding assay result also supported that DIMT1 and SRP19 proteins indeed 
interacted with DENV C protein. Besides, Figure 5.21 also showed that biotinylated 
full-length DENV C protein interacted with both SRP19 and DIMT1 proteins coated 
on ELISA plates in an increasing dose-dependent manner.  





Figure 5.20: Reciprocal binding assay to confirm the interaction between DENV 
C protein and SRP19 / DIMT1 proteins. Purified DENV C protein (100 ng) is 
coated on the MaxiSorp well in triplicates. Same amount of SRP19 and DIMT1 
proteins are added into the wells and bound proteins are detected by horseradish 
peroxidase (HRP)-conjugated anti-glutathione S transferase (GST) antibody. Higher 
absorbance is also detected for SRP19 and DIMT1 protein as compared to the 




Figure 5.21: Protein binding assay with increasing amount of SRP19 / DIMT1 
proteins. Increasing amount of SRP19 and DIMT1 proteins (100 ng, 200 ng, and 
300 ng) are coated on MaxiSorp well in triplicates. Same amount of purified 
biotinylated DENV C proteins (100 ng) are added into each well for binding. 
Streptavidin-horseradish peroxidase (HRP) is used to detect bound DENV C protein. 
Unlike bovine serum albumin (BSA), DENV C protein interacts with SRP19 and 
DIMT1 proteins in an increasing dose-dependent manner.  
 
The bindings between DENV C protein and DIMT1 / SRP19 proteins were not 
only observed in vitro, but also in vivo. Immuno-fluorescence assay result in 
Figure 5.22 (A and B) illustrated that DENV C protein co-localized with DIMT1 and 




SRP19 proteins in BHK cell nucleus, especially in the nucleolus. Co-localization 
analysis using JACoP plugin (Bolte & Cordelieres, 2006) in ImageJ software (Section 
2.4.5) demonstrated that the Pearson’s coefficients for the positive correlation 
between DENV C protein and SRP19 or DIMT1 proteins were 0.864 and 0.930, 
respectively [Figure 5.22 B(i and ii)]. The closer the coefficient value to 1, the higher 
the correlation between DENV C protein and the interacting partners. The results 
corroborated that SRP19 and DIMT1 proteins were novel interacting partners of 
DENV C protein. 
 
Figure 5.22: Co-localization between DENV C protein and SRP19 / DIMT1 
proteins in the nucleolus. (A) FLAG-tagged full-length DENV C plasmid is 
transfected into BHK cells seeded on coverslips. The transfected cells are fixed and 
stained with anti-FLAG and anti-SRP19 / DIMT1 antibodies. Alexa Fluor-488 
secondary antibody is used to detect anti-FLAG antibody while Alexa Fluor-594 
secondary antibody is used for anti-SRP19 / DIMT1 antibodies. 4’,6’-diamino-2-
phenylindole (DAPI) is used to stain the nucleus. The overlay images show that 
DENV C protein co-localizes with SRP19 and DIMT1 in the nucleus. (B) Co-
localization analysis is performed using JACoP plugin in ImageJ software. The 
cytofluorograms of SRP19 (i) and DIMT1 (ii) show that there is a positive correlation 
between SRP19 / DIMT1 proteins and DENV C protein with Pearson’s coefficient of 
0.864 and 0.930, respectively. 




5.4.2.2. Effect of signal recognition particle 19 (SRP19) and dimethyladenosine 
transferase 1 homolog (DIMT1) gene over-expression and knock-down upon 
Dengue virus (DENV) replication 
To delineate the role of SRP19 and DIMT1 proteins during DENV replication, 
over-expression and knock-down experiments were carried out. DIMT1 is involved in 
ribosomal biogenesis whereas SRP19 is related to protein biogenesis. The hypothesis 
was that DENV C protein controlled these host protein in the nucleolus through direct 
interaction to aid virus replication.  
To over-express SRP19 and DIMT1 genes, commercially available clones 
were purchased from OriGene, USA. After confirming the DNA sequence and 
identity of the clones via DNA sequencing, the plasmids were transfected into 
HEK293 cells according to Section 2.3.6. To examine the effect of the genes over-
expression upon DENV infection, the transfected cells were infected with DENV at 
M.O.I of 1 after 24 hr post-transfection (Section 2.8). Empty vector clone expressing 
myc-FLAG tag only was used as a negative control. After 24 hr post-infection, the 
infected cell lysates were collected for RNA extraction and protein analyses. 
Western-blot (Section 2.5.3.2) and real time-PCR (Section 2.3.8) were carried 
out to ensure that SRP19 and DIMT1 proteins were over-expressed. Since both clones 
contained a myc-FLAG tag at the C-terminus, the presence of over-expressed SRP19 
and DIMT1 proteins were detected by anti-FLAG antibody. The molecular weight of 
SRP19 and DIMT1 proteins are approximately 20 kDa and 36 kDa, respectively. 
Figure 5.23 (A) demonstrated that both proteins were expressed well in the 
transfected HEK293 cells as thick bands were observed in both the infected (INF) and 
mock-infected (UI) Lanes. Real-time PCR result in Figure 5.23 (B) also showed that 
SRP19 (i) and DIMT1 genes (ii) were significantly higher in the respective clone 




transfected cells as compared to tag control. Interestingly, it was also noticed that 
SRP19 and DIMT1 gene levels in the infected cells (INF) was significantly higher as 
compared to mock-infected cells (UI). This implied that SRP19 and DIMT1 genes 
were up-regulated during DENV infection.     
 
Figure 5.23: Over-expression of SRP19 and DIMT1 proteins in HEK293 cells. 
(A) HEK293 cells are transfected with SPR19 and DIMT1 plasmids and the over-
expressed proteins are detected via Western-blot using anti-FLAG antibody. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody is used as loading 
control antibody. SRP19- and DIMT1-corresponding bands are observed in both the 
infected (INF) and mock-infected (UI) cells. Tag control (Tag Ctrl) is used as 
negative control to examine the effect of genes over-expression on DENV infection. 
(B) Real-time PCR result showing the over-expression of SRP19 (i) and DIMT1 (ii) 
genes in the transfected cells. The genes level in the infected cells (INF) is 
significantly higher than the mock-infected cells (UI). *p-value < 0.05 
 
To examine the effect of the SRP19 and DIMT1 proteins over-expression 
upon DENV infection, virus titer in the supernatant of the infected cells were 
quantitated via plaque assay (Section 2.2.2). As shown in Figure 5.24 (A), the virus 
titers in DIMT1 protein over-expressed cells was not significantly different from that 
in myc-FLAG tag over-expressed cells. In other words, over-expression of DIMT1 




protein did not have any effect on DENV replication. Nevertheless, there was a 
statistically significant reduction in virus titer (P=0.0131) when SRP19 protein was 
over-expressed in HEK293 cells [Figure 5.24 (A)]. There was approximately 60 % 
virus titer reduction as compared to tag control cells [Figure 5.24 (B)].  
 
Figure 5.24: Effect of SRP19 and DIMT1 proteins over-expression on DENV 
infection. (A) The supernatant of the infected cells is harvested for plaque assay. 
There is no significant difference in virus titer between DIMT1 protein and tag 
control over-expressed cells. However, virus titer in SRP19 protein over-expressed 
cells is significantly lower than that in tag control over-expressed cells. *p-value<0.05 
(B) Percentage of virus titer reduction in SRP19 and DIMT1 protein over-expressed 
cells as compared to tag control over-expressed cells. This data is contributed by two 
independent experiments. 
 
As for knock-down experiment, human shRNA constructs of SRP19 and 
DIMT1 genes were purchased from OriGene, USA. To ensure multiple splice variants 
were targeted during knock-down, four unique shRNA constructs for each gene were 




combined in one single transfection in HEK293 cells (Section 2.9). Scrambled 
shRNA was included as a negative control. Besides, the shRNA constructs contained 
green fluorescent protein (GFP) so transfection efficiency could be monitored. Figure 
5.25 (A) illustrated the transfection efficiency of the shRNA constructs into HEK293 
cells at 24 hr post-transfection. Intense green fluorescence was clearly observed in 
majority of the cell population. 
The transfected cells were then infected with DENV at M.O.I of 1. After 24 hr 
post-infection, the infected cells were collected for real-time PCR (Section 2.3.8) and 
Western-blot (Section 2.5.3.2) analyses. As shown in Figure 5.25 (B), both the SRP19 
(i) and DIMT1 (ii) genes were successfully knock-downed by approximately 80 %, 
even after 48 hr post-transfection. Reduction in band intensity was observed for both 
SRP19 and DIMT1 proteins in Western-blot [Figure 5.25 C(i)]. Densitometry analysis 
showed that both SRP19 and DIMT1 protein expression levels were reduced to 
approximately 50 % and 40 %, respectively [Figure 5.25 C(ii)].  
The effect of SRP19 and DIMT1 genes knock-down upon DENV infection 
was examined by quantitating the virus titer in the supernatant of infected cells via 
plaque assay (Section 2.2.2). Figure 5.26 showed that there was no significant virus 
titer reduction in both the SRP19 and DIMT1 genes knock-downed cells. Hence, 
SRP19 and DIMT1 genes knock-down did not affect DENV production.  
In brief, over-expression and knock-down of DIMT1 genes did not affect 
DENV production (Figures 5.24 and 5.26). Nevertheless, the underlying reason for 
the binding of DENV C protein to DIMT1 protein still warrants further investigation. 
On the other hand, over-expression of SRP19 protein resulted in significant virus titer 
reduction although knock-down of SRP19 gene did not have any effect on DENV 
production. 





Figure 5.25: Knock-down of SRP19 and DIMT1 genes. (A) Human shRNA 
constructs targeting SRP19 and DIMT1 genes are transfected into HEK293 cells. 
Transfection efficiency is monitored by green fluorescent protein (GFP) expression. 
Immuno-fluorescence images (10 x magnifications) show the expression of GFP in 
the transfected cells. (B) At 24 hr post-transfection, the cells are infected with DENV. 
Total RNA was extracted from the infected cells at 24 hr post-infection and real-time 
PCR is performed to detect SRP19 (i) and DIMT1 (ii) genes level. Both of the genes 
level is significantly reduced as compared to scrambled shRNA-transfected cells. (C) 
The protein expression level of SRP19 and DIMT1 proteins is detected via Western-
blot (i) and densitometry analysis is carried out using ImageJ software (ii). After 
normalization with GAPDH loading control, SRP19 and DIMT1 protein expression 
levels are reduced to approximately 50 % and 40 %, respectively, as compared to 
scrambled. 





Figure 5.26: Effect of SRP19 and DIMT1 genes knock-down upon DENV 
infection. Supernatant of SRP19 and DIMT1 genes knock-downed HEK293 cells is 
harvested for plaque assay analysis. No significant difference in virus titer is observed 
in all the SRP19-, DIMT1- and scrambled-transfected cells. 
 
5.4.2.3. Role of signal recognition particle 19 (SRP19) during Dengue virus 
(DENV) infection 
The main function of signal recognition particle 19 (SRP19) is to facilitate the 
binding of SRP RNA, also known as 7SL RNA, to other SRP components such as 
SRP54, SRP68 and SRP72 proteins to form SRP ribonucleoprotein complex (Wild et 
al., 2010). This SRP ribonucleoprotein complex is a ubiquitous initiator of protein 
translocator that facilitates targeting nascent polypeptide to the rough endoplasmic 
reticulum (ER) so that translating protein could be inserted into the membrane 
(Grudnik et al., 2009; Lutcke, 1995; Rapiejko & Gilmore, 1992). This is an important 
process for DENV replication too because the replication site of flavivirus is at the ER 
regions where the viral genome is translated into a single polyprotein. However, it 
was also reported that ribonucleoprotein complex bound to translating protein can 
retard the protein elongation before targeting them to the ER (Lutcke, 1995; Walter et 
al., 1981). Therefore, there are two possible outcomes for the interaction between 
SRP19 protein and DENV C protein: (1) DENV C protein binds to SRP19 protein and 




brings the whole ribonucleoprotein complex to the virus replication site to facilitate 
viral protein translation. (2) Ribonucleoprotein complex binds to translating DENV 
polyprotein and retards the protein elongation. Figures 5.24 and 5.26 indicated that 
over-expression of SRP19 protein resulted in lower virus yield and on the other hand, 
knock-down of SRP19 gene did not affect DENV production. Hence, this implied that 
the presence of SRP19 protein was in fact inhibiting DENV replication. 
To investigate the level of SRP19 protein expression level during DENV 
replication, HEK293 cells were infected with DENV at M.O.I. of 1 and the infected 
cells were harvested for real-time PCR (Section 2.3.8) and Western-blot (Section 
2.5.3.2) analyses at 24 hr, 48 hr, and 72 hr post-infection. As shown in Figure 5.27 
(A), the gene expression level was up-regulated from 24 hr post-infection to 72 hr 
post-infection as compared to mock-infected cells. This result confirmed the 
observation in Figure 5.23 B(i) that DENV infection resulted in up-regulation of 
SRP19 genes. It was interesting to note that SRP19 protein level was, on the other 
hand, down-regulated during DENV infection [Figure 5.27 B(i and ii)]. The SRP19 
protein level increased slightly at 24 hr post-infection and then decreased significantly 
at 72 hr post-infection by up to 80 %. This result indicated that host cells attempted to 
up-regulate the expression of SRP19 gene but DENV reduced the SRP19 protein level. 
This revealed that over-expression of SRP19 led to reduction of virus titer in Figure 
5.24.  





Figure 5.27: Expression of SRP19 protein during DENV infection. (A) HEK293 
cells are infected with DENV at M.O.I. of 1 and at various post-infection time points, 
total RNA was extracted from the infected cells for real-time PCR analysis. SRP19 
gene is generally up-regulated during DENV infection. The gene level increases from 
24 hr to 48 hr post-infection and then decreases at 72 hr post-infection. (B) The 
protein expression level of SRP19 protein is detected via Western-blot (i) and the 
band intensity is analyzed via densitometry using ImageJ software (ii). After 
normalization with GAPDH loading control, SRP19 protein expression level increases 
slightly at 24 hr post-infection and then decreases from 48 hr to 72 hr post-infection.  
  
The results so far implicated that SRP19 protein inhibited DENV replication. 
To examine whether SRP19 protein affects the viral RNA replication, real-time PCR 
(Section 2.3.8) was carried out to detect the level of intracellular DENV RNA in the 
infected cells that were over-expressing SRP19 proteins. Figure 5.28 demonstrated 
that intracellular DENV RNA was reduced significantly in SRP19 protein over-
expressed HEK293 cells. On the other hand, no significant difference in viral RNA 




level was detected in SRP19 gene and scrambled knock-downed cells. Hence, 
excessive SRP19 protein reduced DENV RNA replication which in turn resulted in 
lower virus titer.   
 
Figure 5.28: DENV RNA level in the SRP19 gene over-expressed and knock-
downed HEK293 cells. HEK293 cells over-expressing SRP19 protein are infected 
with DENV and at 24 hr post-infection, viral RNA was extracted from the infected 
cells for real-time PCR analysis. SRP19 gene and scrambled knock-downed HEK293 
cells are included as negative controls. Intracellular DENV RNA is reduced to 
approximately 60 % in SRP19 over-expressed cells whereas no difference is observed 
for both SRP19 gene and scrambled knock-downed cells. *p-value < 0.05 
 
Since SRP19 protein inhibited DENV replication, it is possible that DENV 
attempts to counter this effect through the action of DENV C protein in the nucleolus. 
Newly synthesized DENV C protein translocated into nucleolus to reduce SRP19 
protein level, thereby nullifying the effect of SRP19 protein creating a conducive 
environment for virus replication. To investigate this hypothesis, HEK293 cells were 
transfected with DENV C plasmid (Section 2.3.6) and Western-blot (Section 2.5.3.2) 
was carried out to detect the level of SRP19 protein at 24 hr post-transfection.  
As shown in Figure 5.29 A(i), the SRP19 protein band intensity was much 
lower in DENV C-transfected cells as compared to mock-transfected cells. 




Densitometry analysis revealed that the SRP19 protein level was reduced to 
approximately 60 % [Figure 5.29 A(ii)]. To measure the level of SRP19 protein in the 
whole cells lysates, transfected cell lysates were coated onto 96-well plate and anti-
SRP19 antibody was used to detect the presence of SRP19 protein. The absorbance 
was then normalized with housekeeping protein, glyceraldehydes 3-phosphate 
dehydrogenase (GAPDH). Figure 5.29 (B) showed that SRP19 protein was indeed 
reduced significantly in the DENV C-transfected cells as compared to mock-
transfected cells. Co-immuno precipitation (Co-IP) was also carried out to examine if 
the degradation of SRP19 protein was due to the direct interaction with DENV C 
protein. Figure 5.29 (C) demonstrated that DENV C protein was pulled down together 
with SRP19 protein, implicating that DENV C protein degraded SRP19 protein via 
direct interaction.  
In summary, excessive SRP19 protein resulted in decreased DENV viral RNA 
and thus caused lower virus production. Hence, one of the non-structural roles of 
DENV C protein in the nucleolus was to counter the effect of SRP19 protein by 
degrading the protein through direct interaction. 
 





Figure 5.29: Degradation of SRP19 protein by DENV C protein. (A) HEK293 
cells are transfected with DENV C protein and the level of SRP19 protein at 24 hr 
post-transfection is detected via Western-blot (i). As compared to mock-transfected 
cells, significant reduction in SRP19 protein band intensity is observed for DENV C-
transfected cells. Densitometry analysis (ii) is performed using ImageJ software and 
normalized with GAPDH loading control. As compared to mock-transfected cells, 
SRP19 protein level is reduced to approximately 60 %. (B) ELISA is also carried out 
to quantitate the level of SRP19 protein in the whole cell lysates. SRP19 protein is 
reduced significantly in the DENV C-transfected cells (P=0.004). (C) Co-immuno 
precipitation (Co-IP) is carried out to pull-down FLAG-tagged DENV C protein and 
the presence of SRP19 protein is detected using anti-SRP19 antibody via Western-
blot (WB). A band corresponding to SRP19 protein can be observed in the DENV C 
protein-transfected cells after Co-IP, indicating that there is a direct interaction 





6.  Discussions 
The single, positive-stranded RNA genome of flavivirus encodes for three 
structural proteins and seven non-structural proteins. It is not surprising that flavivirus 
employs a sophisticated method to overcome its limited genomic information 
constraint by having multifunctional viral proteins. With those multifunctional viral 
proteins, flavivirus can hijack the host cellular components and manipulate host 
intracellular or even extracellular environment to establish its infection within its host. 
Dengue virus (DENV) capsid (C) protein is a viral structural protein that performs 
multifunctional roles during virus replication and pathogenesis. Understanding the 
non-structural roles of DENV structural C protein will help to uncover the missing 
puzzle of the underlying molecular mechanism of DENV replication. Only by 
stitching all these missing pieces together, novel antiviral strategies can be rationally 
designed. 
The main function of DENV structural C protein is to bind to progeny DENV 
RNA genome, homo-oligomerize, and assemble into spherical cage-like nucleocapsid. 
Even though DENV C protein is the first viral protein synthesized, its structural role 
is only required during virus assembly which is at the late phase of virus life cycle. 
Therefore, it is not surprising that DENV C proteins will have other functions to 
perform before the assembly stage.  
One such non-structural function was the translocation of DENV C proteins 
into the nuclei. Lad and colleagues (1993) demonstrated that replication of DENV and 
West Nile virus (WNV) was negatively affected in the enucleated cells (cells without 
nuclei). Bhuvanakantham and co-workers (2009) further illustrated that abolishment 





This confirmed the importance of the presence of flavivirus C protein in the nucleus. 
Nonetheless, the exact mechanism of nuclear translocation of DENV C protein and its 
roles in the nucleus have yet to be clearly unravelled. The findings from this project 
have delineated the molecular mechanism of nuclear translocation of DENV C protein 
and uncovered some of the potential non-structural roles of C protein in the nucleus.  
The results confirmed that DENV C proteins indeed localized in the nuclei / 
nucleoli of transfected cells, independent of other viral proteins (Figures 3.2-3.4). 
However, it was discovered that not all the DENV C proteins were required to 
translocate into the nucleus (Figures 3.5-3.7). It is possible that only sub-molar 
quantity of DENV C protein is sufficient to carry out its non-structural roles in the 
nucleus.  
Two bipartite NLS motifs (residues 5-22 and 85-100) in DENV C protein 
were proven to be functional (Figure 3.14). It is not surprising that DENV C protein 
needs more than one functional NLS motif to ensure efficient nuclear import of 
DENV C proteins. Suzuki and co-workers (2005) showed that Hepatitis C virus (HCV) 
C protein contained a non-classical NLS motif which comprised three basic-residue 
clusters of which at least two out of three were required for efficient nuclear 
translocation. The nucleoprotein (NP) of Influenza A virus, a negative-stranded RNA 
virus, also contained two functional NLS motifs for the nuclear import of NP proteins 
(Wu et al., 2007).  
In this study, amino acid residues from 97 to 100 of bipartite NLS2 motif was 
found to be the most crucial residues for nuclear localization of DENV C protein 
while bipartite NLS1 motif (residues 5-22) enhanced the nuclear translocation ability 





colleagues (2002) is that site-directed mutagenesis was performed instead of 
truncation of the protein. This is because site-directed mutagenesis can minimize the 
negative impact on the protein folding and also pinpoint the exact amino acid residues 
that are crucial for nuclear translocation of DENV C proteins.  
In addition, this finding also resolved the discrepancy of the published results 
by Mori and colleagues (2005). It was proven that mutation on residues 42 and 43 did 
not completely abolish the nuclear localization of DENV C protein (Figures 3.17 and 
3.18) as claimed by Mori and colleagues (2005). Ward and Davidson (2007) also 
supported that the nuclear localization of DENV C protein was not completely 
abrogated when the residues 42 and 43 were mutated to alanine in an infectious clone. 
However, mutations on these residues did affect virus yield. The actual reason why 
these residues are important for virus production has yet to be answered. One reason 
could be that residues 42 and 43 are in the linker region connecting two α-helices (α1 
and α2) as shown in Figure 6.1. Hence, mutations on these two residues may affect 
the structure of C protein which in turn disrupt virus assembly event. 
 
Figure 6.1: Positions of NLS1, NLS2 motifs, residues S71 and G42&P43 in 
DENV C protein. Protein image is reproduced by Rasmol (http://rasmol.org/) using 
1R6R.pdb file from Research Collaboratory for Structural Bioinformatics (RCSB) 
Protein Data Bank website (http://www.rcsb.org/). It only shows residues from 21 to 
100. Both NLS1 and NLS2 motifs are highlighted in red. Residue 71 is shown in 
space-filled form while residues 42 and 43 are shown in ball-and-stick representation. 





Similar to WNV C protein (Bhuvanakantham et al., 2009), this project 
demonstrated that there was a direct binding between DENV C protein and importin-α 
protein but not with importin-β protein (Figure 3.23). Importin-α protein has two 
separate NLS binding sites, namely major and minor sites (Fontes et al., 2000). Co-
immunoprecipitation (co-IP) and mammalian-2-hybrid (M2H) assay indicated that the 
whole NLS2 motif of DENV C protein was the main binding site for the interaction 
with importin-α protein while NLS1 motif was important to enhance this binding 
(Figures 3.24 and 3.27). Requirement of two NLS motifs for efficient binding to 
importin-α protein was also reported in other viruses such as simian 
immunodeficiency virus (SIV). Translocation of Vpx protein of SIV into nucleus 
involved interaction between importin-α protein and two NLSs (amino acid residues 
20-40 at N-terminus and residues 65-75 at C-terminus) in Vpx protein (Singhal et al., 
2006).  
It is known that phosphorylation is involved in regulating the binding between 
importin-α protein and NLS-bearing proteins (Fontes et al., 2003). Further 
investigation in this study showed that protein kinase C (PKC) was important for the 
translocation of DENV C protein into nucleus (Figure 3.30). It was also demonstrated 
that residue 71 of DENV C protein, which was shown in space-filled form in Figure 
6.1, located in the middle of NLS1 and NLS2 motifs, was the phosphorylation site for 
nuclear translocation of DENV C protein (Figure 3.29). This finding is similar to 
WNV C protein as reported by Bhuvanakantham and colleagues (2010) and other 
viruses such as Hepatitis B virus (HBV). Kann and colleagues (1999) showed that 
only phosphorylated core particles of HBV can bind to importin-α and importin-β 
proteins for nucleus import. As such, phosphorylation is a common regulator for 





A model for the molecular mechanism of nuclear translocation of DENV C 
protein is summarized in Figure 6.2. First, newly synthesized DENV C protein is 
phosphorylated by PKC at residue 71. The phosphorylated C protein is then 
recognized by importin-α protein that binds to C protein at bipartite NLS2 motif 
(residues 85-100). Bipartite NLS1 motif (residues 5-22) enhances the binding 
between DENV C protein and importin-α protein. Following that, importin-β protein 
binds to the importin-α protein and brings the whole complex into the nucleus.  
 
Figure 6.2: Model of transportation mechanism of DENV C protein into nucleus. 
1. DENV C protein is phosphorylated by protein kinase C at amino acid residue 71. 2. 
Phosphorylated form of C protein is recognized by importin-α protein which is 
recognized by importin-β protein. Importin-α protein binds directly to phosphorylated 
C protein at NLS2 motif and NLS1 motif enhances the binding. Importin-β protein 





Alanine substitution mutagenesis of DENV infectious clone at residues 97-100 
of DENV C protein demonstrated that no viable virus was produced when nuclear 
localization ability of DENV C protein was abolished (Figure 3.22). Hence, this 
substantiated the fact that nuclear phase of C protein during DENV replication was a 
crucial event. Thus, this project continued to decipher more roles of DENV C protein 
in the nucleus and several important non-structural roles of DENV C protein were 
uncovered.  
 High-throughput protein microarray screening using ProtoArray® platform 
identified 31 novel interacting partners of DENV C protein, among which 17 of them 
localized in the nucleus (Table 5.2 and Figure 5.5). The high-throughput screening 
method employed in this study allowed identification of direct protein-protein 
interaction in a robust and cost-effective manner. All 9400 proteins can be screened 
within one day without any additional cloning steps or cultivation of micro-organism. 
This robust technology is employed to map protein-protein interactome for better 
understanding or discovery of novel pathways in diseases (Fenner et al., 2010; Virok 
et al., 2011). 
Nevertheless, it is noted that not all the known protein are available in the 
ProtoArray® platform. Some proteins contain several isoforms but not all of them are 
available in this platform. This is understandable because some proteins are not easily 
expressed and purified. Although there are five isoforms of importin-α proteins 
available in the ProtoArray® platform, importin-α protein that was identified to be the 
transporting partner of DENV C protein (Figure 3.23) was not picked up by this 
ProtoArray® platform. One of the possible reasons is that phosphorylation is required 
for the binding between DENV C protein and importin-α proteins. Therefore, non-





proteins in the ProtoArray® platform. Although this ProtoArray® technology is not 
able to reflect the controlled event of protein-protein interaction inside the cell, direct 
interaction between DENV C protein and human proteins can be identified easily in 
this platform. Screening of more than 9000 human proteins in one protein microarray 
is considered one of the highest end technologies available to date. It is a very useful 
technology for the first screening to identify potential interacting partners that have 
direct binding with DENV C protein.  
Although the obtained potential interactors are novel, most of the interactors 
do cluster into important pathways or processes that involved flavivirus C protein 
(Figure 5.4).  For instance, protein interactors such as CTTN, WIPF1, SLAIN2, and 
MAP2 proteins are pertaining to cytoskeleton organization (Figure 5.4). DENV C 
protein may help in the virus budding during maturation by promoting actin 
polymerization and regulating microtubule organization via interaction with these 
potential interactors. CTTN and WIPF1 are important regulators controlling the 
organization of actin cytoskeleton whereas SLAIN2 and MAP2 are involved in 
microtubule organization. It was reported that maturation of flavivirus was associated 
with rough endoplasmic reticulum (ER), vesicles and convoluted smooth membranes, 
followed by virus egression from vacuolar lumen through exocytosis (Hase et al., 
1987; Ng, 1987). Chu and co-workers also demonstrated that WNV C protein and E 
protein bound to actin filament and microtubule during virus maturation (Chu & Ng, 
2002; Chu et al., 2003). Thus, ProtoArray® was able to uncover protein interactors 
that may be involved during the maturation and egression of flavivirus. 
Besides, CACNB1 and KCTD18 which are involved in regulating calcium and 
potassium ions transport were also identified as potential DENV C protein-binding 





(LD) in the cytoplasm to provide a scaffold for genome encapsidation during 
assembly and this C protein-LD interaction was potassium ion dependent (Carvalho et 
al., 2012; Samsa et al., 2009). Hence, DENV C protein might manipulate intracellular 
potassium ions via direct interaction with KCTD18 channels. Other putative 
interacting partners of DENV C protein were associated with metabolic processes 
(CHKA and SAT2), B cell activation (IGBP1), activation of synapse (CAMK2A and 
PCLO) and signaling pathway activation (PRKCI). Among all these putative 
interacting partners, SAT gene was reported to be up-regulated during WNV infection 
in A172 brain cells (Koh & Ng, 2005). Thus, flavivirus C protein could be attributed 
to this gene up-regulation.  
DENV C protein localized predominantly in the nucleoli of infected cells. 
Therefore, it is deemed that DENV C protein might be associated with ribosomal 
biogenesis in the nucleolus to promote viral protein synthesis. Nucleolus is involved 
in a number of cellular mechanism including ribosomal rRNA synthesis, ribosomal 
biogenesis, gene silencing, senescence and cell cycle regulation (Olson et al., 2002). 
DENV C protein of other positive-stranded RNA virus such as Semliki Forest virus 
(SFV) was shown to be associated with 60S ribosomal subunit to promote assembly 
and uncoating of nucleocapsid during infection (Singh & Helenius, 1992; Ulmanen et 
al., 1976). 
Nucleopcapsid of porcine reproductive and respiratory syndrome virus (PRRSV) 
was demonstrated to interact with small nucleolar RNA (snoRNA)-associated protein 
fibrillarin that is involved in pre-ribosomal RNA processing in the nucleolus (Yoo et 
al., 2003). HCV was also shown to enhance ribosomal RNA transcription through the 
action of NS5A protein to activate upstream binding factor (UBF) in the nucleolus 





The findings from this project revealed that over-expression and knock-down of 
DIMT1 gene, which is involved in ribosomal RNA synthesis, did not affect DENV 
production. Interestingly, over-expression of SRP19 protein was shown to reduce 
DENV replication (Figure 5.24). SRP19 protein (144 amino acids) is one of the main 
components of SRP ribonucleoprotein complex that recognizes and targets specific 
proteins to the endoplasmic reticulum (ER) (Walter et al., 1981). Ribonucleoprotein 
complex contains a 300-nucleotide length 7SL RNA and one or more SRP proteins, 
namely SRP-9, -14, -19, -54, -68, and -72 (Grudnik et al., 2009). SRP19 binds to the 
signal peptide of newly synthesized proteins and targets the synthesizing proteins 
together with ribosomes to the translocon (protein translocation channel in the ER 
membrane) via the interaction with SRP receptor (Lutcke, 1995; Maity et al., 2006; 
Walter et al., 1981). Such binding between SRP19 and synthesizing protein complex 
leads to protein elongation arrest (Walter & Blobel, 1983). Once the whole complex is 
translocated into ER lumen, SRP19 will be released from the receptor and ribosomes 
via guanosine triphosphate (GTP) hydrolysis and protein synthesis will resume 
(Grudnik et al., 2009; Rapiejko & Gilmore, 1992).  
During DENV infection, it was demonstrated that SRP19 gene expression was 
up-regulated but the protein level was reduced (Figure 5.27). Hence, it implied that 
host cell attempted to up-regulate SRP19 gene to form more ribonucleoprotein 
complexes. However, excessive SRP19 protein reduced DENV RNA replication 
resulting in lower virus titer (Figure 5.28). To encounter this effect, DENV degraded 
SRP19 protein level via DENV C protein direct interaction in the nucleolus. The 
interplay between DENV C protein and SRP19 protein is portrayed in Figure 6.3.  
Another main category of the identified interacting partners of DENV C protein 





regulated for the survival of cells, including detection of DNA damage, DNA repair, 
cellular response to stress, invasion of pathogens and uncontrolled cell division. 
Investigation revealed that both DENV and WNV infections arrested HEK293 and 
BHK cells in S-phase (Figures 5.7-5.11). This cell cycle arrest was shown to be 
attributed to DENV C protein (Figure 5.15). Besides, it was also shown that G1-phase 
was not favourable for DENV replication because arresting host cell at G1-phase 
affected DENV replication significantly (Figure 5.14). The S-phase arrest 
phenomenon was also reported in other viruses such as infectious bronchitis virus 
(IBV) in H1299 and Vero cells (Li et al., 2007). S-phase is the point where DNA 
replication occurs during cell cycle. Hence, the results implied that flaviviruses may 






Figure 6.3: Model depicting the role of SRP19 and DENV C proteins during 
DENV replication. In normal circumstance, SRP19 protein facilitates the formation 
of ribonucleoprotein complex which will translocate into cytoplasm to direct 
translating protein to the rough endoplasmic reticulum. However, high level of SRP19 
protein causes decrease in viral RNA replication, resulting in reduced virus 
production. To counteract the effect of ribonucleoprotein complex formation, DENV 
C protein in the nucleolus binds to and degrades SRP19 protein (DENV-induced 
pathway), resulting in reduced ribonucleoprotein complex formation. DENV protein 
synthesis and RNA replication are not interrupted and thus increases virus production.   
 
Scholle and co-workers (2004) demonstrated that viral RNA synthesis was 
enhanced in the S-phase of HCV-infected Huh-7 cells. Other than enhancing viral 





phase in mammalian cells (Jackowski, 1996). As cellular membranes are essential for 
the replication of flaviviruses by providing surfaces for viral translation, RNA 
replication and viral assembly (Gillespie et al., 2010; Lindenbach et al., 2007; Nakano 
et al., 2009), DENV and WNV may arrest mammalian cells at S-phase to increase the 
accumulation of membrane phospholipids which subsequently enhance the viral 
replication and assembly. 
Other than S-phase arrest, it was also noticed that significant amount of DENV-
infected HEK293 cells (Figure 5.8) and WNV-infected BHK cells (Figure 5.11) were 
arrested at G2- / M-phase as compared to mock-infected cells. In fact, G2- / M-phase 
arrest was also found in other related viruses. For instance, Honda and colleagues 
(2000) showed that G2- / M-phase arrest promoted HCV viral protein translation 
through internal ribosome entry sites (IRESs)-dependent manner. By doing so, cell 
growth would be delayed to allow sufficient time for virus production.  
Flavivirus-induced cell cycle arrest appeared to be cell line specific. DENV-
infected C6/36 cells were arrested at G2- / M-phase instead of S-phase (Figure 5.12). 
However, infection with wild-type WNV showed no significant cell cycle arrest in 
C6/36 cells (Figure 5.9). The different effect of DENV infection on mammalian and 
mosquito cells could be due to the accessibility of different cell cycle components in 
the cells. Sinarachatanant and Olson (1973) reported that replication of DENV was 
different in C6/36 cells compared to rhesus monkey kidney cells. Additionally, 
differences in viral protein processing were also observed in DENV-2-infected Vero 
and C6/36 cells (Smith & Wright, 1985). The results also showed that cell cycle arrest 
does not only vary among different cell lines, but also among different viruses within 
the same family. This could be due to the evolutionary adaptation of DENV and 





to establish their infections in different hosts. This may explain the different extent of 
infectivities of DENV and WNV in different cell lines and possibly different target 
organs in human infections. 
Different viral proteins were reported attributable to the cell cycle arrest for 
different positive-stranded RNA viruses. HCV, for instance, was shown to promote 
cell growth through the action of NS5A protein to suppress the transcription of cdk 
inhibitor, p21WAF1gene (Ghosh et al., 1999). Nucleocapsid of Coronavirus was 
demonstrated to inhibit S phase progression in mammalian cells by binding to the 
cyclin-cyclin dependent kinase (cdk) complex (Surjit et al., 2006). The findings from 
this project demonstrated that DENV C protein promoted cell cycle progression to S- 
and G2- / M-phases through direct interactions with CCNB3, CHES1 and GADD45A 
proteins as illustrated in Figure 6.4.  
DENV C protein bound to cyclin B3 (CCNB3) that was associated with cdk2 
kinase resulted in S phase progression. CCNB3 or cyclin B3 is a regulatory subunit of 
cyclin-dependent kinase 2 (CDK2) protein which is essential for cell cycle 
progression from G1 to S phase (Nguyen et al., 2002). The gene level of CCNB3 was 
also found to be up-regulated during DENV infection (Figure 5.17). However, PCR 
array data showed that host cells attempted to counter this cell cycle progression by 
up-regulating CDKN2B which is a CDK inhibitor that prevents cell cycle G1 







Figure 6.4: The role of DENV C protein in cell cycle control and apoptosis. 
Although host up-regulates CDKN2B to prevent S-phase entry, DENV C protein in 
the nucleus interacts with CCNB3 to promote cell cycle progression from G1-phase to 
S-phase. S-phase is more favourable for DENV replication. CHES1 and GADD45A 
are also up-regulated to arrest cell cycle at G2- / M-phase. Besides, DENV C protein 
binds to CDKN2AIP and VRK1 proteins, resulting in p53-dependent apoptosis. 
 
DENV did not target on CCNB3 protein only to achieve S-phase progression, it 
also up-regulated CHES1 and GADD45A to arrest cell cycle at G2- / M-phase as 
observed in Figures 5.8 and 5.11. GADD45A gene is a main regulator of p38/JNK 
pathway, mediating G2- / M-phase checkpoint in response to environmental stress via 





2009) while CHES1 or FOXN3 is involved in cell cycle checkpoint at G1- and G2-
phase in response to DNA damage (Busygina et al., 2006). 
Despite all the evidence showing the interaction of virus with host cell cycle, it 
is worth noting that cell cycle arrest could also be induced in response to cellular 
stress. Under cellular stress, p53 will be activated and induce cell cycle arrest or 
apoptosis (Harper & Brooks, 2006; Hiscox, 2007; Suzuki et al., 2012). It is possible 
that the cell cycle arrest is the downstream effect of virus infection rather than the 
direct effect of virus-host interaction.  
However, it is still controversial as to whether DENV C protein induces 
apoptosis or prevents apoptosis for its own benefits. DENV C protein was reported to 
induce apoptosis (Limjindaporn et al., 2007; Netsawang et al., 2010) and WNV C 
protein was shown to induce apoptosis by sequestrating HDM2 to stabilize p53 
(Bhuvanakantham et al., 2010; Yang et al., 2008). On the other hand, there was also 
report indicating that DENV C protein subverted apoptotic event to favour virus 
production by manipulating cyclophilin-binding ligand (CAML) level via direct 
interaction (Li et al., 2012). Thus, the advantage of activating p53 by flavivirus C 
protein still remains disputable. 
Some of the identified DENV C protein interactors were related to p53 pathway 
and apoptosis. CDK2AIP and VRK1, for instance, are known to activate p53 by 
perturbing the interaction between p53 and MDM2. Hence, DENV C protein may 
induce apoptosis by stabilizing p53 through direct interaction with CDK2AIP and 
VRK1 proteins which in turn sequestrated MDM2 protein resulting in p53-mediated 
apoptosis as reported by Bhuvanakantham and colleagues (2010). Both CDK2AIP 





5.17). The role of DENV C protein in causing p53-mediated apoptosis through direct 
interaction with CDK2AIP and VRK1 proteins was also illustrated in Figure 6.4.  
In this study, ubiquitin-conjugating enzyme (UBE2S) was also shown to be the 
potential interacting partner of DENV C protein (Figure 5.4). Ubiquitin-proteasome 
pathway was reported to be crucial biological process for DENV infection (Kanlaya et 
al., 2010). It was demonstrated that ubiquitin-activating enzyme E1 (UBE1) was up-
regulated in the infected HUVEC cells and inhibition of this enzyme affected viral 
protein synthesis. The significant of ubiquitin-proteasome pathway for flavivirus 
genome amplification was also supported by Fernandez-Garcia and co-workers 
(2011). However, Nag and Finley (2012) illustrated that enhancing the proteasome 
activity by inhibiting proteasome-associated deubiquitinating enzyme USP14, reduced 
DENV propagation. As such, the association between ubiquitin-proteasome pathway 
and flavivirus replication is still unclear and warrants further investigation. 
Taken altogether, this study unravelled the transportation mechanism of DENV 
C protein into nucleus and delineated the non-structural roles of DENV C protein in 
the nucleus. A summary on the mechanism of DENV C protein nuclear translocation 






Figure 6.5: Model depicting the nuclear translocation mechanism of DENV C 
protein and its non-structural roles in the nucleus. 1. DENV C protein is 
phosphorylated by protein kinase C (PKC) at residue 71. 2. Importin-α protein can 
recognize phosphorylated DENV C protein and bind to the C protein at NLS2 motif. 
NLS1 motif of DENV C protein enhances the binding with importin-α protein. 3. 
Importin-β protein binds to importin-α protein and brings the whole complex into the 
nucleus. In the nucleus, DENV C protein carries out several non-structural functions. 
It binds to SRP19 protein and causes diminishing level of SRP19 proteins. As a result, 
SRP19 cannot facilitate the formation of ribonucleoprotein complex that causes 
decrease in virus production. DENV C protein also plays an important role to arrest 
host cell cycle at S- and G2- / M-phases to favour virus replication. Host cell attempts 
to prevent S-phase entry by up-regulating CDK inhibitor, CDKN2B protein. 
However, DENV C protein counters this effect through direct interaction with 
CCNB3 to promote cell cycle progression from G1- to S-phase. In addition, DENV C 
protein also binds to CHES1 and GADD45A protein to promote further cell cycle 
progression from S- phase to G2- / M-phase. DENV C protein also induces p53-





Other than discovering the non-structural roles of DENV C protein in the 
nucleus, an optimized protocol to engineer, express and purify the biotinylated, full-
length DENV C protein was developed in this study. Biotinylation is a popular 
process in protein engineering to ease detection and purification (Chapman-Smith & 
Cronan, 1999; Cull & Schatz, 2000). Biotinylated hemagglutinin, for instance, was 
generated to develop a subtype-specific serological assay to diagnose influenza A 
virus in patients’ sera (Postel et al., 2011). One of the advantages of using 
biotinylated protein is that the detection sensitivity of the biotinylated protein is 
greatly enhanced by the high affinity and specificity between biotin and streptavidin 
(Bayer & Wilchek, 1990a). This advantage is exploited for techniques such as co-
immunoprecipitation or library screening of interaction proteome (He et al., 2009; 
Markham et al., 2007; Moreland et al., 2010). Not only that, site-specific biotinylation 
was also developed as a means for molecular labeling and imaging (Howarth & Ting, 
2008; Sueda et al., 2011). Thus, biotinylated DENV C protein generated in this study 
is useful for various cellular, molecular and imaging experiments because of the high 
detection limit while the function of the protein is still well preserved. 
There are various approaches to biotinylate a protein, either chemically or 
enzymatically (Cull & Schatz, 2000). Various commercial kits are available in the 
market for chemical biotinylation by conjugating biotin molecules on proteins or 
antibodies that contain primary amines. However, chemical biotinylation may lead to 
non-specific and non-homogenous incorporation of biotin which might result in 
possible loss of activity of the protein (Bayer & Wilchek, 1990b). Moreover, another 






To produce biotinylated DENV C protein, this study opted for site-specific 
biotinylation by engineering a biotin acceptor signal peptide (BAP) in the upstream of 
DENV C proteins (Figures 4.6 and 4.7). To attach a biotin molecule onto BAP either 
in vivo or in vitro, bacterial biotin ligase BirA is required (Chapman-Smith & Cronan, 
1999; Cull & Schatz, 2000; Tan et al., 2004; Yang et al., 2004). Instead of the need to 
perform this biotinylation step in vitro, it was discovered that biotinylation of the 
BAP-containing proteins occurred endogenously in Escherichia coli BL-21 strains 
with high efficiency (Figure 4.11). As such, other proteins that require site-specific 
biotinylation may be produced easily by just simple OE-PCR and expression in 
Escherichia coli BL-21 strains without the need of an additional in vitro biotinylation 
step. A provisional patent (Singapore patent application number: 201208602-1) was 
filed for this discovery and optimized protocol. 
The expression and purification of non-truncated, full-length DENV C protein 
was indeed challenging. The presence of rare codons in the C protein sequence 
necessitates unique expression competent strain for its optimal protein expression 
(Figure 4.8). Due to the hydrophobic C-terminus, aggregation easily occurred and 
most of the expressed proteins were trapped in the inclusion bodies (Figure 4.12). As 
such, 8 M urea was used to denature the proteins and to perform affinity 
chromatography under denaturing condition. The aggregation problem during dialysis 
and refolding was also solved successfully by using non-ionic detergent (Section 
4.3.5.3). This is indeed critical in making this protein purification a success.  
Unlike domain III (DIII) protein (Tan et al., 2010), one single purification step 
was simply not adequate to produce pure DENV C protein. To obtain highly purified 
DENV C protein, two more purification steps were included in the protocol, namely 





chromatography [(SEC) (Figure 4.18)]. This sequential purification strategy can 
produce approximately 1 mg of purified full-length DENV C protein from 1 L of 
bacterial culture. Hence, this optimized sequential purification strategy may be useful 
for other proteins that have the similar properties. 
Purified full-length DENV C protein is useful for various molecular studies to 
further understand the underlying mechanism of C protein in pathogenesis. For 
instance, it can be used to study the interaction of NS2B-NS3 serine proteinase and C 
protein. In order to produce mature C protein for encapsidation and assembly, full-
length C protein has to be cleaved by NS2B-NS3 protein complex. Thus, it is crucial 
to identify the binding sites of NS2B-NS3 complex to full-length C protein, which is 
still unknown. It will in turn lead to the development of novel anti-viral drugs 
targeting the assembly of virus particles. Besides, it is also interesting to examine 
whether the cleaved C-terminus plays any unidentified role in the pathogenesis. The 
crystal structure of DENV NS2B-NS3 protein complex has been resolved (Erbel et al., 
2006). However, the crystal structure of full-length DENV C protein is still not yet 
available, although the NMR structure of partial DENV C protein was obtained (Ma 
et al., 2004).  
Ma and co-workers (2004) proposed a model for the interaction between C 
protein and its viral genome using the partial DENV C protein. However, to date, this 
model is not validated and the exact mechanism of encapsidation is still unclear. 
Investigation of how DENV C protein interacts with its RNA and oligomerizes into 
nucleocapsid during maturation is vital for better understanding of the pathogenesis. 
Recent publications also demonstrated that N-terminus of DENV C protein was 
antigenic in mice study and the first 18 amino acid residues were involved in the virus 





this purified non-truncated DENV C protein is absolutely desirable for delineating the 
whole process of encapsidation and virus assembly.  
 
Conclusion 
Unravelling the mechanism of nuclear translocation of DENV C protein and 
its non-structural roles in the nucleus is important to better understand how 
flaviviruses establish infections in different hosts. This project has elucidated the 
molecular transportation mechanism and identified novel functions of DENV C 
proteins. Better understanding of the replication of DENV will help in the 
development of novel antiviral drug. For instance, drugs inhibiting the nuclear import 
of DENV / WNV C protein, which were shown to be essential for viral replication, 
can be used as an anti-viral therapy strategy. Arylene bis-(methyl ketone) compounds 
such as CNI-H0292 and CNI-H1194 which inhibit the nuclear import of pre-
integration complex (PIC) in human macrophages and monocytes, has been used to 
block HIV-1 replication specifically (Dubrovsky et al., 1995). These drugs are also 
considered to be included as one of the components in multi-drug cocktail for anti-
HIV therapy (Glushakova et al., 2000).  Therefore, this type of drugs can also be 
tested for their efficacy in inhibiting flavivirus replication. 
 Cell cycle arrest-related drugs could also be used as anti-viral drugs. For 
example, chemotherapeutic agents which can arrest cell cycle at specific cell cycle 
phase have been used to suppress virus replication (Foli et al., 2007). Hydroxyurea 
and mycophenolic acid were shown by Foli and colleagues (2007) to be useful to 





Therefore, the observed findings on cell cycle arrest in this study could also contribute 
to the development of novel antiviral strategies for flaviviruses. 
 
Future Direction 
This project has successfully identified several non-structural roles of DENV 
C protein in the nucleus. Two of the most exciting potential roles of DENV C protein 
in the nucleus are pertaining to cell cycle control and regulation of transcriptional and 
translational activities. It was found that DENV tried to drive host cell cycle from G1-
phase to S- and G2- / M-phases during infection because virus production was 
significantly reduced when host cells were arrested at G1-phase. Further investigation 
demonstrated that DENV C protein interacted with cyclin B3 (CCNB3), GADD45A, 
and CHES1 proteins to promote cell cycle progression from G1- to S-phase and from 
S- to G2- / M-phase. To uncover the underlying molecular mechanism behind this cell 
cycle manipulation, the whole profile of cyclins and cyclin-dependent kinases (cdks) 
expression during wild-type virus infection and over-expression of DENV C protein 
should be determined via quantitative real-time reverse transcription polymerase 
chain reaction and Western blotting. This will reveal the entire cascade of affected 
genes and proteins in the cell cycle signalling pathway. Hence, a more comprehensive 
understanding of the interplay between flavivirus C protein and cell cycle control can 
be obtained.  
The importance of C protein-cell cycle-related protein interactions during 
virus replication can also be examined by performing gene silencing and over-
expression studies. When host genes or proteins that are found to be inhibiting 





versa. These experiments should also be repeated using infectious clones carrying 
mutations on the bipartite NLS or phosphorylation sites that are important for nuclear 
translocation as negative controls to substantiate the effect of C protein in the nucleus. 
Truncation mapping analyses can then be performed to delineate the actual binding 
sites of C proteins and the interacting partners. 
Another exciting non-structural role of DENV C protein in the nucleus is to 
manipulate host transcriptional and translational activities. Over-expression of SRP19 
protein was found to reduce DENV viral RNA and virus titer. However, over-
expression of DENV C protein degraded SRP19 protien via direct interaction. Hence, 
it is hypothesized that DENV C protein attempts to counteract the anti-viral effect of 
SRP19 protein by degrading it. To examine whether DENV C protein causes 
degradation of SRP19 protein through proteasome pathway, MG132 which is a 
proteasome inhibitor can be employed. Cells are treated with MG132 first for 1 hr 
before infection with DENV or transfection with recombinant DENV C proteins. 
MG132 drug should be present throughout the infection or transfection period. At 
24-hr post infection or transfection, the level of SRP19 protein is quantitated via 
ELISA platform. To further investigating which proteasome pathway is involved in 
the degradation of SRP19 protein, the proteolytic activities of 20S proteasome can be 
examined using Proteasome-Glo cell-based assay kits for chymotrypsin-like, trypsin-
like and caspase-like activities (Promega, USA).  
SRP19 protein is only part of the ribonucleoprotein complex to target specific 
secreted protein to the ER for protein translation. Hence, the effect of 
ribonucleoprotein complex upon DENV replication should also be examined. Co-
immuno precipitation can be carried out to pull down viral replication complex using 





complex indeed interacts with viral replication complex, ribonucleoprotein complex 
should be detected in the pull-down elute using anti-H/ACA ribonucleoprotein 
complex antibody. The effect of over-expression of DENV C protein upon 
ribonucleoprotein complex level can then be examined. If SRP19 protein level is 
reduced by DENV C protein during infection, the level of ribonucleoprotein complex 
in the cytoplasm should also be decreased. If this hypothesis holds true, DENV C 
protein with mutations on the essential bipartite NLS motif should not affect the 
levels of SRP 19 proteins and ribonucleoprotein complex.  
Investigating these novel non-structural roles of flavivirus C protein in the 
nucleus will provide better understanding of the underlying molecular mechanism of 
flavivirus infection. This knowledge is essential for more refinement of anti-viral drug 
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APPENDIX 1: MEDIA FOR TISSUE CULTURE 
a) RPMI-1640 Growth Medium 
Items Amount Source 
RPMI-1640 powder 16.4 g Sigma, USA 
NaHCO3 2.0 g Merck, Germany 
Foetal Calf Serum (FCS) 100 ml Biological Industries, Israel 
 
One bottle of powdered RPMI-1640 with HEPES and NaHCO3 were dissolved in 
900 ml of autoclaved Reverse Osmosis (RO) water and the pH was adjusted to 7.2 with 
5 M NaOH. Sterilization was carried out by filtration with 0.2 micron filter and then 
100 ml FCS was added into the medium. It was stored at 4 oC. 
 
b) L-15 Growth Medium 
Items Amount Source 
L-15 powder  13.8 g Sigma, USA 
Foetal Calf Serum (FCS) 100 ml Biological Industries, Israel 
 
One bottle of L-15 powder was dissolved in 900 ml of autoclaved RO water and the pH 
was adjusted to 7.2 with 5 M NaOH. Sterilization was carried out by filtration through a 
0.2 micron filter. One hundred ml FCS which had been inactivated at 56 oC for half an 





c) Dulbecco’s Modified Eagle’s Medium (DMEM) Growth Medium 
Items Amount Source 
DMEM powder 13.8 g Sigma, USA 
NaHCO3 3.7 g Merck, Germany 
Foetal Calf Serum (FCS) 100 ml Biological Industries, Israel 
 
One bottle DMEM powder and NaHCO3 were dissolved in 900 ml of autoclaved RO 
water and the pH was adjusted to 7.2 with 5 M NaOH. Sterilization was carried out by 
filtration through a 0.2 micron filter. One hundred ml FCS which had been inactivated 
at 56 oC for half an hour was added to the medium. It was stored at 4 oC. 
 
d) Dulbecco’s Modified Eagle’s Medium (DMEM)-293FT Growth Medium 
Items Amount Source 
DMEM powder 13.8 g Sigma, USA 
NaHCO3 3.7 g Merck, Germany 
200 mM L-Glutamine (100x) 10 ml Invitrogen, USA 
10 mM MEM Non-Essential 
Amino Acids (100x) 
10 ml Invitrogen, USA 
100 mM MEM Sodium 
Pyruvate (100x)  
10 ml Invitrogen, USA 
Geneticin® (500 mg/ml) 1 ml Invitrogen, USA 
Foetal Calf Serum (FCS) 100 ml Biological Industries, Israel 
 
One bottle of DMEM powder and NaHCO3 were dissolved in 900 ml of autoclaved RO 
water and the pH was adjusted to 7.2 with 5 M NaOH. Sterilization was carried out by 
filtration through a 0.2 micron filter. One hundred ml FCS which had been inactivated 
at 56 oC for half an hour was added to the medium, followed by L-glutamine, NEAA, 





e) 1 x Phosphate-Buffered Saline (PBS), pH 7.4 
Items Amount Source 
NaCl 8.0 g Merck, Germany 
KCl 0.2 g Merck, Germany 
KH2PO4 0.2 g Merck, Germany 
Na2HPO4 11.5 g Merck, Germany 
 
All the above items were dissolved in 900 ml RO water and the pH was adjusted to 7.4 
with 5 M NaOH before topping up to 1 L. It was autoclaved and stored at 4 oC. 
 
f) Trypsin 
Ten ml of sterile porcine pancreas-derived trypsin 10x solution (Sigma-Aldrich, USA) 
was diluted with 90 ml of sterile 1x PBS (Appendix 1e). The trypsin solution was stored 





APPENDIX 2: MEDIA FOR VIRUS INFECTION AND 
PLAQUE ASSAY 
a) Virus Diluent 
Items Amount Source 
Hank’s Balanced Salt 9.8 g Sigma, USA 
Bovine Albumin Fraction V 0.2 g Invitrogen, USA 
 
One bottle of Hank’s balanced salt powder and bovine albumin fraction V were 
dissolved in 900 ml autoclaved RO water and the pH was adjusted to 7.2 with 5 M 
NaOH. Final solution was topped up to 1 L and sterilization was carried out by filtration 
with 0.2 micron filter. 
 
b) Overlay Medium 
Items Amount Source 
RPMI-1640 powder 16.4 g Sigma, USA 
NaHCO3 2.0 g Merck, Germany 
Foetal Calf Serum (FCS) 100 ml Biological Industries, Israel 
Carboxymethylcellulose (CMC) 4 g Calbiochem, USA 
     
One bottle of powdered RPMI-1640 with HEPES and NaHCO3 were dissolved in 
480 ml autoclaved RO water and the pH was adjusted to 7.2 with 5 M NaOH. 
Sterilization was carried out by filtration with 0.2 micron filter and then 20 ml FCS was 
added into the medium to obtain double-strength (2X) maintenance medium. Four gram 
of CMC was dissolved in 200 ml of RO water and autoclaved. Then, 200 ml of the 2X 
maintenance medium was mixed thoroughly with the autoclaved CMC to obtain 400 ml 








c) Crystal Violet Staining Solution 
Items Amount Source 
Crystal Violet 1.85 g Sigma, USA 
37 % formaldehyde 270 ml Merck, Germany 
1 x PBS 120 ml Appendix 1e 
        
All the above items were mixed to make a final working crystal violet staining solution 
for plaque assay. Formaldehyde is volatile and hazardous so preparation must be done 









APPENDIX 3: MATERIALS FOR MOLECULAR 
TECHNIQUES 
a) 2 % Agarose Gel 
Items Amount Source 
Agarose 2.0 g Bio-Rad, USA 
1 x Tris / Acetate / EDTA (TAE) Top up to 100 ml  
GelRedTM  Nucleic Acid Gel Stain 
(10,000X) 
10 µl Biotium, USA 
    
Agarose powder was boiled with 1 x TAE buffer (diluted from 10 x TAE buffer in 
Appendix 3b) in microwave until all powder was dissolved and the solution became 
clear. The solution was then cooled down with running water and gel red was added into 
the solution. After mixing well, all the solution was poured into a casting tray with 
combs. After the polymerization was complete, the gel was put into an electrophoresis 
tank with 1 x TAE buffer and the comb was removed. 
 
b) 10 x Tris / Acetate / EDTA (TAE) Buffer, pH 8.5 
Items Amount Source 
Tris Base 48.4 g  Promega, USA 
Glacial Acetic Acid 11.4 ml BDH Laboratory Supplies, UK 
Na2EDTA.2H2O 7.44 g BDH Laboratory Supplies, UK 
 
All the above items were mixed together and topped up to 1 L with RO water. The pH 









c) Luria-Bertani (LB) Agar 
Items Amount Source 
Tryptone 10 g Oxoid, UK 
NaCl 10 g Merck, Germany 
Yeast Extract 5 g Oxoid, UK 
Agarose 18 g 1st Base, Singapore 
        
All the above items were weighed and dissolved in 1 L RO water. The mixture was 
autoclaved at 121 oC and 15 lb presure for 15 min. After autoclaving, the bottle was 
cooled down to 55 oC in a water bath before appropriate antibiotic (ampicillin or 
kanamycin) was added. The mixture was pour into Petri dishes (Sterilin, UK) and 
allowed to solify at room temperature in a Biosafety Cabinet. The plates were stored at 
4 oC. 
 
d) Luria-Bertani (LB) Broth 
Items Amount Source 
Tryptone 10 g Oxoid, UK 
NaCl 10 g Merck, Germany 
Yeast Extract 5 g Difco, USA 
        
The above items were weighed and dissolved in 1 L RO water and autoclaved at 121 oC 
and 15 lb presure for 15 min. When the bottle was cooled down to 55 oC, appropriate 








e) 8 % Non-Denaturing Polyacrylamide Gel 
Items Amount Source 
Acrylamide / Bisacrylamide (19:1) 3.2 ml Bio-Rad, USA 
10 x Tris/Borate/EDTA (TBE) 1.2 ml Appendix 3f  
10 % Ammonium Persulfate (APS) 200 µl USB, USA 
N,N,N’N’-tetramethylethylenediamine 
(TEMED) 
10 µl Invitrogen, USA 
        
Acrylamide / bisacrylamide (19:1) and 10 x TBE buffer were mixed together and topped 
up to the final volume of 12 ml with RO water. After the gel casting apparatus was 
assembled, TEMED and 10 % APS were added into the solution and mixed thoroughly. 
The mixture was then pipetted into the spaces between the gel plates immediately and a 
comb was inserted onto the plates. After polymerization was complete, the comb was 
removed and the gel could be used or stored at 4 oC. 
 
f) 10 x Tris / Borate / EDTA (TBE) Buffer, pH 8.0 
Items Amount Source 
Tris Base 108 g Promega, USA 
Boric Acid 55 g Merck, Germany 
EDTA (0.5 M)  40 ml BDH Laboratory Supplies, UK 
      
All the above items were mixed together and topped up to 1 L with RO water. The pH 






g) Diethylpyprocarbonate (DEPC)-Treated Water for Real-Time Polymerase 
Chain Reaction (PCR) 
Items Amount Source 
Diethylpyprocarbonate (DEPC) 1 ml Sigma, USA 
      
Diethylpyprocarbonate (DEPC) was dissolved in 1 L of  RO water overnight with 
constant stirring. After DEPC dissolved completely in the water, it was autoclaved to 
break down the DEPC. DEPC-treated water should be aliquoted into eppendorf tubes 




APPENDIX 4: MATERIALS FOR PROTEIN EXPRESSION 
AND PURIFICATION 
a) Resuspension Buffer  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
NaCl 17.53 g Merck, Germany 
       
The above items were dissolved in 900 ml RO water and pH was adjusted to 8 using 
HCl. The final volume was topped up to 1 L to obtain resuspension buffer (20 mM Tris 
and 300 mM NaCl). 
 
b) Resuspension Buffer with Triton-X  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
NaCl 17.53 g Merck, Germany 
Triton-X  10 ml  
       
Tris and NaCl were dissolved in 900 ml RO water and pH was adjusted to 8 using HCl 
before adding Triton-X. The final volume was topped up to 1 L to obtain resuspension 






c) Lysis Buffer  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
NaCl 17.53 g Merck, Germany 
Urea 480.48 g Vivantis, Malaysia 
Imidazole 0.68 g Sigma, USA 
       
The above items were dissolved in 900 ml RO water and pH was adjusted to 8 using 
HCl. The final volume was topped up to 1 L to obtain lysis buffer (8M Urea, 20 mM 
Tris, 300 mM NaCl and 10 mM imidazole). One tablet of EDTA-free protease inhibitor 
(Roche, Switzerland) was added into 100 ml of lysis buffer. 
 
d) Wash Buffer  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
NaCl 17.53 g Merck, Germany 
Urea 480.48 g Vivantis, Malaysia 
Imidazole 1.36 g Sigma, USA 
       
The above items were dissolved in 900 ml RO water and pH was adjusted to 8 using 
HCl. The final volume was topped up to 1 L to obtain wash buffer (8M Urea, 20 mM 






e) Elution Buffer  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
NaCl 17.53 g Merck, Germany 
Urea 480.48 g Vivantis, Malaysia 
Imidazole 34 g Sigma, USA 
       
The above items were dissolved in 900 ml RO water and pH was adjusted to 8 using 
HCl. The final volume was topped up to 1 L to obtain elution buffer (8M Urea, 20 mM 
Tris, 300 mM NaCl and 500 mM imidazole). 
 
f) Refolding Buffer  
Items Amount Source 
Tris Base 3.03 g Promega, USA 
       
Tris was dissolved in 900 ml RO water and pH was adjusted to 8 using HCl. The final 






g) Starting Buffer for Mono Q Ion-Exchange Chromatography  
Items Amount Source 
Tris Base 2.42 g Promega, USA 
       
Tris was dissolved in 900 ml RO water and pH was adjusted to 8.0 using HCl. The final 
volume was topped up to 1 L to obtain 20 mM Tris-HCl buffer. 
 
h) Elution Buffer for Mono Q Ion-Exchange Chromatography  
Items Amount Source 
Tris Base 3.03 g Promega, USA 
NaCl 58.44 g Merck, Germany 
       
Tris and NaCl were dissolved in 900 ml RO water and pH was adjusted to 8.0 using 
HCl. The final volume was topped up to 1 L to obtain elution buffer (20 mM Tris and 






i) Starting Buffer for Mono S Ion-Exchange Chromatography  
Items Amount Source 
2-[N-morpholino]ethanesulphonic 
acid (MES) 3.9 g Sigma, USA 
       
The above item was dissolved in 900 ml RO water and pH was adjusted to 6.0 using 
NaOH. The final volume was topped up to 1 L to obtain 20 mM MES buffer. 
 
j) Elution Buffer for Mono S Ion-Exchange Chromatography  
Items Amount Source 
MES 3.9 g Sigma, USA 
NaCl 58.44 g Merck, Germany 
       
The above items were dissolved in 900 ml RO water and pH was adjusted to 6.0 using 
NaOH. The final volume was topped up to 1 L to obtain elution buffer (20 mM MES 





APPENDIX 5: MATERIALS FOR PROTEIN ANALYSIS 
a) Glycine Gel  
i) 12 % Separating Glycine Gel 
Items Amount Source 
40 % Acrylamide / Bisacrylamide 3 ml Merck, Germany 
1.5 M Tris buffer, pH 8.8 3.5 ml Appendix 5a(iii) 
Sodium Dodecyl Sulphate (SDS) 100 µl Merck, Germany 
RO Water 3.5 ml  
10 % Ammonium Persulfate (APS) 100 µl USB, USA 
N,N,N’N’-tetramethylethylenediamine 
(TEMED) 4 µl Invitrogen, USA 
        
Gel casting apparatus was assembled first. 40 % acrylamide / bisacrylamide, Tris buffer, 
SDS and RO water were mixed together before adding APS and TEMED. Final solution 
was mixed thoroughly and pipetted carefully into the spaces between the gel plates. A 
layer of isopropanol (Fisher Chemical, USA) was added carefully on top of the mixture 
to avoid oxygen getting in and inhibit polymerization. It was left to polymerize. 
 
ii) 5 % Stacking Glycine Gel 
Items Amount Source 
40 % Acrylamide / Bisacrylamide 500 µl  Merck, Germany 
1.5 M Tris buffer, pH 6.8 670 µl Appendix 5a(iv)  
Sodium Dodecyl Sulphate (SDS) 40 µl Merck, Germany 
RO Water 2.8 ml  
10 % Ammonium Persulfate (APS) 40 µl USB, USA 
N,N,N’N’-tetramethylethylenediamine 





Similarly, acrylamide / bisacrylamide, Tris buffer, SDS and RO water were mixed first 
before adding APS and TEMED. After mixing thoroughly, the layer of isopropanol was 
discarded from the polymerized gel and the mixture was pipetted carefully onto the gel 
to avoid bubbles. Lastly, comb was inserted and it was made sure that there was no 
bubble around the bottom of the wells. 
 
 iii) 1.5 M Tris Buffer, pH 8.8 
Items Amount Source 
Tris Base 182 g Promega, USA 
      
Tris base was dissolved in 900 ml RO water and the pH was adjusted to 8.8 using 
hydrochloric acid (HCl). After that, it was topped up to 1L and stored at 4oC. 
 
iv) 1.5 M Tris Buffer, pH 6.8 
Items Amount Source 
Tris Base 182 g Promega, USA 
 
Tris base was dissolved in 900 ml RO water and the pH was adjusted to 6.8 using 
hydrochloric acid (HCl) before topping up to 1 L. It was stored at 4oC. 
 
v) Glycine Running Buffer 
Items Amount Source 
Tris Base 6.07 g Promega, USA 
Glycine 28.73 g Merck, Germany 
Sodium Dodecyl Sulphate (SDS) 2.0 g Merck, Germany 




Tris base and glycine were dissolved in 900 ml RO water and the pH was adjusted to 
8.8 before adding SDS. The final volume was topped up to 1 L. For upper tank running 
buffer, buffer to RO water ratio of 1:1 was prepared while ratio of 1:4.3 was prepared 
for lower tank running buffer. 
 
b) Tricine Gel 
i) 12 % Separating Tricine Gel 
Items Amount Source 
40 % Acrylamide / Bisacrylamide 3 ml Merck, Germany 
Tricine Gel Buffer 3.3 ml Appendix 5b(iii)  
Glycerol (87 % w/v) 1.3 g Merck, Germany 
RO Water 3.65 ml  
10 % Ammonium Persulfate (APS) 100 µl USB, USA 
N,N,N’N’-tetramethylethylenediamine 
(TEMED) 
5 µl Invitrogen, USA 
        
Gel casting apparatus was assembled first. 40 % acrylamide / bisacrylamide, tricine gel 
buffer, glycerol and RO water were mixed before adding APS and TEMED. Final 
solution was mixed thoroughly and pipetted carefully into the spaces between the gel 
plates. A layer of isopropanol (Fisher Chemical, USA) was added carefully on top of the 













ii) 5 % Stacking Tricine Gel 
Items Amount Source 
40 % Acrylamide / Bisacrylamide 625 µl  Merck, Germany 
Tricine Gel Buffer 1.24 ml Appendix 5d  
RO Water 3.08 ml  
10 % Ammonium Persulfate (APS) 50 µl USB, USA 
N,N,N’N’-tetramethylethylenediamine 
(TEMED) 
5 µl Invitrogen, USA 
 
Acrylamide / bisacrylamide, tricine gel buffer, and RO water were mixed first before 
adding APS and TEMED. After mixing thoroughly, the layer of isopropanol was 
discarded from the gel and the mixture was pipetted carefully onto the gel to avoid 
bubbles. Lastly, comb was inserted and ensures that there was no bubble around the 
wells. 
 
iii) Tricine Gel Buffer 
Items Amount Source 
Tris Base 181.7 g Promega, USA 
Sodium Dodecyl Sulphate (SDS) 1.5 g Merck, Germany 
      
Tris base was dissolved in 400 ml of RO water and the pH was adjusted to 8.5 using 










iv) Tricine Gel Upper Tank Running Buffer 
Items Amount Source 
Tris Base 12.1 g Promega, USA 
Tricine 17.9 g Sigma, USA 
Sodium Dodecyl Sulphate (SDS) 1.0 g Merck, Germany 
       
Tris base and tricine were dissolved in 900 ml of RO water and the pH was adjusted to 
8.5 with hydrochloric acid (HCl) before adding SDS. The final volume was topped up to 
1 L. 
 
v) Tricine Gel Lower Tank Running Buffer 
Items Amount Source 
Tris Base 24.2 g Promega, USA 
       
Tris base were dissolved in 900 ml of RO water and the pH was adjusted to 8.5 using 





c) Materials for Western Blot  
i) 5 % Skim Milk Blocking Buffer 
Items Amount Source 
Skimed Milk Powder  5 g Anlene, Australia 
1 x TBST 100 ml Appendix 5c(iii) 
       
Skimed milk powder was dissolved thoroughly in TBST. This mixture was used for 
blocking and diluents for antibodies. 
 
ii) 4 % Bovine Serum Albumin Blocking Buffer 
Items Amount Source 
Bovine Serum Albumin  4 g Sigma, USA 
1 x PBST 100 ml Appendix 5c(iv) 
       
Bovine serum albumin was weighed and dissolved thoroughly in PBST. This mixture 
was used for blocking and diluents for antibodies. 
 
iii) 1 x Tris Buffered Saline / Tween-20 (TBST) 
Items Amount Source 
Tris Base 12.2 g Promega, USA 
NaCl 8 g Merck, Germany 
RO Water 900 ml  
Tween-20 1 ml Sigma, USA 
       
Tris base and NaCl were dissolved in 900 ml of RO water and the pH was adjusted to 
7.7 using hydrochloric acid (HCl) before adding Tween-20. The final volume was 




iv) Phosphate Buffered Saline / Tween-20 (PBST) 
Items Amount Source 
1 x PBS  1 L Appendix 1e 
Tween-20 1 ml Sigma, USA 
       
One ml of Tween-20 was added into 1 L of PBS. 
 
d) Coomassie Staining and Destaining  
i) Coomassie Blue Staining Solution 
Items Amount Source 
Methanol 450 ml Schedelco, Singapore 
Glacial Acetic Acid 100 ml Merck, Germany 
RO Water 450 ml  
Coomassie Brilliant Blue R-20 1 g Sigma, USA 
       
Methanol, glacial acetic acid and RO water were mixed first and then Coomassie 
Brilliant Blue R-20 was weighed and poured into the mixture. Preparation was done in a 
fume hood because of the pungent vapour from acetic acid. 
 
ii) Destaining Solution I 
Items Amount Source 
Methanol 400 ml Schedelco, Singapore 
Glacial Acetic Acid 100 ml Merck, Germany 
RO Water 500 ml  
  






iii) Destaining Solution II 
Items Amount Source 
Methanol 50 ml Schedelco, Singapore 
Glacial Acetic Acid 70 ml Merck, Germany 
RO Water 880 ml  
  
The above solutions were mixed in a fume hood because of the pungent vapour from 
acetic acid. 
 
e) Silver Staining  
i) Fixative Enhancer Solution 
Items Amount Source 
Methanol 200 ml Schedelco, Singapore 
Glacial Acetic Acid 40 ml Merck, Germany 
Fixative Enhancer Concentrate 40 ml Bio-Rad, USA 
RO Water 120 ml  
  







ii) Development Accelerator Solution 
Items Amount Source 
RO Water 35 ml  
Silver Complex Solution 5 ml Bio-Rad, USA 
Reduction Moderator Solution 5 ml Bio-Rad, USA 
Image Development Reagent 5 ml Bio-Rad, USA 
  
Reverse osmosis (RO) water was placed into a beaker first followed by Silver Complex 
Solution, Reduction Moderator Solution, and Image Development Reagent in order. 
Teflon-coated stirring bar was used to ensure proper mixing of the solutions. This 





APPENDIX 6: MATERIALS FOR FLUORESCENCE-
ACTIVATED CELL SORTING (FACS) ANALYSIS 
a) Propidium Iodide Staining Solution 
Items Amount Source 
Propidium Iodide 200 µg Sigma, USA 
Triton-X 10 µl Sigma, USA 
RNase A 2 mg Applichem GmbH, Germany 
      
Propidium iodide was dissolved in 10 ml of  1 x PBS (Appendix 1e) and the bottle was 
covered with aluminium foil to protect it from light. Triton-X was then added into the 






APPENDIX 7: SOFTWARE USED FOR THIS PROJECT 
Bioinformatics software used in this project 









ClustalW http://www.ebi.ac.uk/clustalw/  
Protein sequence  -PROSITE http://ca.expasy.org/prosite/  
analysis -MyHits http://hits.isb-sib.ch/cgi-bin/index  
 -ELM http://elm.eu.org/  


















APPENDIX 8: DNA SEQUENCES AND CONCEPTUAL 
TRANLSATION OF DNA INSERTIONS 
 
a) pcDNA3.1/CT-GFP-TOPO vector with full length capsid gene 
atggatgaccaacggaaaaaggcgagaaatacgcctttcaatatgctgaaacgcgagaga 
 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcaga 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 
 T  A  G  M  I  I  M  L  I  P  T  V  M  A   
 
b) pcDNA3.1/CT-TOPO vector with NLS1 fragment 
atggggcggaaaaaggcgagaaacacgcctttcaatatgctgaaacgcgagagaaaccgc 
 M  G  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  N  R  
 
c) pcDNA3.1/CT-TOPO vector with NLS2 fragment 
atggggaggaaagagattggaaggatgctgaacatcttgaacaggagacgcagaact 





d) R5A & K6A 
atggatgaccaagcggcgaaggcgagaaacacgcctttcaatatgctgaaacncgagaga 
 M  D  D  Q  A  A  K  A  R  N  T  P  F  N  M  L  K  X  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcaga 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 
 T  A  G  M  I  I  M  L  I  P  T  V  M  A   
 
e) K17A & R18A 
atggatgaccaacggaaaaaggcgagaaatacgcctttcaatatgctggcggcggagaga 
 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  A  A  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcaga 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 
 T  A  G  M  I  I  M  L  I  P  T  V  M  A   
 
f) G42A & P43A 
atggatgaccaacggaaaaaggcgagaaatacgcctttcaatatgctgaaacgcgagaga 
 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgagcagcattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  A  A  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcaga 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 






g) R85A & K86A 
atggatgaccaacggaaaaaggcgagaaatacgcctttcaatatgctgaaacgcgagaga 
 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcgcggcggagattggaaggatgctggacatcttgaacaggagacgcaga 
 L  R  G  F  A  A  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 




 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctgaacatcttgaacgcggcagccgct 
 L  R  G  F  R  K  E  I  G  R  M  L  N  I  L  N  A  A  A  A  
actgcaggcatgatcattatgctgattccaacagtgatggcg 
 T  A  G  M  I  I  M  L  I  P  T  V  M  A   
 
i) R5A & K6A & K17A & R18A 
atggatgaccaagcggcgaaggcgagaaacacgcctttcaatatgctggcggcggagag
a 
 M  D  D  Q  A  A  K  A  R  N  T  P  F  N  M  L  A  A  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcgg 




j) R85A & K86A & R(97-100)A 
atggatgaccaacggaaaaaggcgagaaatacgcctttcaatatgctgaaacgcgagaga 
 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcgcggcggagattggaaggatgctgaacatcttgaacgcggcagccgct 
 L  R  G  F  A  A  E  I  G  R  M  L  N  I  L  N  A  A  A  A  
actgcaggcatgatcattatgctgattccaacagtgatggcg 
 T  A  G  M  I  I  M  L  I  P  T  V  M  A   
 
k) Δall (R5A & K6A & K17A & R18A & R85A & K86A & R(97-100)A 
atggatgaccaagcggcgaaggcgagaaacacgcctttcaatatgctggcggcggagag
a 
 M  D  D  Q  A  A  K  A  R  N  T  P  F  N  M  L  A  A  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggga 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccca 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgtt 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcgcggcggagattggaaggatgctgaacatcttgaacgcggcagccgct 
 L  R  G  F  A  A  E  I  G  R  M  L  N  I  L  N  A  A  A  A  
actgcaggcatgatcattatgctgattccaacagtgatggcg 






 M  N  N  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctgaacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  N  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 








 M  S  T  N  E  N  A  N  T  P  A  A  R  L  H  R  F  K  N  K  
ggaaaagacagtacagaaatgaggcgtcgcagaatagaggtcaatgtggagctgaggaa
a 
 G  K  D  S  T  E  M  R  R  R  R  I  E  V  N  V  E  L  R  K  
gctaagaaggatgaccagatgctgaagaggagaaatgtaagctcatttcctgatgatgc
t 
 A  K  K  D  D  Q  M  L  K  R  R  N  V  S  S  F  P  D  D  A  
acttctccgctgcaggaaaaccgcaacaaccagggcactgtaaattggtctgttgatga
c 
 T  S  P  L  Q  E  N  R  N  N  Q  G  T  V  N  W  S  V  D  D  
attgtcaaaggcataaatagcagcaatgtggaaaatcagctccaagctactcaagctgc
c 
 I  V  K  G  I  N  S  S  N  V  E  N  Q  L  Q  A  T  Q  A  A  
aggaaactactttccagagaaaaacagccccccatagacaacataatccgggctggttt
g 
 R  K  L  L  S  R  E  K  Q  P  P  I  D  N  I  I  R  A  G  L  
attccgaaatttgtgtccttcttgggcagaactgattgtagtcccattcagtttgaatc
t 
 I  P  K  F  V  S  F  L  G  R  T  D  C  S  P  I  Q  F  E  S  
gcttgggcactcactaacattgcttctgggacatcagaacaaaccaaggctgtggtaga
t 
 A  W  A  L  T  N  I  A  S  G  T  S  E  Q  T  K  A  V  V  D  
ggaggtgccatcccagcattcatttctctgttggcatctccccatgctcacatcagtga
a 
 G  G  A  I  P  A  F  I  S  L  L  A  S  P  H  A  H  I  S  E  
caagctgtctgggctctaggaaacattgcaggtgatggctcagtgttccgagacttggt
t 
 Q  A  V  W  A  L  G  N  I  A  G  D  G  S  V  F  R  D  L  V  
attaagtacggtgcagttgacccactgttggctctccttgcagttcctgatatgtcatc
t 
 I  K  Y  G  A  V  D  P  L  L  A  L  L  A  V  P  D  M  S  S  
ttagcatgtggctacttacgtaatcttacctggacactttctaatctttgccgcaacaa
g 
 L  A  C  G  Y  L  R  N  L  T  W  T  L  S  N  L  C  R  N  K  
aatcctgcacccccgatagatgctgttgagcagattcttcctaccttagttcggctcct
g 
 N  P  A  P  P  I  D  A  V  E  Q  I  L  P  T  L  V  R  L  L  
catcatgatgatccagaagtattagcagatacctgctgggctatttcctaccttactga
t 
 H  H  D  D  P  E  V  L  A  D  T  C  W  A  I  S  Y  L  T  D  
ggtccaaatgaacgaattggcatggtggtgaaaacaggagttgtgccccaacttgtgaa
g 
 G  P  N  E  R  I  G  M  V  V  K  T  G  V  V  P  Q  L  V  K  
cttctaggagcttctgaattgccaattgtgactcctgccctaagagccatagggaatat
t 






 V  T  G  T  D  E  Q  T  Q  V  V  I  D  A  G  A  L  A  V  F  
cccagcctgctcaccaaccccaaaactaacattcagaaggaagctacgtggacaatgtc
a 
 P  S  L  L  T  N  P  K  T  N  I  Q  K  E  A  T  W  T  M  S  
aacatcacagccggccgccaggaccagatacagcaagttgtgaatcatggattagtccc
a 
 N  I  T  A  G  R  Q  D  Q  I  Q  Q  V  V  N  H  G  L  V  P  
ttccttgtcagtgttctctctaaggcagattttaagacacaaaaggaagctgtgtgggc
c 
 F  L  V  S  V  L  S  K  A  D  F  K  T  Q  K  E  A  V  W  A  
gtgaccaactataccagtggtggaacagttgaacagattgtgtaccttgttcactgtgg
c 
 V  T  N  Y  T  S  G  G  T  V  E  Q  I  V  Y  L  V  H  C  G  
ataatagaaccgttgatgaacctcttaactgcaaaagataccaagattattctggttat
c 
 I  I  E  P  L  M  N  L  L  T  A  K  D  T  K  I  I  L  V  I  
ctggatgccatttcaaatatctttcaggctgctgagaaactaggtgaaactgagaaact
t 
 L  D  A  I  S  N  I  F  Q  A  A  E  K  L  G  E  T  E  K  L  
agtataatgattgaagaatgtggaggcttagacaaaattgaagctctacaaaaccatga
a 
 S  I  M  I  E  E  C  G  G  L  D  K  I  E  A  L  Q  N  H  E  
aatgagtctgtgtataaggcttcgttaagcttaattgagaagtatttctctgtagagga
a 
 N  E  S  V  Y  K  A  S  L  S  L  I  E  K  Y  F  S  V  E  E  
gaggaagatcaaaacgttgtaccagaaactacctctgaaggctacactttccaagttca
g 
 E  E  D  Q  N  V  V  P  E  T  T  S  E  G  Y  T  F  Q  V  Q  
gatggggctcctgggacctttaacttt 





 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcggcagtacaacagctgacaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  A  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 






 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 





 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctggcaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  A  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 




 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattcgcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  A  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 







 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggagcaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  A  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
actgcaggcatgatcattatgctgattccaacagtgatggcg 





 M  D  D  Q  R  K  K  A  R  N  T  P  F  N  M  L  K  R  E  R  
aaccgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcaggg
a 
 N  R  V  S  T  V  Q  Q  L  T  K  R  F  S  L  G  M  L  Q  G  
cgaggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatccc
a 
 R  G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  
ccaacagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgt
t 
 P  T  A  G  I  L  K  R  W  G  T  I  K  K  S  K  A  I  N  V  
ttgagagggttcaggaaagagattggaaggatgctggacatcttgaacaggagacgcag
a 
 L  R  G  F  R  K  E  I  G  R  M  L  D  I  L  N  R  R  R  R  
gcagcaggcatgatcattatgctgattccaacagtgatggcg 
 A  A  G  M  I  I  M  L  I  P  T  V  M  A   









M  S  A  L  L I  L  A  L  V  G  A  A V  A  D  Y  K  D  D
gacgacaagcttgactacaaagacgatgacgacaagggactagtaccgcgcggcagcatg
D  D K  L  D  Y  K  D  D D D K  G  L  V  P  R  G  S  M
aataaccaacggaaaaaggcgagaaatacgcctttcaatatgctgaaacgcgagagaaac
N  N Q  R  K  K A  R  N  T  P  F  N  M  L  K  R  E  R  N 
cgcgtgtcgactgtacaacagctgacaaagagattctcacttggaatgctgcagggacga
R  V  S  T  V  Q  Q L  T  K  R  F  S  L  G  M  L  Q  G  R 
ggaccattaaaactgttcatggccctggtggcgttccttcgtttcctaacaatcccacca
G  P  L  K  L  F  M  A  L  V  A  F  L  R  F  L  T  I  P  P
acagcagggatactgaagagatggggaacaattaaaaaatcaaaagccattaatgttttg
T  A  G  I  L  K  R  W  G  T  I  K  K S  K  A  I  N  V  L 
agagggttcaggaaagagattggaaggatgctgaacatcttgaacaggagacgcagaact
R  G  F  R  K  E  I  G  R  M  L  N  I  L  N  R  R R R T 
gcaggcatgatcattatgctgattccaacagtgatggcg







M  G  S  S H  H H H H H S  S G  L  V  P  R  G  S  H 
                                     
                             
                                     
                                       
                                     
                                       
                               
  
His Tag
                         
atggctagctccggcctgaacgacatcttcgaggctcagaaaatcgaatggcacgaaggc
M  A  S  S G  L  N  D  I  F  E  A  Q  K  I  E  W  H  E  G 
ggcgatgacgacgacaagagcatgaataaccaacgaaaaaaggcgagaaatacgcctttc
G  D  D D D K  S  M  N  N Q  R  K  K A  R  N  T  P  F 
                                     
                                       
                                     
                                       
                               
  
Thrombin Cleavage Site
                         
                                     
ggcgatgacgacgacaagagcatgaataaccaacgaaaaaaggcgagaaatacgcctttc
G  D  D D D K  S  M  N  N Q  R  K  K A  R  N  T  P  F 
aatatgctgaaacgcgagagaaaccgcgtgtcgactgtacaacagctgacaaagagattc
N  M  L  K  R  E  R  N  R  V  S  T  V  Q  Q L  T  K  R  F 
tcacttggaatgctgcagggacgaggaccattaaaactgttcatggccctggtggcgttc
S  L  G  M  L  Q  G  R  G  P  L  K  L  F  M  A  L  V  A  F 
cttcgtttcctaacaatcccaccaacagcagggatactgaagagatggggaacaattaaa
L  R  F  L  T  I  P  P T  A  G  I  L  K  R  W  G  T  I  K 
aaatcaaaagccattaatgttttgagagggttcaggaaagagattggaaggatgctgaac
K  S  K  A  I  N  V  L  R  G  F  R  K  E  I  G  R  M  L  N 
atcttgaacaggagacgcagaactgcaggcatgatcattatgctgattccaacagtgatg
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E-mail address: micngml@nus.edu.sg (M.-L. Ng).West Nile virus (WNV) capsid (C) protein has been shown to enter the nucleus of infected cells. However,
the mechanism by which C protein enters the nucleus is unknown. In this study, we have unveiled for the
ﬁrst time that nuclear transport of WNV and Dengue virus C protein is mediated by their direct associ-
ation with importin-a. This interplay is mediated by the consensus sequences of bipartite nuclear local-
ization signal located between amino acid residues 85–101 together with amino acid residues 42 and 43
of C protein. Elucidation of biological signiﬁcance of importin-a/C protein interaction demonstrated that
the binding efﬁciency of this association inﬂuenced the nuclear entry of C protein and virus production.
Collectively, this study illustrated the molecular mechanism by which the C protein of arthropod-borne
ﬂavivirus enters the nucleus and showed the importance of importin-a/C protein interaction in the con-
text of ﬂavivirus life-cycle.
 2009 Elsevier Inc. All rights reserved.Introduction
The Flaviviridae family consists of major disease causing patho-
gens such as West Nile virus (WNV), Dengue virus (DENV) and Yel-
low Fever virus (YFV). West Nile virus causes fever and
encephalitic maladies in both avian and human hosts [1]. Its RNA
genome encodes a single large polyprotein, which is processed
by viral and host proteases into three structural proteins; capsid
(C), membrane (M) and envelope (E) as well as seven non-struc-
tural proteins [2]. The virus RNA genome is packaged within a
spherical nucleocapsid composed of multiple copies of C proteins.
The nucleocapsid is further enwrapped by a modiﬁed lipid bilayer
derived from host cellular membranes through insertion of virus E/
M proteins [3].
The C proteins of various ﬂaviviruses are localized in the cyto-
plasm and nuclei [4–7]. Wang and group [6] reported that when
three copies of GFP were tagged with DENV C protein, it was able
to enter nucleus. Although this suggested the presence of active
transport system for C protein, the exact mechanism by which C
protein of arthropod-borne ﬂaviviruses enters the nucleus is
unknown.
In this study, we investigated the molecular mechanism medi-
ating the nuclear entry of WNV C protein by examining the
involvement of importins. We showed that nuclear transport of
arthropod-borne ﬂavivirus C protein is mediated by importin-a/b
complex and the interaction between C protein and importin-a isll rights reserved.important for efﬁcient nuclear localization of C protein and virus
production.Methods
Cells and viruses. Vero cells were grown in M199 (Sigma) at
37 C in a humidiﬁed 5% CO2 incubator. West Nile virus (Sarafend)
and Dengue 2 virus (NGC), gifts from Emeritus E.G. Westaway (Sir
Albert Sakzewski Virus Research Centre, Australia) were used.
Cloning. The cDNA coding sequences of WNV C protein were
cloned into pcDNA3.1CT-GFP and pcDNA3.1TOPO-V5-His vectors
(Invitrogen) to form pTCS and pV5CS, respectively. Truncated
WNV C gene lacking 39 amino acids (aa) from carboxyl-terminus
and the bipartite nuclear localization signal (NLS) motif of WNV
C protein were cloned into pcDNA3.1CT-GFP to get pTCSD39 and
pWNLS plasmids, respectively. The cDNA coding sequences of
DENV full-length C or NLS regions were cloned into pcDNA3.1CT-
GFP to get pDC or pDNLS, respectively.
The basic residues in the bipartite NLS sequence were mutated
using QuikChangeTM site-directed mutagenesis kit (Stratagene). The
basic residues at positions 85/86 (M1), 97/98 (M2) and 85/86/97/
98 (M1M2) of WNV C protein in pTCS were mutated to create
pTCSM1, pTCSM2 and pTCSM1M2, respectively. Mutagenesis was
also performed to obtain pTCSG42A, pTCSP43A and
pTCSGP4243AA plasmids, which carried the mutations at aa 42
and/or 43 (4243) of C protein. The mutations M1, M2, M1M2 and
4243 were introduced into recombinant DENV C protein to obtain
pDCM1/pDCM2/pDCM1M2/pDCGP4243AA plasmids.
64 R. Bhuvanakantham et al. / Biochemical and Biophysical Research Communications 389 (2009) 63–69Mutations were also introduced into C protein of full-length
WNV infectious clone (pWNS, [8]) to obtain pWNSM1/pWNSM2/
pWNSM1M2/pWNS4243 plasmids. In addition, we deleted the
NLS region of C protein from pWNS clone to obtain pWNSDNLS.
The clones/mutants used in this study were shown in Supplemen-
tary Table S1.
Indirect immuno-ﬂuorescence analysis (IFA). Vero cells (5  105)
were infected with WNV or transfected with various mutated plas-
mids (WNV/DENV) and processed for IFA at the indicated timings
as described earlier [8]. WNV C protein was detected with anti-
WNVC (gift from Emeritus Prof. Westaway) and FITC/Texas Red-
conjugated anti-rabbit IgG antibodies (Amersham Pharmacia).
Optical immuno-ﬂuorescence microscope (Olympus IX-81) was
used to visualize the specimens. The images were taken at 100
magniﬁcation under oil immersion objective using Metamorph
version 6 software (Universal Imaging Corporation).
Co-immunoprecipitation assay. Vero cells (5  105) were infected
with WNV or electroporated with 20 lg of in vitro transcribed
RNAs from pWNS/mutated pWNS plasmids as described earlier
[8]. Various DENV C mutants were also transfected into Vero cells.
At 14 h post-infection (p.i.) or 24 h post-transfection, cells were
lysed using lysis buffer (Miltenyi Biotec) and cell lysates were
pre-mixed with 2 lg of anti-GFP/anti-importin-a/anti-importin-b
(Sigma) conjugated magnetic microbeads and puriﬁed using
lMACs column (Miltenyi Biotec). Samples obtained from co-
immunoprecipitation or transfected cell lysates were subjected to
Western blotting using anti-importin-a/anti-importin-b/anti-GFP/
anti-WNVC antibodies (Ab).
Mammalian two-hybrid (M2H) assay. Mammalian two-hybrid
assays were performed as described by Bhuvanakantham and Ng
[9]. Brieﬂy, WNV/DENV C protein as well as mutated C proteins
were ampliﬁed and joined to pSV40-GAL4 50 element and SV40
pA 30 element to create bait proteins of interest. Similarly, the prey
protein (importin-a) was constructed using pSV40-VP16 50 ele-
ment and SV40 pA 30 element. Co-transfection was performed
using the DNA linear constructs generated from above along with
pGAL/lacZ plasmid using Lipofectamine2000 (Invitrogen). At 12,
24 and 48 h post-transfection, b-galactosidase assay was per-
formed as mentioned earlier [9] and the speciﬁc activity of the
samples were calculated using the following formula: nmoles of
ortho-nitrophenyl-b-D-galactopyranoside hydrolyzed/incubation-
time/mg protein.
Far Western blotting. TNT quick-coupled transcription/transla-
tion system (Promega) was used to in vitro translate Myc-tagged
C/E protein and importin-a/b at 30 C for 1.5 h following manufac-
turer’s instructions. The presynthesized Myc-tagged C, Myc-tagged
E protein, importin-a and importin-bwere puriﬁed using anti-Myc,
anti-importin-a- or anti-importin-b-conjugated magnetic beads as
mentioned earlier. Puriﬁed C/E/importin-a protein was fraction-
ated on polyacrylamide denaturing gels and transferred onto PVDF
membranes. Blots were blocked in binding buffer (20 mM HEPES
KOH [pH 7.6], 75 mM KCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05%
NP-40, 1 mM dithiothreitol, 1% BSA), followed by incubation at
4 C overnight in binding buffer containing 20 nM of puriﬁed
importin-a, importin-b or mixture of importin-a and importin-b.
The C/E-bound importin-a, C/E-bound importin-b or importin-a-
bound importin-b were detected using anti-importin-a or anti-
importin-b Ab.
Virus growth kinetics. Vero cells (5  105) were transfected with
20 lg of puriﬁed RNA obtained from pWNS, pWNSDNLS, pWNSM1,
pWNSM2, pWNSM1M2, and pWNS4243 clones. At various time
points post-electroporation, culture supernatant was collected to
measure the growth characteristics of the resulting viruses by pla-
que assay.
Complementation analysis. Vero cells (5  105) were transfected
with pV5CS plasmid using Lipofectamine2000. Twenty four hourspost-transfection, electroporation was performed using 20 lg of
RNAs transcribed from pWNS, pWNSDNLS, pWNSM1, pWNSM2,
pWNSM1M2 and pWNS4243 clones. At 12, 24, 36, 48 and 56 h
post-electroporation, culture supernatants were sampled for pla-
que assay.Results
Importin-mediated nuclear translocation of WNV C protein
Consistent with previous studies [7,10], we showed that WNV C
protein entered the nucleus during infection and transfection (Sup-
plementary Fig. S1A and B) using time series studies coupled with
IFA. DENV C protein also localized to the nucleoli of the transfected
cells (Supplementary Fig. S1C). Subsequently, we wanted to deter-
mine if importin-a/b played a role in mediating the nuclear trans-
location of WNV C protein. Vero cells were infected with WNV and
at 14 h p.i., cell lysates were precipitated with anti-importin-a/b
Ab and immunoblotted using anti-WNVC Ab. As shown in
Fig. 1A(i and ii, Lane 3), the immuno-reactive band was observed
only with WNV-infected cell lysates. This indicated that WNV C
protein binds to the nuclear receptors, importin-a and importin-b.
Appropriate controls such as precipitation control [Fig. 1A(iii
and iv)], input controls [Fig. 1A(v–vii)] and antibody isotype con-
trol [Fig. 1A(viii)] were included to demonstrate the speciﬁcity of
interaction between WNV C protein and importin-a/b. Moreover,
no interaction between importin-a and ﬂavivirus E protein was de-
tected (data not shown). Similarly, DENV C protein also interacted
with importin-a (data not shown). This demonstrated that ﬂavivi-
rus C protein exploits importin-a/b complex for nuclear entry.
To reafﬁrm these results, M2H analysis was performed by co-
transfecting C (bait), importin-a/b (prey) and the reporter plasmid
encoding b-galactosidase gene. At 24 h post-transfection, cells
were harvested for b-galactosidase assay. As shown in Fig. 1B,
strong b-galactosidase activity was observed only with C protein
and importin-a (C + Impa) and not with C protein and importin-b
(C + Impb). This indicated that C protein interacted with impor-
tin-a and not with importin-b. Therefore, the C-importin–b inter-
action as suggested by co-immunoprecipitation [Fig. 1A(ii)],
could be an indirect interaction mediated by importin-a.
To test this hypothesis, Far Western blotting was performed.
Equal amounts of in vitro translated Myc-tagged C/E/importin-a
protein [Fig. 1C(i, ii, and v)] was fractionated by SDS–PAGE and
blotted to PVDF membrane. The blot was probed with importin-
a (i), importin-b (ii,v) or mixture of importin-a and importin-b
(iii). The formation of C/E-importin-a, C/E-importin-b or impor-
tin-a/b complex was then analyzed by immunoblotting with
anti-importin-a (i) or anti-importin-b (ii,iii,v) Ab. The immuno-
reactive bands were observed with C-importin-a [Lane 2, (i)], C-
importin-a/b mixture [Lane 2, (iii)] and importin-a–importin-b
(v). No bands were observed with E-importin-a [Lane 1, (i)] and
C/E-importin-b [Lanes 1 and 2, (ii)]. Collectively, the absence of
band with C-importin-b (ii) and the presence of band with C-
importin-a/b mixture (iii) as well as importin-a–importin-b (v)
conﬁrmed that C protein interacted with importin-a directly and
importin-a served as a bridge between C protein and importin-b.
NLS-mediated interaction between C protein and importin-a
Prosite scanning (http://ca.expasy.org/prosite) of WNV C pro-
tein revealed the presence of nuclear localization signal (NLS) be-
tween aa 85 and 101 (KKELGTLTSAINRRST). To verify the
functionality of the predicted NLS motif, Vero cells were transfec-
ted with pWNLS/pTCSD39 and their cellular localization was visu-
alized using IFA. Strong nucleolar localization [Fig. 2A (i)-arrows]
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Fig. 1. Interaction between WNV C protein and importin-a. (A) Co-immunoprecipitation studies. Vero cells were infected with WNV and cell lysates were
immunoprecipitated with anti-importin-a(i)/b(ii) Ab and immunoblotted with anti-C Ab. The presence of band in Lane 3 conﬁrms C protein-importin-a/b binding in
WNV-infected Vero cells. (iii and iv) Precipitation controls to ensure successful precipitation in all experimental groups. (v–vii) The amount of endogenous importin-a,
importin-b and C protein in whole cell lysates (WCL) is detected using anti-importin-a/b and anti-C Abs (input controls). (viii) Mouse isotype Ab control to eliminate the
possibility of non-speciﬁc precipitation. (B) M2H assay. BCLac and NC are negative controls. PC and PIC represent positive control and positive interaction control,
respectively. bcc, BCImpa and BCImpb represent the background controls for bait protein (C) and prey proteins (importin-a/b, respectively. C + Impa/C + Impb represent the
interacting partners. Strong interaction signal is only observed for C protein/importin-a (C + Impa) pairing. (C) Far Western blotting. In vitro translated Myc-C/Myc-E/
importin-awas subjected to Western blotting. The blot was then incubated with importin-a and/or importin-b. The presence of C/E-importin-a or C/E-importin-b complexes
is analyzed by immunoblotting with anti-importin-a (i) or anti-importin-b (ii and iii) Ab. The membrane-bound C/E/importin-a is also detected using anti-Myc/anti-
importin-a Ab (iv and vi). The presence of importin-a–importin-b complex is analyzed by immunoblotting with anti-importin-b Ab (v).
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plasmic distribution was observed in pTCSD39-transfected cells
[Fig. 2A (ii)-arrows]. Similar results were obtained with DENV
NLS motif (Supplementary Fig. S2). This conﬁrmed that the pre-
dicted bipartite NLS motif of ﬂavivirus C protein is functional.
Proteins containing NLS region generally interact with impor-
tin-a through their NLS motif. We thus deleted the entire NLS re-
gion on C protein from pWNS (pWNSDNLS) to examine the
requisite of NLS motif in mediating C-importin-a binding. The
RNAs in vitro transcribed from pWNS and pWNSDNLS were elec-
troporated into Vero cells. Co-immunoprecipitation was performed
using anti-importin-a Ab and immunoblotted with anti-WNVC Ab.The band was detected in pWNS-RNA-transfected cells [Lane 2,
Fig. 2B (i)] and no band was observed in pWNSDNLS-RNA-transfec-
ted cells [Lane 3, Fig. 2B (i)]. This conﬁrmed that C protein–impor-
tin-a association is mediated by NLS motif.
Mutagenesis studies to determine the amino acids mediating
importin-a/C protein binding
To deﬁne the residues mediating C protein–importin-a associa-
tion, we performed site-directed mutagenesis on the consensus ba-
sic residues within the bipartite NLS motif of C protein in pWNS to
generate pWNSM1, pWNSM2 and pWNSM1M2. Since Glycine42
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1        2        3       4        5        6      7
1        2        3       4        5        6      7
IP   : Anti-importinα Ab 
WB : Anti-WNVC Ab 
IP   : Anti-importinβ Ab 
WB : Anti-WNVC Ab 
WCL 
WB: Anti-importinα Ab 
WCL 
WB: Anti-WNVC Ab 
WCL 
WB: Anti-importinβ Ab 
1        2        3       4        5        6      7
   C 
14 kD 





































1         2        3       4        5        6      7
1        2        3       4        5        6       7







1   2       3
IP   : Mouse isotype control 
WB: Anti-WNVC Ab
(v)









WB: Anti-importinα Ab (iii)
Importinα
58 kD
1       2    3
IP   : Anti-importinα Ab
WB: Anti-importinα Ab (ii)
1      2       3
C
14 kD
IP   : Anti-importinα Ab












Fig. 2. NLS-mediated interplay between C protein and importin-a. (A) pWNLS transfected into Vero cells shows intense green ﬂuorescence in the nucleoli region (arrows, i) in
contrast to pTCSD39-transfected cells where only cytoplasmic ﬂuorescence is observed even after 24 h post-transfection (arrows, ii). (B) Co-immunoprecipitation. Vero cells
transfected with RNAs in vitro transcribed from pWNV/pWNVDNLS were immunoprecipitated with anti-importin-a Ab and immunoblotted with anti-C Ab. The presence of
band in Lane 2 and absence of band in Lane 3 conﬁrm that C protein–importin-a binding is mediated by the NLS motif of C protein. (ii–v) Precipitation control, input controls
and mouse isotype Ab controls. (C) Co-immunoprecipitation. Vero cells were transfected with RNA transcribed from pWNS/pWNSM1/pWNSM2/pWNSM1M2/pWNS4243/
pWNSDNLS plasmids. At 24 h post-transfection, immunoprecipitation was performed using anti-importin-a (i) or anti-importin-b (ii) Ab followed by immunoblotting using
anti-WNVC Ab. The presence of bands in Lanes 2–6 and absence of bands in Lane 7 in anti-importin-a–b antibody-immunoprecipitated samples conﬁrm the binding between
importin-a/b and mutated C proteins except for pWNSDNLS. (iii–v) Input controls.
66 R. Bhuvanakantham et al. / Biochemical and Biophysical Research Communications 389 (2009) 63–69and Proline43 of Japanese encephalitis virus (JEV) C protein inﬂu-
enced its nuclear translocation [4], these residues were also mu-
tated to obtain pWNS4243 mutant. The RNAs transcribed frompWNS, pWNSM1, pWNSM2, pWNSM1M2, pWNS4243 and
pWNSDNLS were then electroporated into Vero cells and co-immu-
noprecipitation was performed using anti-importin-a/b Ab and
R. Bhuvanakantham et al. / Biochemical and Biophysical Research Communications 389 (2009) 63–69 67immunoblotted using anti-WNVC Ab. The interaction between
importin-a/b and intact/mutated C protein was observed with all
the introduced mutations except pWNSDNLS [Fig. 2C (i and ii)],
although the band intensity observed with pWNSM1, pWNSM2,
pWNSM1M2, pWNS4243 mutants were lower (Lanes 3–6) com-
pared to pWNS (Lane 2). The reduced band intensity on the immu-
noblot observedwithM1,M2,M1M2 and 4243mutations indicated
that the basic residues of NLSmotif and the residues 42/43 of C pro-
tein were important in modulating C-importin interaction.
Measuring the strength of interaction between importin-a and C
protein
Since the above co-immunoprecipitation results [Fig. 2C (i and
ii)] suggested altered binding efﬁciency between importin-a andFig. 3. Strength of interaction between WNV C protein and importin-a and its inﬂuenc
BCC43, BCC4243 and BCCDNLS represent the background controls for full-length/mutate
protein (importin-a C + Imp, CM1 + Imp, CM2 + Imp, CM1M2 + Imp, C42 + Imp, C43 + Im
strength is signiﬁcantly higher for full-length C protein/importin-a pairing compared to
between CDNLS and importin-a. *Represents P < 0.05. (B) IFA. Vero cells transfected with
pTCSG42A (x–xii), pTCSP43A (xiii–xv) and pTCSGP4243AA (xvi–xviii) were processed for
mutants show strong ﬂuorescence predominantly in nucleus and perinuclear regions at 1
48 h post-transfection).M1/M2/M1M2/4243 mutants, we measured the strength of inter-
action between mutated C protein and importin-a using M2H
analysis. The binding strength between importin-a and intact/mu-
tated C protein varied signiﬁcantly (P < 0.05, Fig. 3A). Moreover, the
binding between mutated C and importin-a was signiﬁcantly low-
er (P < 0.05) at 12 h post-transfection compared to 24 and 48 h
post-transfection. Similar trends were observed with DENV C pro-
tein (Supplementary Fig. S3).
Cellular localization of mutated C protein
To investigate if the introduced mutations inﬂuence the nuclear
localization pattern of C protein, IFA was performed in Vero cells
transfected with pTCSM1/pTCSM2/pTCSM1M2 plasmids. At 12 h
post-transfection [Fig. 3B (i, iv, vii)], intense ﬂuorescence wase on nuclear translocation. (A) V2Y assay. BCC, BCCM1, BCCM2, BCCM1M2, BCC42,
d/truncated C proteins (bait). BCImp represents the background control for the prey
p, C4243 + Imp and CDNLS + Imp represent the interacting partners. The binding
other mutated C proteins/importin-a pairings while there is no detectable binding
the different mutant plasmids, pTCSM1 (i–iii), pTCSM2 (iv–vi), pTCSM1M2 (vii–ix),
IFA. The pTCSM1, pTCSM2, pTCSM1M2, pTCSG42A, pTCSP43A and pTCSGP4243AA
2 h post-transfection compared to predominant nuclear staining at late timings (24/
68 R. Bhuvanakantham et al. / Biochemical and Biophysical Research Communications 389 (2009) 63–69detected around the nuclear membrane and in the nuclei/nucleoli
of mutated plasmids-transfected cells. At 24 [Fig. 3B (ii, v, viii)] and
48 h [Fig. 3B (iii, vi, ix)] post-transfection, peri-nuclear staining was
not as prominent except for pTCSM1M2 [Fig. 3B (viii)]. Vero cells
transfected with pTCSG42A/pTCSP43A/pTCSGP4243AA plasmids
also showed strong ﬂuorescence signal in the nucleoli with peri-
nuclear staining [Fig. 3B (x–xviii)] at all time points. The kinetics
of WNV C protein nuclear localization at 12/24/48 h post-transfec-
tion was also measured by enumerating 50 transfected cells dis-
playing peri-nuclear and/or nuclear staining (Supplementary
Fig. S4A). The kinetics of nuclear entry of mutant C proteins corre-
lated with the binding efﬁciency of these mutants with importin-a
at the respective timings (Fig. 3A).
Similar to WNV, the mutations introduced into DENV C protein
also altered the nuclear localization pattern of C protein (Supple-
mentary Fig. S4B and C). Collectively, these results implied that
the mutations introduced on C protein led to reduced binding efﬁ-
ciency with importin-a, and thus interfered with the nuclear local-
ization ability of arthropod-borne ﬂavivirus C proteins.
Growth kinetics of pWNS mutants and trans complementation studies
To examine if virus replication is affected by the introduced
mutations, virus growth characteristics in Vero cells transfected
with pWNS-/pWNSM1-/pWNSM2-/pWNSM1M2-/pWNS4243-/
pWNSDNLS-RNA were measured (Fig. 4). The pWNSM1/
pWNSM2/pWNSM1M2/pWNS4243 mutants showed 2–3 log units
reduction in their virus titres at all timings compared to parentalFig. 4. Comparison of growth kinetics for parental WNV (pWNS) and various mutated pW
produce detectable levels of viable virus. (B) Complementation studies with pV5CS are ab
to pWNS, except for pWNSDNLS where virus production is partially restored. The aver
experiments.WNV (pWNS) (Fig. 4A, P < 0.05). The pWNSDNLS mutant did not
generate any viable virus even after 120 h post-transfection
(Fig. 4A). The observed differences in growth characteristics of
these mutant viruses correlated with the binding efﬁciency of the
corresponding mutant C proteins with importin-a.
To ensure that the altered growth kinetics observed were not
due to random second-site mutations, we performed complemen-
tation analysis using V5-tagged full-length C protein (pV5CS). This
positive complementation restored the virus titre of pWNSM1/
pWNSM2/pWNSM1M2/pWNS4243 mutants, comparable to pWNS
(Fig. 4B). Viable, single-round infectious virus was also obtained
from pWNSDNLS-RNA transfected cells (Fig. 4B). The ability of
full-length C protein to resuscitate the defective nature of
pWNSDNLS virus eliminated the possibility that the defective phe-
notype was caused by serendipitous inactivating mutations that
may have occurred in other parts of the virus genome. Hence, this
signiﬁes that virus production was signiﬁcantly compromised by
all the introduced mutations and that the bipartite NLS motif in
WNV C protein is vital for efﬁcient virus production.
Discussion
Studies have demonstrated that C proteins of ﬂavivirus were
observed in both cytoplasm and nucleus [4–7]. However, the exact
mechanism by which arthropod-borne ﬂavivirus C protein enters
the nucleus is unknown. Nuclear translocation of several proteins
containing NLS motif is generally mediated by importins [11].
Since our study conﬁrmed the presence of functional NLS motifNS. (A). All the mutants show reduced virus titre except pWNSDNLS which failed to
le to restore virus production in various mutants-RNA transfected cells, comparable
age value with standard deviation (±) is a representative from three independent
R. Bhuvanakantham et al. / Biochemical and Biophysical Research Communications 389 (2009) 63–69 69on WNV/DENV C protein (Fig. 2A and Supplementary Fig. S2), we
investigated the role of importins in mediating the active transpor-
tation of ﬂavivirus C protein into nucleus. Co-immunoprecipitation
and M2H analyses conﬁrmed that the nuclear translocation of
WNV/DENV C protein occurs through importin-dependant path-
way (Fig. 1). Using a combination of M2H analysis and Far Western
blotting, we showed that C protein associated with importin-a di-
rectly and importin-a acted as an adaptor to bind with importin-b.
This is the ﬁrst study that unveils the role of importins in mediat-
ing the active transport of arthropod-borne ﬂaviviruses C protein
into nucleus.
Although the C protein of hepatitis C virus (HCV) also utilized
importin-a for nuclear entry, the in vitro assays employed in an
earlier study might not fully recapitulate the in vivo scenario since
recombinant HCV C protein was used [5]. In contrast, our study
employed full-length infectious clone of WNV with various muta-
tions to study the authencity of WNV C protein/importin-a
association.
Our study also demonstrated that the binding strength between
C protein and importin-a is the rate-limiting step in controlling the
kinetics of nuclear localization of ﬂavivirus C protein. Using M2H
analysis and IFA, we have shown that signiﬁcantly lower binding
strength between mutated C protein and importin-a at early tim-
ings led to predominant peri-nuclear staining besides nucleolar
staining (Fig. 3 and Supplementary Fig. S4A).
The mutations introduced in this study affected the growth
characteristics of the resulting viruses (Fig. 4). One might argue
that the observed differences in growth characteristics of mutant
viruses could result from inefﬁcient ER anchoring or NS2B-NS3
cleavage. However, the domains assisting ER membrane associa-
tion (aa 46–62, [12]) and NS2B-NS3 cleavage site (aa 104–106,
[13]) were not mutated in this study. Thus, the introduced muta-
tions should not have affected the membrane association/NS2B-
NS3 cleavage. Patkar and colleagues [14] showed that deletion of
NLS motif did not affect the packaging of YFV capsid protein. Thus,
it is unlikely that the packaging of WNV is affected by the intro-
duced mutations.
Many viruses utilize nuclear proteins such as PTB, nucleophos-
min and hnRNPK for their efﬁcient transcription and translation
[15–17]. Similarly, WNV C protein could possibly exploit certain
nuclear/nucleolar proteins and transcriptional regulators to estab-
lish a suitable environment for WNV replication. This could explain
the observed differences in the growth characteristics of mutant
viruses.
Our study also illustrated a positive correlation between nucle-
ar localization and virus production. This ﬁnding is in agreement
with JEV infection [4]. Mori and colleagues [4] reported a positive
correlation between nuclear localization of JEV C protein and viral
replication, although they did not address the interaction of C-
importin-a and the inﬂuence of binding strength between these
proteins on nuclear localization and virus production.
Overall, our ﬁndings unravelled the signiﬁcance of importin-a/
b/C protein association in mediating C protein nuclear transloca-
tion. We have also shown that nuclear entry of C protein is essen-
tial for efﬁcient virus production. Understanding the precise
molecular mechanism behind the association of importin-a/C pro-
tein and the inﬂuence of nuclear phase of C protein on the efﬁ-ciency of virus replication will expand our current knowledge on
the non-structural roles of C protein.
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Supplementary 1. Nuclear localization of C proteins. (A) Nuclear localization of C protein 
during WNV infection. WNV-infected Vero cells were processed for IFA. The C protein was 
detected with anti-WNVC antibody followed by Texas red-conjugated secondary antibody. 
WNV C protein is detected predominantly in the cytoplasm and perinuclear region at 30 min 
p.i. (i). By 60min p.i. (ii), C protein is localized at the perinuclear and nuclear regions. 
Nucleolar translocation is more obvious at 90min p.i. (iii). (B) Nuclear localization of 
recombinant WNV C protein. Optical fluorescence microscopy images of pTCS/pV5CS-
transfected Vero cells at 12 (i, v), 24 (ii, vi) and 48h (iii, vii) post-transfection. Arrows 
indicate intense fluorescence localized in the nucleoli/nuclei. Expression control plasmids 
[pcDNA3.1CT-GFP (iv)/lacZ-V5 (viii)]-transfected cell show diffuse fluorescence 
distribution in both nucleus and cytoplasm. (C) Recombinant GFP-tagged DENV C protein 
was transfected into Vero cells and processed for IFA. DENV C protein is able to localize 
into nucleoli (arrows) as indicated by the intense green fluorescence (i & iii). Cell nuclei are 
stained with DAPI (ii & v). Expression control is included to show the diffused fluorescence 
distribution pattern in both nucleus and cytoplasm (iv & vi).  
 
Supplementary 2. Nuclear localization of DENV NLS motif. pDNLS which contained only 
DENV NLS motif fused with GFP was transfected into Vero cells to examine its 
functionality. Intense green fluorescence is observed in the nuclei as indicated by the arrows. 




Supplementary 3. Binding efficiency of mutated DENV C protein with importin-α. The 
relative β-galactosidase activities of full-length DENV C protein and C protein mutants (M1, 
M2, and M1M2) were measured and plotted. An arbitrary value of 1 is set for the binding 
efficiency of full-length DENV C protein and importin-α association. The binding efficiency 
between C protein and importin-α is reduced up to 50% for M1 mutant and 80% for M2 and 
M1M2 mutants.  
 
 Supplementary 4.  
Optical fluorescence 
microscopy images of 
mutated DENV C 
protein and the kinetics 
of nuclear entry of 
mutant WNV/DENV C 
proteins. (A) The 
kinetics of nuclear entry 
of mutated WNV 
recombinant C protein 
noted in 50 transfected 
cells. (B) Recombinant 
GFP-tagged DENV C 
protein with different 
mutations 
(pDCGP4243AA, 
pDCM1, pDCM2, and 
pDCM1M2) were 
transfected into Vero 
cells and processed for 
IFA to examine the 
nuclear localization of 
these mutants. 
pDCGP4243AA (i-iii) 
and pDCM1 (iv-vi) 
mutants still show strong 
fluorescence in the 29 
nucleoli with perinuclear 
staining. However, 




staining after 24h post-
transfection. (C) 50 
transfected cells were 
counted and categorized 
into different cellular 
localization pattern. 
Most of the mutant C 
proteins are localized in 
the nuclei except when 
the second basic residue 
cluster (M2) is mutated 
to alanine. (N - Nucleus; 
N,PN,C - Nucleus, peri-
nucleus, cytoplasm).  
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Dengue virus (DENV) capsid (C) protein is one of the three
structural proteins that form a mature virus. The main chal-
lenge impeding the study of this protein is to generate pure
non-truncated, full-length C proteins for structural and
functional studies. This is mainly due to its small molecular
weight, highly positively charged, stability and solubility
properties. Here, we report a strategy to construct, express,
biotinylate and purify non-truncated, full-length DENV C
protein. A 63 His tag and a biotin acceptor peptide (BAP)
were cloned at the N-terminus of C protein using overlap-
ping extension-polymerase chain reaction method for site-
specific biotinylation. The final construct was inserted into
pET28a plasmid and BL-21 (CodonPlus) expression compe-
tent cell strain was selected as there are 12% rare codons in
the C protein sequence. Strikingly, we found that our re-
combinant proteins with BAP were biotinylated endogen-
ously with high efficiency in Escherichia coli BL-21 strains.
To purify this His-tagged C protein, nickel-nitriloacetic acid
affinity chromatography was first carried out under de-
naturing condition. After stepwise dialysis and concurrent
refolding, ion exchange-fast protein liquid chromatography
was performed to further separate the residual contami-
nants. To obtain C protein with high purity, a final round of
purification with size exclusion chromatography was carried
out and a single peak corresponding to C protein was
attained. With this optimized sequential purification proto-
col, we successfully generated pure biotinylated full-length
DENV C protein. The functionality of this purified non-
truncated DENV C protein was examined and it was suit-
able for structural and molecular studies.
Keywords: biotinylation/capsid protein/dengue virus/
expression and purification
Introduction
Dengue virus (DENV) belongs to the Flavivirus genus
within the Flaviviridae family. Other members of the
Flavivirus genus include Yellow Fever virus, West Nile virus
(WNV), Kunjin virus, Japanese Encephalitis virus and
Tick-Borne Encephalitis virus, just to name a few. DENV in-
fection encompasses a wide spectrum of severity ranging
from mild asymptomatic dengue fever to critical and fatal
dengue hemorrhagic fever/dengue shock syndrome. DENV
caused about 15 000 deaths annually and it is estimated that
more than 2.5 billion people are at risk of DENV infection in
more than 100 countries (Gubler, 2002). However, anti-viral
drug and vaccine are yet to be available in the market.
The whole mature virion particle is about 50 nm in diam-
eter. Each virion contains a single positive-stranded RNA
that is encapsulated by multiple copies of capsid (C) protein
to form a spherical cage-like structure called nucleocapsid or
core. The core is approximately 30 nm in diameter which
can be seen as a dense particle under electron microscope
(Hase et al., 1987). Nucleocapsid is surrounded by a
10-nm-thick lipid bilayer derived from host cell membrane
anchored with 180 membrane (M) protein and 180 envelope
(E) protein (Zhang et al., 2003).
DENV C protein is the first structural protein found in the
open reading frame of its genome. Although the sequence
homology of C proteins among other flaviviruses is poorly
conserved (Fig. 1A and B), they are still structurally and func-
tionally similar. The C-terminal hydrophobic signal sequence
of full-length DENV C protein is cleaved by its NS2B-NS3
proteins to generate mature DENV C protein (Markoff, 1989;
Amberg and Rice, 1999). DENV C protein has a molecular
weight of about 12–15 kDa and is a highly basic protein that
contains about 25% of lysine and arginine residues. The high
basic-residue content confers its RNA-binding property to
neutralize the negatively charged viral RNA. This explains the
main function of C protein which is to encapsidate its viral
RNA and form nucleocapsid.
Other than its structural function, DENV C protein is
also known to carry non-structural functions. It is currently
believed that multifunctional C protein is essential in the
viral replication, assembly, RNA encapsidation, as well as
pathogenesis. The role of C protein in inducing apoptosis
by activating caspase-3 and caspase-9 leading to mitochon-
drial dysfunction was reported (Yang et al., 2008).
Recently, our laboratory also discovered that WNV and
DENV C protein interact with human Sec3 exocyst protein
(hSec3p) to antagonize the antiviral effect caused by
hSec3p (Bhuvanakantham et al., 2010). Moreover, DENV
C protein was also known to localize in the nucleus of
infected cells during replication (Tadano et al., 1989). We
found that C protein was transported into the nucleus by
importain-a/b complex and the loss of the nuclear trans-
location ability affected virus replication (Bhuvanakantham
et al., 2009). However, the exact role of C protein in the
nucleus still remains unclear and further investigation is
warrant.†Contributed equally in this project.
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There is also a lack of information about the interaction of
DENV C protein with either prM and E proteins or even its
RNA genome. The binding of NS2B-NS3 protein with C
protein and how it cleaves C-prM polyprotein is also unclear.
This is mainly due to the difficulty of expressing and purify-
ing full-length C protein for functional and structural studies.
The NMR structure of DENV C protein studied thus far only
encompasses 80 residues from the 21st to 100th amino acid
(Ma et al., 2004). The N-terminus is removed from the struc-
tural study because it is conformationally labile and unstable
(Jones et al., 2003). The hydrophobic C-terminus of DENV
C protein is also excluded due to its solubility problem.
Nevertheless, the N-terminus of C protein is found to be
antigenic as predicted by bioinformatics analysis (Fig. 1C).
This is also supported by Puttikhunt et al. (2009) that the
N-terminus of DENV C protein was immunogenic in mice.
Recently, Samsa et al. (2012) found that the first 18 amino
acid residues from the N-terminus were essential for virus
particle assembly. Taken together, these suggest that the
N-terminus of DENV C protein have important roles in the
pathogenesis and viral replication.
In this project, we aimed to express and purify full-length
DENV C protein for structural and functional studies. Since
biotinylation has been widely used to date for purification,
detection, diagnostic, protein–protein interaction studies,
imaging studies and other molecular studies (Chapman-
Smith and Cronan, 1999a,b; de Boer et al., 2003; Howarth
and Ting, 2008; Postel et al., 2011; Qi and Katagiri, 2011),
a biotinylation site was engineered into C protein to ease
further downstream experiments. Using our expression and
purification strategy, we have successfully obtained function-
al biotinylated full-length DENV C protein.
Materials and methods
Construction of pET28aDENVBioCap plasmid
DENV C gene was amplified from cDNA synthesized from
DENV-2 (NGC strain; accession number: M29095; nucleotide
100–438) RNA using SuperScriptTM III First-Strand Synthesis




C_R (50-CCGCTCGAGTTACGCCATCACTGT-30) were used
to join biotin acceptor peptide (BAP) gene (Cull and Schatz,
2000) containing an enterokinase cleavage site with DENV
C gene via overlap extension polymerase chain reaction
(OE-PCR). Gel-purified PCR products containing the joined
fragments were subsequently inserted into expression vector,
pET28a (Novagen, Germany) via NheI and XhoI cut sites.
6 His tag and thrombin cleavage site are at the N-terminus
of signal peptide followed by enterokinase cleavage site and
DENV C protein. DNA sequences of the constructs were
confirmed by sequencing.
Competent cell strain screening
Transformed bacterial colonies of each strain [BL-21 (DE3)
and BL-21-CodonPlus] (Agilent Technologies, USA) were
picked and grown in 20 ml Luria-Bertani (LB) broth with
30 mg/ml kanamycin antibiotic. When the bacteria absorb-
ance OD600nm reached 0.65, protein expression was induced
with 1 mM isopropyl b-D-thiogalactoside (IPTG) overnight
at 288C. After IPTG induction, the bacteria absorbance
OD600nm was measured again and 200 ml of equal bacteria
density for both strains were used for expression level screen-
ing. Bacterial cells were pelleted down with centrifugation
at 8000 rpm for 15 min at 48C and resuspended with 100 ml
1 protein sample buffer containing b-mercaptoethanol. The
samples were boiled for 10 min with constant vortexing at
1 min interval. Insoluble substances were pelleted down with
centrifugation for 2 min at 20 000 g.
Protein expression and extraction
pET28aDENVBioCap plasmid was transformed into BL-21-
CodonPlus expression competent cells (Agilent Technologies,
USA) and grown on LB agar containing 30 mg/ml kanamycin.
Selected clones were cultured in 1 l LB broth (30 mg/ml kana-
mycin) at 308C until absorbance OD600nm of 0.65. Expression
of DENV C protein was induced with 1 mM IPTG overnight
at 288C. Bacterial cells were pelleted down with centrifugation
at 8000 rpm for 15 min at 48C. Pellet was then resuspended in
10 ml resuspension buffer (20 mM Tris, 300 mM NaCl, 0.2%
Triton-X, pH 8.0) and pelleted down again at 8000 rpm for
15 min. The pellet was washed with wash buffer (20 mM Tris,
300 mM NaCl, pH 8.0) before it was resuspended in 30 ml
lysis buffer (8 M urea, 20 mM Tris, 300 mM NaCl, 10 mM
Imidazole, pH 8.0) containing EDTA-free protease inhibitor
(Roche, Switzerland). The mixture was incubated at room
temperature for 30 min and the lysate was subsequently clari-
fied by centrifugation at 13 200 rpm for 20 min.
Nickel-nitriloacetic acid affinity chromatography
Bacterial lysate containing denatured DENV C protein was
incubated with nickel-nitrilotriacetic acid resin (Bio-Rad,
USA) for binding in a chromatography column overnight at
48C. Ten column volume of wash buffer (8 M urea, 20 mM
Tris, 300 mM NaCl, 20 mM Imidazole, pH 8.0) was used to
wash away non-specific binding proteins. DENV C protein
was eventually eluted out with elution buffer (8 M urea,
20 mM Tris, 300 mM NaCl, 500 mM Imidazole, pH 8.0) in
10 fractions. Next, all eluates were combined for refolding
and dialysis to remove 8 M urea. Briefly, all eluates were
Fig. 1. Bioinformatics analysis of flavivirus C protein. (A) Multiple sequence alignment of mosquito-borne flavivirus C protein sequences using ClustalW
method in MegAlign, DNASTAR Lasergene 7.2 software. Sequences with the highest consensus strength among the nine flavivirus C proteins are highlighted.
(B) Sequence distances analysis using the ClustalV method shows that the protein sequence similarities among the nine flavivirus C proteins are mostly lower
than 50% and the sequence divergence is more than 100%. The percent identity refers to the percentage of sequence similarity between two sequences whereas
percent divergence is obtained by comparing two sequences in relation to their relative positions in the phylogenetic tree. (C) Antigenic plot of DENV2 C
protein generated by Protean, DNASTAR Lasergene 7.2 software, using Jameson-Wolf methodology. The higher the antigenic index, the more likely the
region will be recognized by immune system. The secondary structures are also shown in parallel with the antigenic plot. Alpha helices are shown in rounded
rectangles while beta sheets are shown in regular rectangles. The high antigenicity of the first 20 amino acids is highlighted in dotted box. DENV1-4, dengue
virus serotype 1-4; JEV, Japanese Encephalitis virus; MVEV, Murray Valley encephalitis virus; UV, Usutu virus; YFV, Yellow Fever virus. Accession number
of the protein sequence is shown in the bracket.
Production of biotinylated dengue capsid protein
379







pooled into a SnakeSkin dialysis membrane tubing, 3.5 k
MWCO (Thermo Scientific, USA) and 0.5% of Tween-20
was added into the samples. The dialysis tubing was incu-
bated in 1 l of 6 M urea for 6–12 h at 48C and 250 ml of
25 mM Tris (pH 8.0) was added into the solution at every
6–12-h interval. When the final volume reached 3 L, the dia-
lysis tubing was transferred into 2 L of 20 mM Tris (pH 8.0)
for 6 h. Refolded DENV C proteins were collected from the
dialysis tubing.
Ion exchange chromatography
Ion exchange chromatography column, ResourceTM Q/S
1 ml-packed size column (GE Healthcare, UK), was con-
nected to fast protein liquid chromatography (FPLC) system.
The column was equilibrated with 10 column volumes of
20 mM Tris (pH 8.0) until the UV baseline and conductivity
were stable. Refolded DENV C protein was injected into the
column and the flow rate was set to 0.5 ml/min. After the
sample passed through the column, 10 column volumes of
20 mM Tris (pH 8.0) was used to wash away all the unbound
proteins. Ionically bound proteins were eluted out with in-
creasing concentration of sodium chloride to a final concen-
tration of 1 M (100%). All the fractions were analyzed via
enzyme linked immunosorbent assay (ELISA) to determine
the presence of biotinylated C protein.
Size exclusion chromatography
Superdex 75 10/300 GL chromatographic separation column
(GE Healthcare, UK) was connected to the FPLC system.
The column was washed with five column volumes of
MilliQTM water and then equilibrated with two column
volumes of 1 phosphate-buffered saline (PBS) (pH 7.2).
Samples were injected into the column and the flow rate was
set to 0.25 ml/min. All the eluates were analyzed via ELISA
to determine the presence of biotinylated C protein.
Enzyme-linked immunosorbent assay
To determine whether the expressed protein is biotinylated or
not, 50 ml of samples were added into the wells of MaxiSorp
plate (eBioscience, USA) in triplicate for coating overnight
at 48C. After washing with 1 0.1% PBST, 150 ml blocking
buffer (4% bovine serum albumin) was added into each well
and incubated for another hour at room temperature. Next,
150 ml streptavidin-horseradish peroxidase (HRP) enzyme
conjugates (1 : 5000 dilution) was added and incubated for
1 h. The plate was washed with 1 PBST three times to
remove unbound conjugates and then 100 ml substrate solu-
tion, tetramethyl benzidine (TMB; Promega, USA), was
added for development. To stop the reaction, 50 ml of 0.5 M
H2SO4 solution was added. The absorbance was measured at
450 nm.
Product analysis
Samples collected from flow through, wash, and eluates were
analyzed by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) and western blot. Twelve %
Tris-tricine polyacrylamide denaturing gel was used to separ-
ate proteins in the samples and subsequently stained with
Coomassie blue for detection. The presence of biotinylated
DENV C protein was confirmed by western blot via two dif-
ferent approaches. First, the identity of DENV C protein was
determined with anti-His antibody. Briefly, separated
proteins were transferred from polyacrylamide gel onto a
polyvinylidene difluoride (PVDF) membrane using iBlotw
Dry Blotting System (Life Technologies, USA). Blocking
was done with 5% skimmed milk for 1 h at room tempera-
ture. Next, the membrane was incubated with 0.1 mg/ml
mouse anti-His antibody (Qiagen, Germany) overnight at
48C. The membrane was then washed with 1 tris-buffered
saline with Tween (TBST) and incubated with 0.1 mg/ml
goat anti-mouse secondary antibody conjugated with HRP
(Thermo Scientific, USA) for 1 h at room temperature. After
washing with 1 TBST, the membrane was developed using
SuperSignalw West Pico/Dura/Femto chemiluminescent sub-
strate (Thermo Scientific, USA).
For the second approach, DENV C protein was detected
directly using streptavidin conjugated with HRP. After trans-
ferring the samples onto a PVDF membrane, it was blocked
with 4% bovine serum albumin (BSA) for 1 h at room tem-
perature. The membrane was then incubated with
HRP-conjugated streptavidin (Millipore, USA) for another
hour at room temperature. Subsequently, the membrane was
washed thoroughly with 1 PBST for 1 hr at room tempera-
ture and developed with chemiluminescent substrate.
Sample preparation for mass spectrometry
Purified protein was electrophoresed through SDS-PAGE using
12% Tris-tricine polyacrylamide denaturing gel and stained
with Coomassie blue. The background of Coomassie-stained
gel was removed with destaining solution (40% methanol,
10% glacial acetic acid, 50% distilled H2O). DENV C protein-
corresponding band was excised from the gel and kept in
eppendorf tube containing distilled water. Samples were sub-
mitted to Dr Lim Yong Pin (Department of Biochemistry,
NUS) for matrix-assisted laser desorption/ionization-time of
flight (MALDI-TOF) mass spectrometry analysis.
Biotinylated protein-binding assay
The binding affinity of purified biotinylated DENV C protein
was tested using streptavidin magnetic beads (GE
Healthcare, UK) according to the manufacturer’s protocol.
Briefly, samples were mixed with the streptavidin magnetic
beads and incubated for 1 h with gentle mixing at 48C.
Unbound proteins were removed with wash buffer while
biotinylated proteins were eluted out with elution buffer
provided in the kit. Eluted proteins were analyzed by ELISA
to confirm the biotinylation.
DENV C protein functional assay
Pure Sec3 protein (Abnova, Taiwan; known interacting
partner of flavivirus C protein; Bhuvanakantham et al., 2010)
was added into the wells of MaxiSorp plate (eBioscience,
USA) for coating overnight at 48C. After washing with 1
PBST, blocking buffer (4% bovine serum albumin) was
added into each well and incubated for another hour. Purified
DENV C protein was added into the well for binding at 378C
for 1 h. Next, streptavidin-HRP enzyme conjugates was
added and incubated for another hour at 378C. After washing
three times with 1 PBS, 100 ml TMB substrate (Promega,
USA) was added for development and 50 ml 0.5 M H2SO4
solution was added to stop the reaction when necessary. The
absorbance was measured at 450 nm.
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Engineering of biotin acceptor peptide into full-length
DENV capsid (C) plasmid, pET28aDENVBioCap
To avoid non-specific biotinylation, we engineered a BAP at
the N-terminus of DENV C protein. Biotin is a very small
molecule (molecular weight ¼ 244.31) so it is unlikely to
affect the structure and function of the protein. To ensure
that the BAP will not result in any steric hindrance to the
protein conformation, a secondary structure prediction was
performed. As shown in Fig. 2A, the predicted secondary
structures of DENV C protein with and without BAP do not
differ from each other.
To clone the full-length DENV C protein, nucleotides 100
to 438 from DENV-2 genome (GeneBank accession number:
M29095) were amplified, whereas the BAP sequence (Cull
and Schatz, 2000) was synthesized together with an enteroki-
nase cleavage site at the C-terminus. Both fragments were
joined together through the OE-PCR method as illustrated in
Fig. 2B. Schematic representations of the final recombinant
gene and protein are shown in Fig. 2C and D, respectively.
The final ligated product was then cloned into bacterial ex-
pression vector, pET28 which consisted of a 6 His tag and
a thrombin cleavage site in the upstream of the multiple
cloning site. Hence, the recombinant full-length DENV C
construct (pET28aDENVBioCap) contained two tags (6
Fig. 2. Cloning strategies. (A) Secondary structure prediction of biotinylated C (BNC) and unbiotinylated C (UBNC) proteins shows that BAP insertion does
not affect the overall secondary structure formation when it is added to the N-terminus of C protein. Alpha helices are represented in gray, rounded rectangles
while beta sheets in black, regular rectangles. (B) Schematic diagram showing the OE-PCR technique. The 30 overhang of BAP sequence is complementary to
the 50 overhang of DENV C protein sequence. As such, primers B and C are complementary to each other. Both fragments are joined together with primers A
and D. (C) Plasmid vector map of pET28aDENVBioCap construct. (D) Final construct of recombinant protein generated. 6 His tag is at the N-terminal
followed by thrombin cleavage site and BAP. Enterokinase cleavage site is included at the downstream of BAP. 6 His tag is used for affinity purification
while BAP is the signal peptide for biotinylation.
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His tag and BAP) at the N-terminus and two different
enzyme cleavage sites (thrombin cleavage site and enteroki-
nase cleavage site) for tag removal when necessary.
Five successfully transformed bacterial colonies were
picked for colony PCR screening and DNA sequencing was
performed to verify the constructs. The final DNA and
protein sequence were shown in Supplementary Table S1. To
further support our site-specific biotinylation strategy, WNV
domain III (DIII) protein which has similar molecular weight
as the C protein, was also engineered with a BAP concur-
rently via the same procedure. DENV C and WNV DIII pro-
teins without BAP were also constructed for comparison
purposes.
Optimal expression competent bacterial strain for DENV
C protein
To express DENV C protein, an optimal expression compe-
tent bacterial strain is requisite. We detected 14 rare codons
in the full-length DENV C protein DNA sequence
(Supplementary Table S2). This raised a concern for protein
expression because 12% of the total 115 codons are rare
codons. To screen for the optimal bacterial expression
competent cell, pET28aDENVBioCap plasmid was trans-
formed into BL-21 (DE3) and BL-21-CodonPlus. BL-21
(DE3) is a common bacterial strain for high expression of re-
combinant proteins while BL-21-CodonPlus is a bacterial
strain specifically engineered for expression of proteins with
rare codons.
The expression of DENV C protein was indeed much
higher in BL-21-CodonPlus strain. As indicated in Fig. 3,
an obvious band corresponding to the recombinant full-
length DENV C protein was detected in the lysate of
IPTG-induced CodonPlus strain but not in the BL-21
(DE3) strain (Fig. 3Ai). Western blotting with anti-His
antibody revealed that DENV C protein was expressed in
both BL-21 (DE3) and BL-21-CodonPlus strains because
C protein-corresponding bands were detected in the lysates
of both strains (Fig. 3Aii). Nonetheless, the observed
bands were much thicker in BL-21-CodonPlus strain as
compared with BL-21 (DE3) strain. This demonstrated that
DENV C protein expression level was much higher in
BL-21-CodonPlus strain under the same condition. As for
WNV DIII protein, the expression was good enough in
normal BL-21 (DE3) strain (data not shown).
Fig. 3. Expression screening of bacterial clones with recombinant DENV C protein and detection of biotinylation. (A) Two expression competent cells are
tested, namely BL-21 (DE3) and BL-21-CodonPlus. The presence of C protein band in the IPTG-induced bacterial cell lysate, as indicated by arrow, is
detected via SDS-PAGE stained with Coomassie blue (i) and western blot (ii) using anti-His antibody. The expression of C protein is much higher in
CodonPlus competent cells as the band intensity is much higher than normal BL-21 (DE) competent cells. (B) (i) The presence of His tag was detected using
monoclonal mouse anti-His antibody and goat anti-mouse HRP-conjugated secondary antibody. Bands can be observed in both DENV C proteins with and
without BAP. The molecular weight of C protein with BAP is higher than C protein without BAP. (ii) When western blot is performed using streptavidin-HRP
secondary antibody, band is only observed in the DENV C and WNV DIII proteins lanes with BAP. Likewise, band is only observed in the biotinylated (BN)
MBP and not unbiotinylated (UBN) MBP.
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Discovery of endogenous biotinylation in BL-21 strains
As comparing DENV C protein with and without BAP via
western blot using anti-His antibody, bands were observed in
all the lanes for DENV C and WNV DIII proteins (Fig. 3Bi).
As shown in Fig. 3Bi, recombinant proteins with BAP have
higher molecular weight than those without BAP. This also
indicated that all the DENV C and WNV DIII proteins with
and without BAP were expressing well in the BL-21 strains.
Besides detecting the proteins of interest using anti-His
antibody, streptavidin-HRP was also employed to detect the
presence of biotinylated protein. Surprisingly, we found that
our proteins of interest were biotinylated even before any
in vitro biotinylation process. As shown in Fig. 3Bii, thick
bands can be observed in the BAP-containing DENV C and
WNV DIII proteins when streptavidin-HRP antibody was
used. Similar bands were not detected in DENV C and WNV
DIII proteins without BAP. Commercially available biotiny-
lated and unbiotinylated maltose-binding protein (MBP;
GeneCopoeia, USA) were used as positive and negative con-
trols for biotinylation, respectively. Similarly, band was only
seen in the biotinylated MBP lane. This result suggested that
DENV C and WNV DIII proteins with BAP were biotiny-
lated endogenously in BL-21 strains.
We postulated that bacterial BL-21 strains may contain
biotin holoenzyme synthetase BirA gene that encodes for
biotin ligase protein in their genome. To investigate the
reason behind endogenous biotinylation, BirA gene sequence
was analyzed using BLAST software and the result showed
that BL-21 strains indeed possess BirA gene in their genome
(Supplementary Table S3). It was also reported that biotin
molecules were present in the LB broth (Tolaymat and
Mock, 1989). As a result, proteins engineered with BAP
could be directly expressed and biotinylated in BL-21 strains
without the extra in vitro enzymatic biotinylation step.
Optimized sequential purification protocol for full-length
C proteins
After confirming the expression and biotinylation of the
protein of interest, large-scale production of bacterial culture
was carried out. The initial attempt was to perform all
the extraction and purification steps in native form so that the
protein structure could be preserved without the need of
refolding. However, the extraction of DENV C protein from
the bacterial cells was not effective in native condition.
There were still considerably large amounts of DENV C
protein trapped in the pellet (data not shown). Therefore,
8 M urea was used to lyze the bacterial cells and affinity
His-tag chromatography purification was first performed
under denaturing condition.
The bacterial cell lysate with biotinylated DENV C protein
was incubated with nickel-nitrilotriacetic acid resin to purify
His-tagged proteins. Recombinant full-length DENV C protein
contained 6 His tag at the N-terminus bound to the resin
and unbound proteins were removed during washing with
20 mM imidazole. To ensure that most of the unbound pro-
teins were washed away, 10 column volumes of wash buffer
were used. The bound proteins were eluted out with 500-mM
imidazole. However, many non-specific bands were still
observed in the eluates of DENV C protein (Fig. 4A), espe-
cially in the second eluate fraction. Nonetheless, western blot
result confirmed that most of the DENV C proteins were
eluted out starting from fraction E2 until E10 (Fig. 4B and C).
Partially purified DENV C proteins from eluates E2 to
E10 were pooled together for step-wise dialysis and concur-
rent refolding. Owing to its hydrophobic C-terminus, DENV
C protein easily aggregated, resulting in major loss in
amounts during refolding and dialysis. To prevent protein
aggregation and to enhance efficient refolding, 0.05% of
Tween-20 was added to the samples (Krupakar et al., 2012).
With this addition, protein aggregation was reduced signifi-
cantly. No obvious precipitation was observed and the
solution was clear after dialysis and refolding. This partially
purified DENV C protein was then subjected to a second
round of purification using ion exchange chromatography-
fast protein liquid chromatography system (IEX-FPLC).
Theoretically, DENV C protein is a positively charged
protein so cation-exchanger column, Resource MonoS, should
be used. However, we found that biotinylated DENV C
protein was not eluted out at a specific concentration of
sodium chloride (NaCl). Miniature amount of the protein was
eluted out slowly in an increasing gradient manner and it
reached plateau at 70 mM of NaCl (Supplementary Fig. S1).
This indicated that Resource MonoS column is not suitable
for separating DENV C protein from the contaminants.
Counter intuitively, we were able to obtain better separ-
ation when we used anion-exchanger, Resource MonoQ,
column (Fig. 5Ai). This could be due to the presence of
BAP in the DENV C protein conferring its ability to bind to
positively charged beads. As shown in Fig. 5A, biotinylated
full-length DENV C protein bound perfectly to Resource
MonoQ column as no biotinylated proteins were detected
by ELISA in the flow although there was high UV absorb-
ance detected in those fractions. During elution, one high
peak was detected when the NaCl concentration reached
approximately 350 mM (35%) while there was another small
peak detected at the elution concentration of 100 mM of
NaCl (10%). These peaks were confirmed to be biotinylated
proteins as detected by ELISA using streptavidin-HRP
antibody. This result showed that the second purification step
managed to further separate most of the contaminants from
DENV C protein.
To avoid any other contaminants that may have similar
charge as biotinylated DENV C protein, eluates correspond-
ing to the high UV absorbance peak after IEX-FPLC were
injected into size exclusion chromatography (SEC), Superdex
75 10/300 GL column. It was previously reported that SEC
could not be used to estimate the molecular weight of DENV
C protein because there were many unspecific interaction
between the gel matrix and C protein (Jones et al., 2003).
Nevertheless, it is still a good method to further isolate the
proteins of interest from other possible residual contaminants
based on the molecular weight differences. After SEC,
three peaks were observed in the chromatogram (Fig. 5Bi).
The first peak was identified to be the biotinylated DENV C
protein as the fractions detected with high absorbance in
ELISA using streptavidin-HRP antibody coincided with
the first peak in the elution profile (Fig. 5Bii). The identity
of this highly purified protein was further validated with
matrix-assisted laser desorption/ionization-time of flight
(MALDI-TOF) mass spectrometry analysis (Supplementary
Table S4).
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With this optimized sequential purification protocol, we
were able to obtain 0.8–1.0 mg of highly purified biotiny-
lated non-truncated, full-length DENV C protein from 1 l of
IPTG-induced bacterial culture repeatedly.
High in vivo biotinylation efficiency in BL-21 strains
To compare the biotinylation efficiency of our strategy, the
same amount of purified biotinylated DENV C, WNV DIII
and MBP proteins were coated on the ELISA plate and
streptavidin-HRP antibody was used for detection. Assuming
that the coating efficiencies are the same among all three
proteins, the absorbance detected via ELISA should be pro-
portional to the number of coated proteins and inversely pro-
portional to the power of two-third of its molecular size.
Hence, the larger the protein, the lesser the proteins can be
coated on the plate:
Absorbance/ Protein Concentration
Protein Size2=3
The molecular weight of MBP is approximately 42.5 kDa
while DENV C and WNV DIII proteins have an approximate
mass of 15.4 and 14 kDa, respectively. Assuming that one
protein only carries one biotin which will bind to one
streptavidin-HRP only, the absorbance of MBP should be
roughly two times lower than our purified proteins for
the same protein concentration. As shown in Fig. 6Ai, the
absorbance of purified biotinylated DENV C and WNV DIII
proteins indeed showed approximately two times higher the
absorbance as compared with commercial biotinylated MBP.
The same phenomenon was also observed when the bio-
tinylated proteins were streptavidin captured by streptavidin-
magnetic beads and detected via direct ELISA (Fig. 6Aii).
The absorbance of eluted biotinylated DENV C protein and
WNV DIII protein were two times higher than that of eluted
biotinylated MBP. No significant absorbance was detected
for unbiotinylated C and DIII proteins.
This result further supported that engineering an additional
BAP on a protein could result in site-specific endogenous
biotinylation with high efficiency in Escherichia coli BL-21
strains, without the need of an extra in vitro enzymatic
or chemical conjugation step. Our strategy could produce
biotinylated proteins that were as good quality as the manu-
factured biotinylated MBP.
Fig. 4. Purification of biotinylated DENV C protein. IPTG-induced bacteria are lyzed in lysis buffer containing 8-M urea and the lysate (L) is incubated with
nickel-charged resin overnight. Next, the resin is packed in a column and the flow through (FT) is kept for SDS-PAGE. 20 mM imidazole is used to wash away
the unbound proteins (W) and 500 mM imidazole is used to elute the C protein in ten fractions (E1-10). SDS-PAGE is carried out and stained with Coomassie
blue (A). Fraction E2 shows the most intense band but there are also many contaminants in the eluates. Western blot is also performed for the samples using
anti-His antibody (B) and streptavidin-HRP secondary antibody (C). C protein-corresponding bands can be observed from fraction E2 until E10. The band
intensity is the highest in fraction E2 and decreases until fraction E10. A faint C protein dimer-corresponding band can also be observed in fraction E2 as
detected by anti-His antibody.
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Fig. 5. Sequential purification of DENV C protein using the FPLC system after first round of affinity his-tag purification. Dialyzed and refolded DENV C
protein from eluates E2 to E10 are injected into Resource MonoQ ion exchange chromatography column. Bound proteins are eluted out using increasing
concentration of sodium chloride until final NaCl concentration of 1 M. One high peak can be observed when the sodium chloride concentration reaches
350 mM [A(i)]. The identity of the peak is confirmed to be C protein as detected by ELISA using streptavidin-HRP antibody [A(ii)]. The eluates from the peak
are combined and inserted into size exclusion chromatography for further purification. One high peak is observed in the elution profile [B(i)] and this peak is
identified to be C protein as confirmed by ELISA using streptavidin-HRP antibody [B(ii)].
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Purified non-truncated, full-length DENV C protein
is functional
It is essential to ensure that the purified proteins are functional
before they are used for any further studies. According to our
recent findings, WNV and DENV C proteins were found to
interact with human Sec3 exocyst protein (Bhuvanakantham
et al., 2010). Thus, we examined the functionality of the puri-
fied DENV C protein by revisiting the interaction between
biotinylated DENV C protein and Sec3 protein using ELISA.
Pure Sec3 protein was coated overnight on ELISA plate and
purified biotinylated DENV C protein was used as the probe.
Bound DENV C proteins were detected with streptavidin-HRP
antibody. As shown in Fig. 6B, statistically significant absorb-
ance was detected in Sec3 protein-coated wells but not in
BSA-coated wells. Thus, our purified DENV C protein did
interact with Sec3 protein. This corroborated that our purified
biotinylated full-length DENV C protein is functional and can
be used for structural and molecular studies.
Discussion
Biotinylation is a popular process in protein engineering to
ease detection and purification (Chapman-Smith and Cronan,
1999a,b; Cull and Schatz, 2000). Biotinylated hemagglutinin,
for instance, was generated to develop a subtype-specific
serological assay to diagnose influenza A virus in patients’
sera (Postel et al., 2011). One of the advantages of using bio-
tinylated protein is that the detection sensitivity of the bioti-
nylated protein is greatly enhanced by the high affinity and
specificity between biotin and streptavidin (Bayer and
Wilchek, 1990a,b). This advantage is exploited for techni-
ques such as co-immunoprecipitation or library screening of
interaction proteome (Markham et al. 2007; He et al., 2009;
Moreland et al., 2010). Not only that, site-specific
biotinylation was also developed as a means for molecular
labeling and imaging (Howarth and Ting, 2008; Sueda et al.,
2011). As such, biotinylated DENV C protein is useful for
various cellular, molecular, and imaging experiments
because of the high detection limit while the function of the
protein is still well preserved.
There are various approaches to biotinylate a protein, either
chemically or enzymatically (Cull and Schatz, 2000). Various
commercial kits are available in the market for chemical bioti-
nylation by conjugating biotin molecules on proteins or anti-
bodies that contain primary amines. However, chemical
biotinylation may lead to non-specific and non-homogenous
incorporation of biotin which might result in possible loss of
activity of the protein (Bayer and Wilchek, 1990a,b).
Moreover, another step of removing the excess biotin reagent
will increase the chance of losing more proteins. To produce
biotinylated proteins, we opted for site-specific biotinylation
by engineering a biotin acceptor signal peptide (BAP) in the
upstream of our proteins. To attach a biotin molecule onto
BAP either in vivo or in vitro, bacterial biotin ligase BirA is
required (Chapman-Smith and Cronan, 1999a,b; Cull and
Schatz, 2000; Tan et al., 2004; Yang et al., 2004). Instead of
performing this biotinylation step in vitro, we found that bioti-
nylation of the BAP-containing proteins occurred endogenous-
ly in Escherichia coli BL-21 strains with high efficiency. As
such, other proteins that require site-specific biotinylation may
be produced easily by just simple OE-PCR and expression in
Escherichia coli BL-21 strains without the need of an
additional in vitro biotinylation step.
The purification of non-truncated, full-length DENV C
protein was indeed challenging. Unlike DIII protein (Tan
et al., 2010), one single purification step was simply not ad-
equate to produce pure DENV C protein. The presence of
rare codons in the C protein sequence necessitates unique ex-
pression competent strain for its optimal protein expression.
Fig. 6. Biotinylation efficiency and functional analysis of purified full-length DENV C protein. (A) (i) ELISA screening of 30 ng biotinylated (BN) and
unbiotinylated (UBN) proteins. All three BN MBP, DENV C and WNV DIII proteins show high absorbance at 450 nm as compared with the protein without
BAP. (ii) Biotin-streptavidin binding assay also shows that only BN proteins bind to streptavidin-magnetic beads and are detected in the eluates. (B) The
functionality of DENV C protein is examined via a binding assay with Sec3 protein which is known to interact with C protein in host cells. Pure Sec3 protein
is coated onto ELISA plate and purified full-length DENV C protein is added into the well for binding. Bovine serum albumin (BSA) is used as negative
control. Significant absorbance is detected using streptavidin-horseradish peroxidase antibody in the wells with Sec3 protein coated (Sec3-DENVC) but not
with BSA (BSA-DENVC). *P, 0.05.
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Due to the hydrophobic C-terminus, aggregation easily oc-
curred and most of the expressed proteins were trapped in
the inclusion bodies. As such, we had to use 8 M urea to de-
nature the proteins and perform affinity chromatography
under denaturing condition. We also managed to solve the
aggregation problem during dialysis and refolding by using
non-ionic detergent. This is indeed critical in making this
protein purification a success. To obtain highly purified
DENV C protein, two more purification steps were included
in our protocol, namely IEX and SEC. This sequential purifi-
cation strategy can produce approximately 1 mg of purified
full-length DENV C protein from 1 l of bacterial culture.
This optimized sequential purification strategy may be useful
for other proteins that have the similar properties.
This purified non-truncated, full-length DENV C protein is
useful for various molecular and structural studies. For in-
stance, it can be used to study the interaction of NS2B–NS3
serine proteinase and C protein. In order to produce mature
C protein for encapsidation and assembly, full-length C
protein has to be cleaved by NS2B–NS3 protein complex.
Thus, it is crucial to identify the binding sites of NS2B–NS3
complex to full-length C protein, which is still unknown. It
will in turn lead to the development of novel anti-viral drugs
targeting the assembly of virus particles. Besides, it is also
interesting to examine whether the cleaved C-terminus plays
any unidentified role in the pathogenesis. The crystal struc-
ture of DENV NS2B–NS3 protein complex has been
resolved (Erbel et al., 2006). However, the crystal structure
of full-length DENV C protein is still not yet available, al-
though the NMR structure of partial DENV C protein was
obtained (Ma et al., 2004). We are now taking up the chal-
lenge to resolve the 3D structure of full-length DENV C
protein using our purified protein.
Ma et al. (2004) proposed a model for the interaction
between C protein and its viral genome using the partial
DENV C protein. However, to date, this model is not vali-
dated and the exact mechanism of encapsidation is still
unclear. Investigation of how DENV C protein interacts with
its RNA and oligomerizes into nucleocapsid during matur-
ation is vital for better understanding of the pathogenesis.
Recent publications also demonstrated that N-terminus of
DENV C protein was antigenic in mice study and the first 18
amino acid residues were involved in the virus assembly
during maturation (Puttikhunt et al., 2009; Samsa et al.,
2012). As a result, our purified non-truncated DENV C
protein is absolutely desirable for delineating the whole
process of encapsidation and virus assembly.
Another difficulty of studying DENV C protein is that
anti-C antibody is yet to be available commercially. Most of
the laboratories need to raise this antibody on their own
before any further downstream experiments (Wang et al.,
2002; Puttikhunt et al., 2009). Hence, pure full-length DENV
C protein can be obtained simply by enterokinase cleavage
and subsequently used to raise antibody in mice or rabbits
for laboratory research usage and diagnostic tool. Both full-
length DENV C protein and anti-DENV C antibody will be
of commercial values.
In conclusion, we have developed an optimized protocol
to engineer, express and purify the first biotinylated, full-
length DENV C protein. This purified protein is useful for
various molecular studies to further understand the under-
lying mechanism of C protein in pathogenesis. Only by
stitching all these missing pieces of the puzzle together,
novel antiviral strategies can be rationally designed.
Supplementary data
Supplementary data are available at PEDS online.
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Suppl. Fig. 1. Cation exchange purification of DENV C protein using Resource MonoS 
column. (A) Dialysed and refolded DENV C proteins after affinity chromatography are 
injected into Resource MonoS ion exchange chromatography column. Bound proteins are 
eluted out using increasing concentration of sodium chloride until final concentration of 1 M. 
However, there is no obvious peak during the elution steps except a small increase of UV 
absorbance when the concentration of NaCl reaches 400 mM (40 %). (B) The presence of C 
protein is detected by ELISA using streptavidin-HRP antibody. An increasing amount of 
biotinylated DENV C protein is detected during elution and it reaches plateau at 
approximately 70 % of NaCl (700 mM NaCl). 
  
 
Suppl. Table 1: DNA and protein sequences of full-length DENV C protein. 







Suppl. Table 2. Rare codon analysis of full-length DENV C protein. Rare codons are in 
BOLD and underlined.  
Rare Codon Number 
Arg (AGG, AGA, CGA) 12 
Leu (CTA) 1 
Ile (ATA) 1 
Pro (CCC) 0 
Full-length DENV C DNA sequence: 
atg aat aac caa cga aaa aag gcg aga aat acg cct ttc aat atg 
ctg aaa cgc gag aga aac cgc gtg tcg act gta caa cag ctg aca 
aag aga ttc tca ctt gga atg ctg cag gga cga gga cca tta aaa 
ctg ttc atg gcc ctg gtg gcg ttc ctt cgt ttc cta aca atc cca 
cca aca gca ggg ata ctg aag aga tgg gga aca att aaa aaa tca 
aaa gcc att aat gtt ttg aga ggg ttc agg aaa gag att gga agg 
atg ctg aac atc ttg aac agg aga cgc aga act gca ggc atg atc 




M  G  S  S H  H H H H H S  S G  L  V  P  R  G  S  H 
                                     
                             
                                     
                                       
                                     
                                       
                               
  
His Tag
                         
atggctagctccggcctgaacgacatcttcgaggctcagaaaatcgaatggcacgaaggc
M  A  S  S G  L  N  D  I  F  E  A  Q  K  I  E  W  H  E  G 
ggcgatgacgacgacaagagcatgaataaccaacgaaaaaaggcgagaaatacgcctttc
G  D  D D D K  S  M  N  N Q  R  K  K A  R  N  T  P  F 
                                     
                                       
                                     
                                       
                               
  
Thrombin Cleavage Site
                         
                                     
ggcgatgacgacgacaagagcatgaataaccaacgaaaaaaggcgagaaatacgcctttc
G  D  D D D K  S  M  N  N Q  R  K  K A  R  N  T  P  F 
aatatgctgaaacgcgagagaaaccgcgtgtcgactgtacaacagctgacaaagagattc
N  M  L  K  R  E  R  N  R  V  S  T  V  Q  Q L  T  K  R  F 
tcacttggaatgctgcagggacgaggaccattaaaactgttcatggccctggtggcgttc
S  L  G  M  L  Q  G  R  G  P  L  K  L  F  M  A  L  V  A  F 
cttcgtttcctaacaatcccaccaacagcagggatactgaagagatggggaacaattaaa
L  R  F  L  T  I  P  P T  A  G  I  L  K  R  W  G  T  I  K 
aaatcaaaagccattaatgttttgagagggttcaggaaagagattggaaggatgctgaac
K  S  K  A  I  N  V  L  R  G  F  R  K  E  I  G  R  M  L  N 
atcttgaacaggagacgcagaactgcaggcatgatcattatgctgattccaacagtgatg






Suppl. Table 3: Competent cells identified through BLAST analysis of BirA gene. 
Competent Cells Accession Number Features 
BL-21 (DE3) AM946981 Bifunctional biotin-[acetyl-CoA-carboxylase] 
ligase and transcriptional repressor 
BL-21-CodonPlus CP001665 Bifunctional BirA, biotin operon                 
repressor/ biotin--acetyl-CoA-carboxylase ligase 
 
 
Suppl. Table 4. MALDI-TOF mass spectrometry analysis of purified DENV C protein. 
Identity Fragment Peptide Sequence Calculated (Da) Measure (Da) Error (Da) 
Dengue virus 2 
core protein 
81-89 FSLGMLQGR 1007.52 1007.49 -0.03 
104-116 FLTIPPTAGILKR 1425.87 1425.8 -0.07 
 
 
 


